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Introduction
Most of the arterial changes are at
multiple levels in the infrainguinal region,
which is the main challenge for vascular
surgeons treating CLI. The treatment of CLI
has undergone profound evolution over the
past 20 years. The expectations of surgeons
and patients have been elevated as
infrainguinal bypass procedures and the
resultant limb salvage have become
increasingly successful. In particular, this
improvement has been achieved through an
appreciation of the superiority of the
autogenous vein as a bypass conduit. (Hall,
KV 1964; Shah, DM et al. 1995; TASC
2000) Despite advances in the diagnosis of
CLI and technical refinements in infra-
inguinal bypass surgery, the high failure rate
of the reconstructions is still a matter of
concern. Also after the immediate post-
operative period the survival rates achieved
with these grafts show steady attrition as a
result of late graft thrombosis. The published
long-term results show a large variation in
graft patency from 80 percent at 5 years to 30
percent at 12 months. (Hobson, RWd et al.
1980; Leather, RP et al. 1988) The durability
of good initial success rates is most commonly
threatened by the development of intrinsic
vein graft stenosis, accounting for
approximately 60% of all graft thromboses.
(Szilagyi, DE et al. 1973; Mills, JL 1993) The
greatest potential for further improvement
of infrainguinal revascularisation lies is in
the prevention and management of these
lesions. It has been established, that the
stenoses developing within the vein conduit
or at the anastomotic areas are due to
Following the developments in modern
surgery over the last few decades, vascular
surgery has evolved as a discipline in which
huge leaps have been made not only in the
adoption of new treatment techniques, but
also in the areas of biomedical basis for
vascular diseases, clinical physiology, internal
medicine, vascular imaging and interventional
radiology.  The  vascular surgeon is no longer
just a master of surgical techniques. His field
of knowledge must cover the essentials of all
the aforementioned areas if he is to be of
maximum benefit to   the patient.
Chronic leg ischaemia is a gradually
developing process caused by a constantly
insufficient blood flow. The leading symptom
of milder peripheral arterial occlusive disease
(PAOD) is intermittent claudication, where
the insufficient circulation manifests itself
only during exercise. Critical leg ischaemia
(CLI) is the result of a more serious
impairment in blood flow in which the
vitality of the leg is endangered. The
development of CLI is a harbinger of a
particularly poor prognosis in terms of
decreased life expectancy and a high risk of
major lower limb amputation. (Beard, JD
1992; Lepäntalo, M and Mätzke, S 1996;
Bertele, V et al. 1999) The clinical, epidemio-
logical and public health importance of
PAOD has increasingly been recognised.
(Golledge, J 1997) Furthermore, the problem
is growing over time. In Finland, it was
predicted at the beginning of the 1990’s that
a 50% increase in the incidence of major
amputations could be expected within the
next 20-30 years. (Pohjolainen, T 1991)
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progressive neointimal hyperplasia. (Davies,
MG and Hagen, PO 1995) As the patho-
physiology of neointimal hyperplasia is
unknown, no effective clinical regimen to
limit its development is available. (Davies,
MG and Hagen, PO 1995) Thus, the
treatment strategy has been surgical or
endovascular correction of already established
stenoses. (Veith, FJ et al. 1984; Nehler, MR et
al. 1994)
The aim of this study is to identify the
risk factors for the development of graft
stenosis, improve the accuracy of the
methods used for the detection of the
stenosis and analyse the potential benefits
for the outcome of infrainguinal bypass
surgery of a treatment policy, that consists of
intensive surveillance and prophylactic
correction of asymptomatic stenoses. This
might result in better patient selection and
an improved focusing in postoperative
follow-up and reinterventions.
INTRODUCTION
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1. Infrainguinal vein
bypass reconstruction
1.1. Indications for
revascularisation
It is quite rare, technically speaking,  not to
be able to perform some kind of arterial
reconstruction in the lower extremities, if
only anatomic considerations are taken into
account. A distal tibial or pedal artery
suitable for reconstruction can almost always
be found. An adequate perfusion to limb can
be achieved to allow a distal foot or toe
amputation to heal. However, the identi-
fication of patients who will fare well after
reconstruction and benefits from the
operation  may be  difficult and may demand
exquisite judgement. As a rule, arterial
reconstruction should be advised in all
patients who are mobile and lead
independent lives; in contrast, it makes little
sense in the case of nonambulatory nursing-
home patients. (Luther, M 1997) During the
decision-making process the degree of leg
ischaemia and other possible comorbidities
must be considered. Severe distal tibial and
pedal arterial disease, (Albäck, A and Lepän-
talo, M 1998) the presence of end-stage
renal disease (Whittemore, AD et al. 1993;
Peltonen, S et al. 1998) and a previously
failed arterial reconstruction (Belkin, M et
al. 1995; Robinson, KD et al. 1997) are
factors which speak against durable patency
of the graft and limb salvage. The two proven
factors which determine the technical
Review of the literature
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success of distal grafts are patency of the
pedal outflow vessels and the use of vein
grafts. (Londrey, GL et al. 1991; Lundell, A et
al. 1993; Seeger, JM et al. 1999).
1.2. Definition of outcome
parameters commonly used in
vascular surgery
The first-line measure of outcome in vascular
surgery is whether the reconstruction is
technically successful. This is reported as graft
patency rates. Primary patency usually refers to
grafts that have uninterrupted patency. This
means that no future intervention after initial
surgery neither to open an occluded graft
nor to perform dilatations or revision
procedures to prevent eventual graft failure
while the graft is  still patent, has been
necessary. Assisted primary patency is applied in
situations where patency was never lost but
maintained by prophylactic intervention.
Secondary patency refers to all grafts that remain
primarily patent, as well as those which had
occluded and whose patency regained by
means of lysis or thrombectomy with revision.
These rates should not be confused with
patency achieved across the same limb
segment by means of secondary or tertiary
reconstruction i.e redo bypasses, where most
of the original graft and at least one
anastomosis is omitted. (Rutherford, RB et
al. 1997)
Limb salvage is the ultimate goal of
reconstructive surgery for CLI. This is
successfully achieved in limbs requiring only
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minor amputations to the metatarsal level.
Even though limb salvage is quite soundly
defined, some critical remarks should be made
when assessing the results of infrainguinal
bypass surgery. Firstly, the limb salvage rates
are enhanced when a large proportion of
claudicants is included in the study material.
Secondly, not all legs with CLI will necessarily
undergo a major amputation when not
reconstructed (Lepäntalo, M and Mätzke, S
1996).
1.3. Outcome of infrainguinal
vein bypasses
The published studies on the outcome of
infrainguinal arterial reconstruction with a
vein graft show a large variation due to
several confounding factors. Usually
retrospective historical series of a single unit
are reported that represent different clinical
practices. The reports are not adjusted for
known risk factors, indication for procedure,
or bypass anatomy. The completeness of
postoperative follow-up also varies. In a
survey of published clinical follow-up papers
of 2 years time in European Journal of
Vascular and Endovascular Surgery, 51% of
the articles did not contain sufficient
information to permit assessment of the
completeness of the follow-up. (Jensen, LP
and Schroeder, TV 1999) If a significant
proportion of the patients are lost to follow-
up, reliability of the reported results can be
unacceptably poor. (Jensen, LP et al. 1996) A
fact which further precludes statistically valid
comparisons is that standardised methods of
reporting, proposed by the ISCVS/SVSD,
are not uniformly adopted. (Rutherford, RB
et al. 1997) These facts make a comprehensive
assessment of the efficacy of infrainguinal
reconstructions difficult.
Table I shows the outcome of unselected
consecutive clinical series of infrainguinal
vein bypasses according to the type of conduit
used. As indicated, the 5-year cumulative
secondary patency exceeds 70% in reported
series utilising single long saphenous vein
(LSV) as a graft material. It is also shown, that,
armed with a reliable venous conduit, more
distal outflow tracts can be revascularised in
selected patients with impunity. (Hickey, NC
et al. 1991; Davidson, JTd and Callis, JT
1993) If an adequate long saphenous vein is
not available, the options are to use prosthetic
grafts, composite grafts of prosthetic and
autogenous vein or alternative vein grafts
(arm vein, short saphenous vein (SSV) or
remnants of LSV). In reported series, the
patency of alternative vein grafts is inferior to
the best reported patency rates for LSV grafts.
However, the reported series using alternative
veins have a significant proportion of
secondary or tertiary procedures. (Harward,
TR et al. 1992; Londrey, GL et al. 1994; Tisi,
PV et al. 1996) Despite this excellent long-
term results have been published. (Edwards,
JE et al. 1990; Taylor, LM, Jr. et al. 1990) This
was affirmed recently, when results of 520
infrainguinal reconstructions using arm vein
were reported. (Faries, PL et al. 2000) The
5-year overall primary patency, secondary
patency and limb salvage rates were 55%,
58% and 72%, respectively. In addition, a
sample of 246 primary procedures was
subanalysed. They showed respective primary
and secondary patency rates at the same point
in time of 68% and 70%. These results, which
approaches those achieved with a single long
vein conduit for infrainguinal revascularisa-
tion, are clearly superior when compared to
prosthetic graft materials. (Londrey, GL et al.
1991; Sayers, RD et al. 1998) As morbidity in
harvesting vein grafts from alternative sources
appears to be low, (Faries, PL et al. 2000) an
all-autogenous policy for infrainguinal arterial
reconstruction seems to be justified. The
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Table I. Results of primary infrainguinal bypass surgery according to the type of vein conduit.
Long saphenous vein
Primary patency (%) Secondary patency (%)
Author Year No. of
reconstructions 1m 1y 2y 5y 1m 1y 2y 5y
Bergamini 1991 361 93 78 71 63 97 92 89 81
Donaldson 1991 440 89 81 79 72 93 87 85 83
Taylor 1990 285 89 86 80 90 88 84
Quinones-Baldrich6 1993 46 72
Shah 1995 2058 93 84 80 71 96 91 88 81
Davidson1,7 1993 75 96 83 79 68 96 88 82 70
Alternative conduits*
Primary patency (%) Secondary patency (%)
Author Year No. of
reconstructions 1m 1y 2y 5y 1m 1y 2y 5y
Taylor 1990 231 84 78 68 89 86 77
Tisi2 1996 42 36 60
Chang 1995 184 85 72 64 453 88 79 73 61
Londrey4 1994 257 68 50 39 70 52 43
Hölzenbein 1996 85 525
Harward2 1992 43 67 58 74 64
Calligaro 1997 45 33 46
Faries 2000 246 683 703
*Alternative conduits include the use of arm and lesser saphenous veins or vein segment splicing
1Only reconstructions to single patent crural or pedal vessel
2 Only arm veins, 52% secondary or tertiary procedures
34-year patency rate
470% secondary or tertiary reconstructions
53-year patency rate
6Only pedal bypasses
75 bypasses with arm vein
Table 2. Mechanisms of vein graft failure
Intrinsic Extrinsic
Poor vein quality Compromised outflow
Missed valve/branch Compromised inflow
Branch ligature placement Thromboembolism
Intimal flaps Hypotension
Focal vein stenosis (anastomotic or intra-graft) Hypercoagulability
Accelerated atherosclerosis Graft sepsis
Aneurysmal degeneration Graft entrapment or kinking
REVIEW OF THE LITERATURE
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weight of evidence in support of this attitude
was further increased by a recent multicenter
clinical trial, in which above knee-bypasses
with vein grafts also had a significantly lower
risk of occlusion than non-venous bypass
grafts. (Tangelder, MJ et al. 2000)
2. Reasons for postoperative
graft failure
2.1. Classification of the
postoperative period
Generically the reasons for graft failure can
be divided into intrinsic and extrinsic lesions
(Table 2). In a study by Donaldson et al.
(1992) of 104 causes contributing to primary
graft failure of in situ bypasses, 63% were
judged to have an intrinsic cause. (Donaldson,
MC et al. 1992) Because the reasons for vein
graft failure vary as a function of the time
elapsed since the operation (Figure 1), it is
Fig. 1.  The temporal occurence of graft failures by postoperative interval grouped into intrinsic (white)
and extrinsic (grey) categories. The proportion of causes amenable to physician control is cross-hatched.
(From Donaldson et al., J Vasc Surg 1992, with permission)
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practical to classify the postoperative period
into several phases.
The most widely used classification of
graft failures divides the postoperative period
into three temporal categories: early or
immediate (0 to 30 days), intermediate (30
days to 2 years) and late (greater than 2
years). (Whittemore, AD et al. 1981) It is an
accepted concept that immediate failures
are predominantly caused by physician-
determined judgemental or technical error.
Intermediate-term failures are attributed
largely to the development of myointimal
hyperplasia in the graft both within the
conduit and at the anastomotic areas. Finally,
late failures appear to be associated with the
progression of the underlying atherosclerotic
process involving compromise of outflow
and inflow arteries. (Whittemore, AD et al.
1981; Berkowitz, HD et al. 1989; Mills, JL
1993) Many authors have, however, extended
the early postoperative period to 3 to 6
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months. (O’ Mara, CS et al. 1981; Lundell, A
and Bergqvist, D 1993; Ihnat, DM et al.
1999)
It is established, that of all graft failures,
15% will take place within the first month,
almost 80% during the first 2 years and the
remainder will fail after this time. (Brewster,
DC et al. 1983).
However, the causes contributing to graft
failure are multiple and complex, sometimes
with simultaneous interaction. In that sense
classifications are always somewhat arbitrary.
2.2. Technical and judgement
errors
Technical errors and errors of judgement
are the main cause of immediate thrombosis
of the arterial bypasses. In the literature, the
reported incidence of immediate failure of
in situ grafts varies from 5 to 34%. (Miller, A
et al. 1993; Sayers, RD et al. 1993) This large
variation indicates that several preoperative
and intraoperative factors determine the
immediate success of the reconstruction.
These factors include patient selection, pre-
implantation quality of the vein graft, vein
preparation, construction of the anastomosis
and quality of the intraoperative assessment.
2.2.1. The impact of inflow and
outflow arteries
As far as technical success is concerned, the
first critical step is the proper selection of
the inflow and outflow sites of the bypass.
The aortoiliac segment is usually not
diseased and the selection of inflow site does
not pose a clinical problem. If there is
evidence of inflow occlusive disease, it is
generally believed that it should be treated
meticulously prior to or at the time of
infrainguinal bypass reconstruction. There is
evidence showing that when femoral
outflow increases as a result of the bypass,
iliac flow may be greatly enhanced and a
functionally important inflow pressure
gradient generated. (Gupta, SK et al. 1990)
However, no data exists to show whether
hemodynamically compromised inflow has
an impact on bypass patency. Also in dispute
is whether inflow stenoses and occlusions
developing during follow-up are a cause of
reconstruction failure. (Mills, JL et al. 1993;
Taylor, SM et al. 1994)
The level of outflow arteries and the
condition of runoff vessels influence the
patency rates. The longer the bypass, the
higher the risk of early thrombosis, (Luther,
M and Lepäntalo, M 1997) although there
are studies in which the patency rates were
not influenced by the site of the distal
anastomosis. (Sayers, RD et al. 1993; Tordoir,
JH et al. 1993) This might not relate only to
the more limited runoff, because the length
of the conduit as such seems to be a predictive
factor for immediate failure. (Ascer, E et al.
1988) In clinical retrospective series
compromised runoff due to occlusive disease
of outflow vessels is reported to be the cause
of early graft occlusion in 25 to 42% of cases.
(Miller, J et al. 1990; Sayers, RD et al. 1993;
Varty, K et al. 1993; Albäck, A et al. 1998)
However, when the impact of runoff on
bypass patency has been prospectively tested
with a scoring system, (Rutherford, RB et
al. 1986) the results have been contradictory.
(Okadome, K et al. 1991; Tordoir, JH et al.
1993; Takolander, R et al. 1995; Albäck, A et
al. 1998)
2.2.2. The quality of the vein graft
A good-quality vein graft has a sufficient
transverse diameter and shows no signs of
pre-existing vein disease. Generally, the
minimum vein diameter should exceed 3
mm, as the risk of occlusion is markedly
increased for small-calibre (< 3mm) grafts.
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(Buxton, B et al. 1980; Wengerter, KR et al.
1990) Some reports claim that with the in
situ technique small calibre veins fare better
than with the reversed vein technique; veins
as small as 2.5 mm can be utilised with good
results. (Corson, JD et al. 1984; Qvarfordt, P
et al. 1988; Bergamini, TM et al. 1991)
Comparison of studies on vein size is difficult
because internal and external measurements
may be quoted, and especially because the
vein wall thickness is extremely variable.
One further explanation of contradictory
results is that the location and intraoperative
timing of the diameter measurement is
probably variable. Vein diameter is probably
a risk factor for early graft failure with no
great effect on long-term outcome. (Towne,
JB et al. 1991) Indeed, there is data to
suggest that vein grafts tend to go through
adaptive changes over time in response to
chronic alterations in blood flow. It is argued
that one year after the operation the vein
diameter has stabilized to a uniform values
regardless of the initial diameter. (Fillinger,
MF et al. 1994)
Frequently encountered pathologic
conditions affecting the LSV include
varicosities, phlebothrombosis and throm-
bophlebitis. It is estimated that pre-existing
vein disease is present in 12% of veins
considered for bypass grafting and that
bypass performed using a saphenous vein
with pre-existing disease has a 30 month
patency of 32% compared with 73% for a
normal saphenous vein. (Panetta, TF et al.
1992) Perhaps the poorer long-term results
obtained with the use of arm veins are
associated with vein quality, as arm veins
have webs and strands not often seen in the
saphenous system. (Marcaccio, EJ et al. 1993)
Their recognizition by means of intra-
operative assessment is desirable. At present,
intraoperative angioscopy for identification
and correction of these imperfections is
perhaps the most effective method for
upgrading the quality of the vein and
thereby possibly improving the patency rates.
(Stonebridge, PA et al. 1991; Marcaccio, EJ
et al. 1993)
2.2.3. Vein preparation and
construction of anastomoses
About 50% of the early graft failures can be
related to technical defects. (Beard, JD et al.
1989; Miller, A et al. 1990; Varty, K et al. 1993)
It is clear that infrainguinal bypass surgery
demands meticulous surgical technique when
preparing the vein for grafting and
constructing the anastomoses. In the
immediate postoperative period residual
anatomical lesions such as valvulotome
scrapes, kinking, torsion and entrapment of
the graft, and retained valve leaflets appear to
play a dominant role. (Donaldson, MC et al.
1992; Mills, JL et al. 1993) With in situ
technique, unligated side branches with
residual AVF have been suspected of leading
to distal graft thrombosis. (Donaldson, MC et
al. 1992) However, in a recent study, residual
AVF did not compromise patency and
thrombosed spontaneously on condition that
they did not alter the hemodynamics of the
graft distal to the AVF (Lundell, A and
Nyborg, K 1999) Mechanical valve lysis is
mandatory for in situ grafts, and it is
documented that with the current
valvulotomes this is often done imperfectly
(Blankensteijn, JD et al. 1995; Albäck, A et al.
1999) or a valvulotome injury to the graft
might take place. (Donaldson, MC et al. 1992)
This may be the cause of graft failure in over
10% of cases. (Donaldson, MC et al. 1992)
19REVIEW OF THE LITERATURE
2.3. Progression of atherosclerotic
disease
The impact of atherosclerotic disease on
infrainguinal bypass failure might be spread
broadly over the postoperative period. When
the revascularisation policy is aggressive,
immediate failures are evident in patients,
where the outflow tract was already highly
compromised at the time of the
implantation. Late failures are due to
progression of the atherosclerotic disease.
However, little is known about the rate of
progression and how it relates to graft failure
after lower extremity revascularisation. When
follow-up studies (20% angiography and
80% duplex scans) were compared with a
presurgical angiography, it was found out
that at a mean follow-up of 4.8 years 18% of
native arteries demonstrated disease
progression. (McLafferty, RB et al. 1995) It
could not be demonstrated that
revascularisation would had adverse
influenced the progression of atherosclerotic
disease. Apart from this publication,
postoperative studies have focused almost
exclusively on graft patency. After the first
postoperative year, the long-term outcome
studies of infrainguinal vein bypass grafts
show a steady failure rate of 1–2% annually.
(Berkowitz, HD et al. 1989; Donaldson, MC
et al. 1991; Shah, DM et al. 1995) These
failures have been categorically attributed to
atherosclerotic disease progression, but this
has not been proved.
2.4. Hypercoagulability
Systemic hypercoagulable states may cause a
graft thrombosis alone or contribute in the
presence of other coincident factors – likely
more often than previously assumed. In a
preoperative screening program of 272
vascular surgical patients, 13.6% had a blood
clotting abnormality, the most common
being antiphospholipid syndrome (APS).
(Donaldson, MC et al. 1990) Other screened
and detected hypercoagulable states were
protein C deficiency, protein S deficiency,
antithrombin III deficiency, heparin-induced
thrombocytopenia (HIT) and plasminogen
abnormality. In a prospective study, lupus
anticoagulant was found in 26 out of 60
vascular patients compared with none
amongst the general surgical controls.
(Fligelstone, LJ et al. 1995) The incidence of
clotting disorders might be even higher
among young adults with lower limb
ischaemia. (Eldrup-Jorgensen, J et al. 1989)
Hypercoagulable states have been shown to
be an independent risk factor for post-
operative bypass failure. (Ray, SA et al. 1997)
Of the known clotting abnormalities, lupus
anticoagulant and heparin-induced platelet
activation appear to be the most important
with regard to early infrainguinal graft
patency. (Donaldson, MC et al. 1990)
Recently, two thrombogenic mutations
have been discovered. The first is in factor V
(FV Leiden), causing resistance to activated
protein C and leading to uncontrolled
coagulation activity (Ouriel, K et al. 1996).
The second is prothrombin G20210A
mutation which leads to increased
prothrombin levels, but it is still unsettled
whether this mutation increases the risk of
arterial thrombosis. (Franco, RF et al. 1999;
Ridker, PM et al. 1999)
It is not clear how actively patients should
be screened for hypercoagulable states and,
furthermore, what action should be taken if
an abnormality is detected. Laboratory
screening is costly, and, when occasionally
fruitful, is likely to result in the institution of
the same preventive measures that would
have been used in the first place. However,
there are recommendations for screening
certain risk groups, including those with: a
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history of previous unexplained thrombosis,
a known hereditary condition, a predisposing
illness (malnutrition, nephrotic syndrome,
malignancy, pregnancy, oral contraceptives,
myeloproliferative disorders), age less than
45 years and elevated PT, PTT, platelets or
hematocrit. (Donaldson, MC 1996; Ray, SA
et al. 1997) If an abnormality is detected,
some advise avoidance of surgical re-
vascularisation wherever possible. (Nitecki,
S et al. 1993) Although there is no data
supporting it, careful combined anti-
coagulation and platelet inhibition is
generally recommended. (Khamashta, MA
et al. 1995) Specifically, deficiencies in
antithrombin III and proteins C and S can
be treated with fresh frozen plasma. If
intervention can be postponed, most patients
with HIT will revert to normal within a few
months provided they are not re-exposed to
heparin in the interim. (Laster, J et al. 1987;
Donaldson, MC 1996)
Aspirin is universally instituted as a long-
term therapy for all patients being treated
for lower limb ischaemia if no
contraindications exist. There is only little
evidence that aspirin enhances infrainguinal
graft patency, but patients taking aspirin have
a significantly better chance of survival.
(McCollum, C et al. 1991; Olojugba, DH et
al. 1999; Tangelder, MJ et al. 1999) However,
evidence for the beneficial effects of
antiplatelet therapy in patients with PAOD
is based on a small number of trials only, and
can be regarded at present as indicative.
3. Graft and anastomotic
stenoses
During the intermediate period, bypass
failure is associated predominantly with the
development of intrinsic graft and
anastomotic stenoses due to myointimal
hyperplasia or, occasionally, fibrosis at the
valve cusps. This group constitutes the largest
proportion of potentially identifiable and
treatable graft lesions. The nature, aetiology
and management of vein graft stenoses will
be discussed in more detail in the following
chapters.
3.1. Pathophysiology of stenosis
development
3.1.1. Anatomy and physiology
of the veins
The wall of a vein is traditionally divided
into three anatomic layers: the intima, the
media and the adventitia. The intima is
composed of a thin layer of endothelial cells
beneath which is a fenestrated basement
membrane, a subendothelial matrix of
glycoproteins and connective tissue
elements. In the media, the smooth muscle
cells are arranged in an inner longitudinal
and an outer circumferential pattern with
collagen and elastic fibrils interlaced. The
adventitia forms the outer layer of vein wall
and is often thicker than the media and
consists of a loose network of longitudinally
orientated collagen bundles and scattered
fibroblasts through which the vasa vasorum
pass.
Veins are highly compliant over the range
of venous pressures and are relatively non-
compliant at arterial pressures. (Wesly, RL et
al. 1975) They appear to have a different
metabolic profile and tissue content
compared to arteries which may in part
account for the distinct patterns of lipid
accumulation found between veins and
arteries. (Sisto, T et al. 1990) The total protein
content does not differ, but the amount of
collagen appears to be greater in the
saphenous veins. The endothelium releases
factors that control vascular relaxation and
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contraction, thrombo-genesis and fibrinolysis,
and platelet activation and inhibition. Nitric
oxide and prostacyclin mediated relaxation
responses of saphenous veins are much
smaller, and the maximal contractile forces
much greater, than those of the internal
mammary artery. (Luscher, TF and Barton,
M 1997)
3.1.2. Myointimal hyperplasia
Myointimal hyperplasia (MIH) is the
universal response of a vein graft to insertion
into the arterial circulation and is considered
to result from both the migration of smooth
muscle cells out of the media and into the
intima and the proliferation of these smooth
muscle cells. Macroscopically, intimal
hyperplastic lesions appear pale, smooth, firm
and homogenous; they are uniformly located
between the endothelium and the medial
smooth muscle layer of the vein graft.
(Chervu, A and Moore, WS 1990)
Although not fully defined, it seems that
the origin of the initiating factors goes back
to the time of surgery. The vein suffers from
implantation injury, which leads to
endothelial dysfunction, endothelial cell
injury, endothelial denudation and smooth
muscle cell injury. Several mediators, such as
fibroblast growth factors and either
endogenous or exogenous platelet derived
growth factors, are activated which contribute
to the medial proliferation and to the
migration of smooth muscle cells from the
media to the intima. Several other mediators
of both the tyrosine kinase (IGF-1, TGF-α,
α-thrombin and inter-leukin-1β) and G-
protein (angiotensin II, endothelin-1,
serotonin) coupled membrane receptors have
been known to participate in these initial
events. (Davies, MG and Hagen, PO 1995) In
addition to the increased number of vascular
smooth muscle cells, stenotic lesions contain
an abundance of extracellular matrix. Recent
studies have suggested that the proliferation
and migration of smooth muscle cells requires
degradation of the surrounding matrix
proteins, and that up regulation of matrix
metalloproteases, the principal physiological
mediators, may play a central role in the
formation of MIH. (Porter, KE et al. 1999)
In general, MIH is a self-limiting process
which does not produce luminal
compromise and which usually calms down
within 2 years of implantation. However, in
focal areas, the intimal hyperplastic process
can proceed to significant stenosis. Primary
cultures from these lesions have suggested
that the smooth muscle cell phenotype
present is more resistant to the action of
growth inhibitors such as heparin than other
areas of the graft. (Chan, P et al. 1993)
Considerable efforts has been put into
finding therapeutic agents to limit the
development of MIH. However, the various
classes of compounds which have shown
promise in experimental models have, by
and large, been ineffective in the clinical
setting. (Davies, MG and Hagen, PO 1995)
Apart from attempting to minimise the
degree of injury at the time of implantation
by using minimum manual and instrumental
contact, no effective strategy has been
developed to prevent the development of
MIH following vascular reconstruction.
3.1.3. Systemic risk factors
As it is likely that some individual grafts are at
a greater risk of stenosis development than
others, the association between the
development of vein graft stenoses and several
risk factors has been studied. Hyperlipidemia
has been shown to correlate with a
progressive narrowing of aortocoronary vein
grafts, but its role in infrainguinal vein bypass
stenoses is unclear. (Lytle, BW et al. 1985)
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Other systemic variables which might be
associated with graft stenosis are lipoprotein
(a), smoking and plasma fibrinogen (Cheshire,
NJ et al. 1996), hyperhomocystinaemia
(Irvine, C et al. 1996; Beattie, DK et al. 1999)
and antibodies to cardiolipin. (Nielsen, TG
et al. 1997) Recently, the female gender was
found to have a higher risk for graft stenosis.
(Watson, HR et al. 2000) No association has
been found with patient age, presenting
symptoms, hypertension, diabetes or the
condition of the outflow vessel. Interestingly,
it has been found that patients who develop
vein graft stenosis in one limb are at a
greater risk of developing a contralateral
vein graft stenosis if that limb is grafted.
(McCarthy, MJ et al. 1998) Whether this is
due to unidentified systemic factors or
individual vein morphology is unknown.
3.1.4. Local graft-related factors
Stenotic lesions have a localized nature. This
has prompted theories that local factors
related to the type, quality, and operative
technique form a ”nidus” for later
development of stenosis. The possible
predisposing factors are pre-existing
morphological changes, vein size, compliance,
tributaries, valves and operative trauma.
As already mentioned, pre-existing
morphological changes at gross inspection
are a very common finding in patients
undergoing peripheral vein bypass surgery.
Further evidence exists showing that
microscopically marked changes of muscle
hypertrophy and intimal hyperplasia are also
present in the vein prior to grafting. (Davies,
AH et al. 1993) Marin et al. (1993) studied
microscopic abnormalities in vein biopsies
taken at the time of surgery. They found that
intimomedial thickening and cellularity were
strongly associated with failed or failing grafts
at 18–30 months. (Marin, ML et al. 1993)
Their findings were supported by studies in
which a link between poor-compliance veins,
usually due to moderate or severe intimal
hyperplasia, and subsequent graft stenosis was
demonstrated. (Davies, AH et al. 1993; Davies,
AH et al. 1994) Furthermore, the presence of
a macrophage or lymphocyte infiltrate in the
prebypass vein increased the likelihood of the
subsequent stenosis development. These
results were, however, contradicted by Varty
et al. (1996), who neither in vitro nor in vivo
could reveal a correlation between intimal or
medial thickness and grafts that subsequently
stenosed and those that did not. (Varty, K et al.
1996) The different results may be partly
explained by the different methods used for
assessing vein wall morphology in these
studies. It seems that vein morphology, with
present methods, is unlikely to be a clinically
useful indicator of the risk of graft stenosis.
It has been documented that a small
diameter vein graft has an unfavourable
effect on durable patency. It has been studied
whether this is due to a higher incidence of
MIH in a small-calibre graft. (Davies, AH et
al. 1994; Idu, MM et al. 1999) Davies et al.
(1994) showed, in a cohort of 88 patients,
that the mean diameter of the vein grafts
that developed stenosis was 3.7 mm
compared to 4.7 mm in those that did not (p
= 0.006), but there was no clear size
discriminator. In the study by Idu et al., 300
vein grafts were grouped in accordance with
their intra-operatively measured minimum
graft diameter into those < 3.5 mm, those
between 3.5 and 4.5 mm, and those ≥ 4.5
mm. (Idu, MM et al. 1999) At 1 year, the
respective free-of-stenosis rates were 40%,
58%, and 75%. In a multivariate analysis the
minimum graft diameter was the single
independent factor which correlated with
the development of an event-causing
stenosis. They postulated that this might be
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due to increased vulnerability of a small
calibre graft during harvesting and valve
lysis which may initiate a local myointimal
hyperplastic response.
Early work suggested that stenoses in
reversed vein grafts occurred at the sites of
valves. (Whitney, DG et al. 1976) This has
been supported by Mills et al (1993), who
found that all midgraft stenoses occurred at
fibrotic valve sites. (Mills, JL et al. 1993)
However, this theory has been tested in
more detailed studies, in which a relationship
between the site of the stenosis and that of
either a tributary or valve cusp could not be
confirmed. (Moody, AP et al. 1992; Davies,
AH et al. 1994) The role of local injury
response resulting from instrumentation and
manipulation in the initiation of neointimal
hyperplasia is also disputed. Mills et al. (1993)
observed that the most common site for
intrinsic lesions was in the juxta-anastomotic
position in the vein graft segment
immediately adjacent to both anastomoses.
(Mills, JL et al. 1993) They discussed whether
the manipulation of the vein graft heel
during the performance of the anastomosis
perhaps sets the stage for intimal hyperplasia.
However, in an elegant study by Moody et
al. (1992) in which the residual valve sites,
clipped tributary veins, venotomy sites, and
areas of clamp application were marked
intraoperatively, no correlation between
these sites and the sites where stenoses
ultimately developed was found. (Moody,
AP et al. 1992) In addition, when the degree
of endothelial injury caused by stripping
was assessed by means of endothelial cell
markers, no relationship with respect to the
development of graft stenoses was observed.
(Davies, AH et al. 1994) Regarding the
influence of grafting techniques on the
stenosis development, results have been
published in which the reversed vein and
alternative vein conduits had an incidence
of stenosis and a need for revision twice as
high as those of in situ bypasses. (Gupta, AK
et al. 1997) These results should, however, be
viewed with some caution, as the series are
prone to the pitfalls of a retrospective study.
Firstly, the grafting technique varied with
the surgeon’s preference as well as with the
sites selected for the proximal and distal
anastomosis. Secondly, the number of redo-
bypasses varied among the groups. Thirdly, a
significant difference in primary patency at
3 years in favour of in situ bypasses was also
seen among those grafts for which the
intraoperative duplex scan was normal.
Attempts to identify promoters of a
subsequent development of graft stenosis
during the operation or in the immediate
postoperative period using duplex scanning
have been made with varying success. Bandyk
et al. (1996) studied the fate of borderline
duplex abnormalities that were encountered
intraoperatively but left untreated. (Bandyk,
DF et al. 1996) A revision was needed in 18 of
40 such grafts (45%). The follow-up, however,
was only 3 months and the study was not
blinded. In the most recent report by the
same group further data on intraoperative
duplex scanning on 626 vein grafts was
provided, in which the 90-day combined
failure and revision rate for those grafts that
had a normal duplex scan was 2.5%, whereas
for grafts that had a residual stenosis or an
unrepaired defect the respective figure was
40%. (Johnson, BL et al. 2000) The conclusion
was, that the borderline abnormalities had a
tendency to progress to a level where
intervention was necessary. However, the
short follow-up time hindered a more
thorough analysis of it was a question of
developing graft stenoses due to MIH. In
contradiction to this study, Passman et al.
(1995) found that duplex scanning within 2
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weeks of surgery could identify only 14 % of
grafts that eventually developed stenoses.
(Passman, MA et al. 1995) The predictive
value of predischarge duplex scanning for
subsequent stenosis development has been
studied with conflicting results. (Wilson, YG
et al. 1995; Olojugba, DH et al. 1998)
In summary, efforts to divide grafts into
high- and low-risk categories with regard to
stenosis development have not been
successful, and as yet no recommendation can
be given with respect to reviewed risk factors
for planning the postoperative follow-up. The
potential of intraoperative assessment using
duplex scanning has recently shown promise,
but these singe-unit experiences have not yet
been confirmed by others.
3.1.5. Biomechanical factors
It has increasingly been recognised that the
vascular endothelium is a living organ in
which metabolism and the synthetic activities
of different vasoactive factors are altered in
response to biomechanical forces generated
by the blood flow. (Gimbrone, MA, Jr. et al.
1999) The mechanisms underlying arterial
wall adaptation to biomechanical forces have
been shown to be closely related to a complex
interaction of molecular and cellular events.
Physical forces sensed at the blood-wall
interface trigger a series of immediate
responses such as platelet activation and the
activation of immediate early genes, as well as
later responses, which include the production
of several growth factors.
Wall shear stress is a direct function of
blood flow and viscosity and inversely
proportional to the the third cube of the
radius of the vessel wall curvature. Shear
stress (t) can be calculated according to
Poiseuille’s law: τ = 4ηQ/πr3, where η=
viscosity, Q = volume flow and r = internal
vessel radius.
In normal arteries, flow-induced
remodelling results in changes in arterial
diameter which have the negative-feedback
effect of returning the wall shear stress
towards normal. (Langille, BL 1996) In
addition, it has been demonstrated that the
same phenomenon also takes place in vein
grafts; as a response to changes in shear stress
small-diameter veins had, one year on from
surgery, remodelled to a final diameter that
was not significantly different from that of
larger veins. (Fillinger, MF et al. 1994)
This remodelling might contribute to
the pathophysiology of neointimal hyper-
plasia as it has been shown that shear stress
can regulate endothelial smooth muscle cell
migration and proliferation. (Mattsson, EJ et
al. 1997) Already in early studies it had been
reported that intimal hyperplasia correlates
with low graft flow. (Faulkner, SL et al. 1975;
Berguer, R et al. 1980) This was verified in a
detailed study by Dobrin et al. (Dobrin, PB
et al. 1989) Their study using a canine model
showed that of nine different mechanical
factors blood flow is best associated with the
formation of neointimal hyperplasia
independently of deformations and stresses
in the circumferential, longitudinal and
radial directions and independent of pulsatile
deformation. Similarly, it was reported that
accelerated intimal thickening develops in
vein grafts under low flow conditions and
the process is reversed when the grafts are
re-implanted into a system with normal
flow parameters. (Morinaga, K et al. 1987)
As there is evidence that endothelial cells
play a pivotal role in modulating the
neointimal hyperplastic response, it has been
hypothesized that the endothelium is
dysfunctional in the low-flow state. Indeed,
it has been demonstrated that the receptor-
mediated release of endothelium-derived
relaxing factors is regulated downwards
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when blood flow is diminished. (Cambria,
RA et al. 1994; Komori, K et al. 1995) It is
probable that release of nitric oxide (NO)
accounts for the biological activity of
endothelium-derived relaxing factor. NO
has been shown to be a very potent
vasodilator and to efficiently inhibit smooth
muscle cell proliferation. In an experimental
in vivo model, endothelial nitric oxide
synthase was induced in high-flow graft
intima. (Mattsson, EJ et al. 1998)
The evidence gathered so far is based on
experimental data, and the clinical relevance
of these findings is still unproven.
Furthermore, it seems evident that this theory
alone does not provide the ultimate solution
and that there are also other mechanical
factors that play a role. Otherwise it would be
difficult to understand how veins survive in
their usual state as low-flow and low-pressure
conduits.
3.2. Diagnosis of vein graft
stenosis
3.2.1. Clinical assessment
When assessing infrainguinal vein grafts
clinically, one looks for symptoms and signs
of deterioration in the hemodynamic
condition of the limb. Sudden onset of
disabling claudication, ischaemic pain or
ischaemic ulcers is a sign of a failing or failed
bypass graft. Clinical signs include changes
in the colour, temperature and capillary
circulation of the limb or loss of previously
palpable graft and distal pulses. However, the
majority of hemodynamically significant
graft stenoses are asymptomatic, and only
11% to 38% can be diagnosed by the return
of ischaemic symptoms or decreased pulses
on the physical examination. (Disselhoff, B
et al. 1989; Moody, P et al. 1990)
3.2.2. Ankle brachial pressure index
(ABI)
Thanks to the introduction of Doppler, the
measurement of lower limb blood pressure
has been possible using non-invasive
techniques for the past 30 years. (Yao, ST et al.
1969) The measurement is quick and easy to
perform, and can be regarded as a standard
noninvasive test in PAOD. (Dormandy, JA
and Murray, GD 1991) Determination of the
ankle brachial systolic pressure index (ABI) is
a simple test for peripheral arterial disease,
and it eliminates the influence of temporal
variations in absolute systolic blood pressure
on the results. (Yao, ST et al. 1969)
In general, a drop in ABI of more than
0.15 compared to the immediate post-
operative value was found to be a more
sensitive indicator than clinical symptoms in
the diagnosis of significant hemodynamic
deterioration in the bypass graft. (Berkowitz,
HD et al. 1981; O’ Mara, CS et al. 1981)
Nevertheless, ABI measurement is not free
from variation, and a cut-off level of 0.15
falls within the biological and measurement
variations of the test, while a decrease greater
than 0.20 is often associated with a bypass
which has already occluded. (Fowkes, FG et
al. 1988; Ray, SA et al. 1994) In the most
recent study, the 95% confidence limits for
the difference were ± 0.21.(Fisher, CM et al.
1996) The variation in ABI could arise from
several different sources, such as differences
in technique and experience (interobserver
variation), non-compressible arteries in the
presence of medial calcification or non-
standardized conditions of measurement.
(Carter, SA 1992; Kaiser, V et al. 1999)
The ABI has been extensively evaluated as
a screening method for vein graft stenosis, but
has been found to be of limited value.
Furthermore, pressure measurements in
respect of paramalleolar and pedal grafts are
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meaningless because the cuff is applied over
the graft; stump pressure is obtained reflecting
only the inflow pressure of the bypass.
(Sumner, DS and Mattos, MA 1995) As ABI
measurements are used routinely in the
assessment of both patients who have
undergone surgery and those who have not,
their use could be justified as a first-line
method, potentially as an adjunct to another
non-invasive method. A pre-requisite for
usefulness should be good sensitivity i.e.
having a minimal risk of false-negative results.
Aggregate data from several studies show that
when cut-off values of 0.1, 0.15, and 0.2 are
used, the respective sensitivity figures are 75%,
45%, and 35%. (Lepäntalo, M et al. 1996)
Even with the lowest cut-off value of 0.1
only one or two authors have proposed the
use of ABI as the sole tool for detecting graft
stenosis. (Brennan, JA et al. 1991; Stierli, P et
al. 1992) Stierli et al. (1992), using the above-
mentioned discriminator found all stenosed
grafts (12/41) and recommended its use as a
primary examination for selecting patients
for colour flow duplex scanning on the
following conditions: the ABI is below 1.3
indicating of compressible distal vessels; the
ABI changes are less than 0.1 on serial testing;
the distal anastomosis is well above the ankle
joint. (Stierli, P et al. 1992) It can be
anticipated that the difference of 0.1 is
associated with an unacceptably poor
specificity due to variations in reproducibility.
This means there is likely to be a large number
of false positive studies, and a large number of
people may therefore be given unnecessary
angiograms. It is questionable whether a
surveillance programme based on ABI is likely
to be any better than no surveillance at all.
Nevertheless, Stierli et al. calculated that 50%
of bypasses would not have needed any other
type of surveillance method. (Stierli, P et al.
1992)
Even though it is has been proved that
stenosed grafts are three times more likely to
occlude, (Moody, P et al. 1989) the majority
of them do not fail. Similarly, some grafts
that have previously undergone invasive and
non-invasive studies occlude suddenly
without warning. (Green, RM et al. 1990)
Thus, while a stenotic graft can be identified
with some accuracy, the one that is likely to
occlude is more difficult to define. On the
basis of this some have advocated that grafts
with diagnosed stenosis should be corrected
only in the presence of a hemodynamically
significant drop in the ABI. (Green, RM et
al. 1990; Dalsing, MC et al. 1995; Nielsen,
TG 1996) According to Green et al. (1990),
in cases where the outcome of the duplex
scan was abnormal but the ABI normal, the
incidence of sudden graft occlusion was
only 4% over the next 3 months. (Green,
RM et al. 1990) In contrast, when both the
duplex scan and the ABI were abnormal, the
risk of a graft occlusion was 66%. A similar
result was observed in a small prospective
series of grafts with duplex-verified stenoses
that were not corrected. (Nielsen, TG 1996)
The cumulative patency at 12 months was
significantly lower for bypasses with
hemodynamically significant stenoses,
defined as an ABI-reduction of more than
0.15 (68% vs. 33%). In contrast, when the
long-term fate of 235 infrainguinal bypasses
was studied, a decrease in the ABI of more
than 0.2 during one or more intervals after
surgery was not predictive of graft failure.
(Barnes, RW et al. 1989) Such disparate
observations have led to equally contra-
dictory recommendations on whether
duplex abnormality alone is a sufficient
indication of the need for further invasive
imaging and/or treatment.
As it is evident that measuring the resting
ABI alone is not a sufficient method of
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screening grafts, and since it is disputed
whether this improves the accuracy of
screening as an adjunct to other methods,
attempts to improve the sensitivity of ABI
by adding of a standard treadmill exercise
have been made. (Wolfe, JH et al. 1987;
Benveniste, GL et al. 1988; Brennan, JA et al.
1991) Even though this might unmask some
stenoses, it seems likely that the overall
sensitivity will not be markedly increased.
Another drawback of this test is that,
typically, older patient population often
cannot perform the treadmill exercise
adequately. Hyperaemia using cuff occlusion
may overcome this problem, but no reports
of its utility in diagnosis of vein graft stenosis
has been published.
3.2.3. Arteriography
Since the report by Szilagyi et al. in 1973,
intra-arterial arteriography has been referred
to as the ”gold standard” for delineating and
grading the degree of stenoses against which
other methods should be compared. (Szilagyi,
DE et al. 1973) It provides fine anatomical
detail (Figure 2) but is, however,
cumbersome, and includes risks that are
related both to the puncture site and contrast
agents used. In addition, it is too expensive
for serial imaging. With the advent of digital
techniques in the 1980’s, intravenous digital
subtraction angiography (IV DSA) was
proposed as a means of detecting stenosed
grafts. (Turnipseed, WD and Acher, CW 1985;
Wolfe, JH et al. 1987; Moody, P et al. 1989)
Because of a lack of spatial resolution, IV
DSA is not necessarily adequate for visualising
the whole bypass, which, in particular, makes
an adequate assessment of the reduction in
diameter difficult. (Sumner, DS et al. 1985) In
addition, the risks of repeated radiation raises
the threshold to its widespread use as a serial
diagnostic procedure.
Consequently, in later studies the use of
angiography has been confined to
determining the localisation and severity of a
stenotic lesion after its presence has been
indicated by other methods. Angiographic
confirmation is usually requested before a
decision on corrective measures can be made.
The technology and quality of magnetic
resonance angiography (MRA) has de-
veloped rapidly over the last decade and
there is potential for overcoming the inherent
limitations of conventional angiography.
However, the data on the utility of the
Figure 2. Angiographic visualisation of a
vein graft stenosis (arrow) in an infrainguinal
bypass graft close to the distal anastomosis.
➘
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MRA in detecting a vein graft stenosis is
scant. In the only published study on the
subject, the MRA demonstrated a satis-
factory correlation with conventional angio-
graphy, but with a tendency towards over-
diagnosis in the presence of turbulent flow.
(Turnipseed, WD and Sproat, IA 1992) At
present, the MRA is still far too expensive
for routine use as a surveillance instrument.
3.2.4. Duplex scanning
Duplex scanning provides both anatomic and
hemodynamic information, as it embodies
both B-mode imaging and Doppler
ultrasound. The diameter changes of the
bypass can be measured both in longitudinal
and transverse projections. Quantitative
pulsed Doppler waveform analysis of blood
flow velocity can be performed. Flow within
the graft can be calculated at any point as the
product of the average velocity and the cross-
sectional area.
Monochrome duplex scanning first
became available for non-invasive vascular
diagnosis about 20 years ago. With that
technique, scanning of the entire bypass was
a long and tedious process, requiring many
Doppler samples to be taken down the
length of the graft. There are studies dating
back to that time in which efforts to simplify
duplex scanning were made. It was proposed
that a single point measurement of peak
systolic velocity (PSV) usually made in the
normal midgraft portion can act as a reliable
screening method for failing grafts. Bandyk
et al (1985), using a PSV < 45 cm/sec as a
criterion, identified 96% of failing grafts
and, furthermore, found an association with
high incidence of graft occlusion during
follow-up. (Bandyk, DF et al. 1985) This was
supported by later studies. (Green, RM et al.
1990; Mills, JL et al. 1990; Schmitt, DD et al.
1990) Nevertheless, it became evident that
low PSV identifies only a minority of
significant graft stenoses (Buth, J et al. 1991;
Robison, JG and Elliott, BM 1991; Belkin,
M et al. 1992; Taylor, PR et al. 1992)
Moreover, it was recognized that low PSV-
values may occur in normal grafts of large
diameter as well as frequently being caused
by run-off or inflow disease (Belkin, M et al.
1992; Belkin, M et al. 1994; Treiman, GS et al.
1999) Further attempts aimed at achieving
simplified identification of failing grafts have
been made. (Chang, BB et al. 1990; Nielsen,
TG et al. 1995) Nielsen et al. (1995) correlated
midgraft PSV, pulsatility index and the ratio
of hyperaemic and resting time-average
mean velocities (TAMV) with the presence
and severity of stenoses. (Nielsen, TG et al.
1995) They found that impaired hyperaemic
response (TAMV ratio ≤ 2.0) was observed
in 88% of stenosed grafts and concluded that
it might be of use as a simple screening
procedure for those grafts that require a
more detailed duplex scanning. In their
study, the accuracy of pulsatility index was
poor, whereas others have achieved better
sensitivity and specificity compared to other
duplex parameters with a one-point
measurement of pulsatility index. (Inoue, Y et
al. 1997) Other single-point measurements
used as indicators of a failing graft include a
change in graft flow waveform from a
triphasic to bi- or monophasic pattern, a
decrease in PSV of more than 30 cm/sec
relative to a previous test and a distal graft
flow lower than 25 ml/min (Bandyk, DF et
al. 1988; Chang, BB et al. 1990), but these
criteria have not gained wider acceptance.
Duplex-derived graft volume measurements
have been shown to be unreliable, as they are
poorly reproducible. (Grigg, MJ et al. 1988)
Flow measurements rely on a detailed
estimation of luminal diameter so a small
inaccuracy in the diameter measurement
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dramatically alters the flow measurement.
The addition of a colour coding facility to
the duplex scanner made scanning of the
whole graft simpler and quicker. Changes in
velocity and poststenotic turbulence are
indicated by alterations in colour-coded
images, and can be interrogated more
carefully with quantitative pulsed Doppler
velocity measurements. Maximum PSV has
been proposed for grading graft stenosis, but
the recommended cut-off value varies from
110 to 300 cm/sec. (Cullen, PJ et al. 1986;
Sladen, JG et al. 1989; Green, RM et al.
1990; Buth, J et al. 1991) An increase in the
end-diastolic velocity (EDV) of greater than
20 cm/sec has also been considered as a
reliable predictor of severe stenosis, with the
optimal measurement taken very close to
the site of maximal diameter reduction.
(Nicholls, SC et al. 1986; Buth, J et al. 1991)
Because graft flow at one point equals
flow at any other point in the graft, provided
no branches lie in between, any change in
luminal area will be associated with a
proportional shift in velocity. (Figure 3). The
V2/V1 ratio (V2: PSV at the site of maximal
stenosis, V1: PSV in a normal graft segment
within 2 cm of the stenotic segment) has
been shown to provide an accurate estimation
of the degree of the stenosis. (Leopold, PW
et al. 1989; Landwehr, P et al. 1991) The use
of a ratio is beneficial, since changes in graft
flow due to variation in cardiac output and
peripheral resistance are eliminated, and
accurate comparisons over a period of time
are possible. The correlation between
velocity shift and percentage diameter
reduction of the stenosis is denoted by the
equation: % diameter reduction = 100 x
(1-√v1/v2) (Grigg, MJ et al. 1988). Using
this equation, a doubling of PSV at the site
of the stenosis denotes a 30% diameter
reduction, a six fold increase a stenosis of
60% and a ten fold increase a stenosis of
70%. However, in practice it is noted that
this equation underestimates the degree of
the stenosis, and a V2/V1 ratio = 2 is usually
considered equivalent to 50% stenosis. (Jager,
KA et al. 1985)
The V2/V1 ratio has become the most
accepted criterion for diagnosis of a stenosis
within the vein graft. (Grigg, MJ et al. 1988;
Giannoukas, AD et al. 1996) Using this as
the sole criterion, a sensitivity of 100% with
IV-DSA as the diagnostic standard was
achieved when screening a total of 412
infrainguinal grafts (Taylor, PR et al. 1990)
Likewise, in a series of 76 grafts, only two
grafts that were not detected by duplex
scanning later occluded during the follow-
up. (Sladen, JG and Gilmour, JL 1981) In a
detailed study of different colour-flow
duplex criteria for grading stenoses, the
midgraft PSV, maximum PSV, V2/V1 ratio,
end-diastolic velocity (EDV) at a stenosis or
from narrowest graft segment and colour-
flow image diameter measurements were
compared for normal appearing grafts using
IV-DSA and for those with suspected
stenosis using IA-DSA. (Buth, J et al. 1991)
The V2/V1 ratio proved to be the optimal
identification of stenoses with more than
49% of diameter reduction (sensitivity 89%
and specificity 92%), whereas severe stenoses
Figure 3. Velocity ratio V2/V1 is calculated
from the stenosis and from the adjacent normal
graft segment within 2 cm of the stenosis
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(70% to 99% diameter reduction were most
associated with an EDV > 20 cm/sec.
Colour-flow duplex scanning, as
described above, permits efficient tracing of
the entire graft. It also improves the
identification of the graft when assessing
difficult areas such as distal or proximal
anastomosis at the popliteal fossa. (Sladen,
JG et al. 1989; Taylor, PR et al. 1992) Despite
this difficulties may arise: Sladen et al. could
not visualize the lower anastomosis in 17%
of the studies. (Sladen, JG et al. 1989) It
seems that when both the high- and low
velocity criteria are combined, they are
complementary, and nearly optimal accuracy
can be achieved (Sladen, JG et al. 1989;
Laborde, AL et al. 1992; Taylor, PR et al.
1992). Sladen et al. scanned 114 grafts using
duplex criteria suggestive of stenosis PSV <
45 cm/sec, maximum PSV > 300 cm/sec, or
V2/V1 ratio greater than three, which were
compared with concurrent angiograms.
(Sladen, JG et al. 1989) Only one false-
negative finding was observed, leading to a
sensitivity of 98% and specificity of 87%.
Nevertheless this was a non-systematic
retrospective study, and the group of patients
represented a data set rather than a
consecutive series where not all patients
during the study period were referred for
angiography. The findings of Taylor et al.
were in accord with the previous ones.
(Taylor, PR et al. 1992) A total of 74 grafts
were studied using duplex scanning, where a
PSV < 45 cm/sec and V2/V1 ratio > 2 were
regarded to sign a significant stenosis.
Subsequent blind IV-DSA was used as an
arbiter for normal and stenosed grafts. With
these two criteria combined, all stenosed
grafts were detected, with only one false-
positive study (Figure 4).
As indicated above, methodological testing
of the accuracy and reproducibility of colour-
flow duplex scanning against the ”gold
standard”, which, historically, is multiplanar
intra-arterial angiography, is difficult to
accomplish and has not yet been properly
performed. In practice, a study of that kind is
difficult to design and also gives rise to
ethical considerations. However, with present
knowledge, it seems that duplex scanning is
a very effective non-invasive tool with an
accuracy close to, or even superior to, that of
other vascular imaging studies in the
detection of hemodynamically significant
lesions in vein grafts. (Lewis, DR et al. 1998)
The main arguments against universal
acceptance of duplex scanning are the
relatively high initial cost of the machines and
the requirement of a well-trained operator
for high-quality studies. In a U.K. survey
encompassing 112 vascular consultants 22%
of teaching hospitals and 44% of district
general hospitals did not use duplex for
Figure 4. In a comparison to subsequent
angiographic findings, combining both the
V2/V1 ratio and a peak systolic velocity
< 45 cm/sec, nearly perfect accuracy is
achieved with duplex scanning in detecting
vein graft stenoses (Taylor et al. 1992,
reproduced with permission of Eur J Vasc
Surg)
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screening vein grafts. The reasons stated for
the negative attitude were either insufficient
resources or a lack of belief in its efficacy.
(Gibbs, RGJ et al. 1997)
3.2.5. Other non-invasive studies
Non-invasive impedance analysis is the most
extensively studied alternative to other non-
invasive studies. (Wyatt, MG et al. 1991;
Davies, AH et al. 1993; Arora, S et al. 1995;
Woodburn, KR et al. 1995; Zhang, Q et al.
1995) Impedance can be defined as an
opposition to pulsatile flow, and for the
calculation pulsatile pressure and flow need
to be assessed. Noninvasive surrogates
utilised for impedance calculations are
pletysmographic pulse volume recordings
and Doppler waveforms. These measure-
ments can be regarded as rough non-invasive
estimates of impedance rather than true
empirical measurement of impedance.
(Wyatt, MG et al. 1991) Yet good results
have been achieved. Wyatt et al. were the
first to report on impedance analysis as a
method for screening vein grafts. (Wyatt,
MG et al. 1991) Their method involved
Doppler waveforms and pulse volume
recordings from the upper and lower ends of
the graft, and the higher of the two
impedance scores was used for subsequent
analysis. An impedance score > 0.45 was
able to detect 20 of 22 grafts determined to
be at risk by arteriography. Similar results
were obtained by Arora et al., who, with a
threshold value of 0.5 achieved a sensitivity
of 91% and a specificity of 94%. (Arora, S et
al. 1995) Woodburn et al. combined direct
Doppler insonation with an impedance
value over 0.55 and were able to identify all
at-risk grafts. (Woodburn, KR et al. 1995)
In the study by Davies et al., impedance
analysis was a better screening method than
single-point PSV measurement or ABI, but
the accuracy was inferior to that provided
by duplex scanning of the entire graft.
(Davies, AH et al. 1993) However, these
results on the accuracy of impedance analysis
were not confirmed by Zhang et al., (Zhang,
Q et al. 1995) who could not recommend
the use of impedance analysis for screening
grafts.
Even though equipment is commercially
available, impedance analysis has not gained
wider popularity. The method per se is cheap,
simple and quick to perform and it may
offer improved accuracy in the detection of
run-off disease over duplex scanning. It does
not, however, grade the stenosis nor does it
give any anatomical information; thus, further
imaging is always necessary if significant
hemodynamic lesions in the bypass are
suspected. It may also be that the practical
difficulties involved in obtaining reliable
graft waveform signals with a hand-held
Doppler, in particular for deeply routed
grafts, are an obstacle to the widespread use
of this method.
3.3. The incidence of vein
graft stenoses
The true incidence and time of onset of
vein graft stenoses is somewhat difficult to
establish, as the definition of vein graft
stenosis depends on the imaging modality
utilised and the variable intensity of serial
imaging studies in published series.
In a landmark study by Szilagyi et al.
(1973), the results of long-term angiographic
follow-up in a large series of lower limb
autogenous vein bypasses performed over
the period 1962 to 1972 were published.
(Szilagyi, DE et al. 1973) In a series of 260
autogenous vein grafts, on the basis of
angiographic appearance, he recognized six
different types of morphological alterations
along the course of the graft or at the
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anastomoses. The most common change was
a wavy narrowing of the lumen (myointimal
hyperplasia?), followed by arteriosclerosis,
fibrotic valve, traumatic stenosis, suture
stenosis and aneurysmal dilatation.
Altogether, these alterations were detected
in almost one-third of grafts. Furthermore,
all the angiographic lesions showed
progression in serial angiographic studies,
albeit with some variations in the rate of
progression. The mean time of onset for
stenotic lesions was over 12 months apart
from suture stenosis (9 months). The rather
late onset is more a reflection of the study
design, where angiograms where obtained
before discharge, at 1 year postoperatively
and at intervals of 1–3 years thereafter. To
date the Szilagyi’s series is the only follow-
up study with serial angiographic data.
The more modern series on incidence of
stenosis are based on data from vein graft
surveillance programmes using duplex
scanning. According to these studies, the
incidence of vein graft stenoses following
bypass remains uncertain ranging from 6 to
36% (Table 3). There are several potential
reasons for the large variation. The follow-
up time in these series is variable, but, the
peak incidence is frequently between 6-9
months, however, and the number of detected
stenoses after one year is only 0 to 20% of all
stenoses. In some series it is not indicated,
how many extrinsic lesions are included. In
addition, even though the stenoses were
usually confirmed with angiography, the
duplex criteria are variable and, furthermore,
in some studies only those stenoses which
were revised are reported. However, it is
justifiable to estimate from this aggregated
data that the ”true” incidence of stenosis of
more than 50% reduction in diameter is at
least 20% and the majority of stenoses
develop within the first postoperative year.
3.4. The natural  history of
untreated vein graft stenoses
To understand the nature and behaviour of
vein graft stenosis is of crucial importance in
providing the theoretical rationale for clinical
decision making. On the whole, there are few
comparative studies concentrating on the
natural course of a stenosed graft left
untreated, and their results are contradictory.
In the original study by Moody et al. (1989),
22 asymptomatic graft stenoses of variable
degree diagnosed with IV-DSA were
followed up by a second IV-DSA for a median
of 13 months (Moody, P et al. 1989). It found
that five of these (23%) were occluded
compared to 4 out of 58 non-strictured grafts
(6,9%). In studies by Mattos et al. (1993) and
Table 3. Incidence of vein graft stenosis
following infrainguinal arterial
revascularisation (at least 1-year duplex
scanning follow-up)
Author (Year) No of Stenosed
grafts  (%)
Grigg (1988) 80 19 (24)
Mills (1990) 379 24 (6)
Moody (1990) 63 15 (24)
Taylor (1990) 301 57 (19)
Bandyk (1991) 394 83 (21)
Stierli (1991) 41 10 (23)
Wyatt (1991) 50 12 (24)
Laborde (1992) 124 38 (31)
Idu (1993) 187 58 (31)
Mattos (1993) 170 62 (36)
Bergamini (1995) 317 56 (18)
Caps (1995) 61 21 (34)
Lundell (1995) 56 9 (16)
Mohan (1995) 171 56 (33)
Passman (1995) 447 36 (8)
Wilson (1996) 275 85 (22)
Olojugba (1998) 44 15 (34)
Avino (1999) 528 87 (16)
Watson (2000) 277 75 (27)
Total 3695 818 (22)
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Wilson et al. (1996) the patency rates were
lower for subgroups of untreated patients
known to have stenosis detected by duplex
scanning (Mattos, MA et al. 1993; Wilson, YG
et al. 1996). However, discordant experiences
have been reported by Dougherty et al.
(Dougherty, MJ et al. 1998) They divided a
cohort of 85 stenosed grafts into three groups:
25 grafts revised early, 20 grafts revised more
than 2 months after the detection of stenosis
and 40 grafts not revised at any time. No
difference in any outcome criteria was
observed between the three groups.
These studies imply that vein graft stenosis
does not inevitably lead to graft occlusion
and the natural course for an individual
lesion can be quite variable. When 158 graft
lesions of variable degree in 61 grafts were
followed, regression was in general more
common than progression and was
dependent on the severity of the stenosis.
(Caps, MT et al. 1995) In that study it was
also observed that lesion progression in vein
grafts with multiple lesions tend to occur in
an all-or-none fashion; progression and the
requirement for revision procedures in these
conduits were usually either not seen at all
or were seen at multiple sites. Dougherty et
al. studied the fate of 42 grafts of high-
degree stenoses, which, for various reasons,
were not revised. (Dougherty, MJ et al. 1998)
Abnormalities regressed in 10 grafts (21.7%),
progressed in 5 (10.9%), and were stable in
the remainder. Fourteen grafts (30.4%) were
ultimately revised. However, 38% of their
series were prosthetic grafts and the results
were not subanalysed for different graft
materials. In a study of 63 duplex-verified
stenoses with over 50% of diameter reduction,
42 stenoses were treated conservatively
mainly because they did not cause
hemodynamically significant ABI-reduction.
(Nielsen, TG 1996) It was found that 16
lesions (38%) regressed or remained stable,
eight (19%) progressed and another 18 (43%)
resulted in bypass thrombosis during a median
follow-up of 8 months. Furthermore, this
study showed that patients who developed
stenoses within 3 months of surgery had a
significantly higher risk of bypass thrombosis
than patients in whom the stenosis
development occurred at a later stage (12
month patency 40% vs. 83%). Accordingly,
Ho et al. (1995) found that the risk of
thrombosis was twice as high in patients
with stenoses detected within three months.
(Ho, GH et al. 1995) The severity of stenosis
at the time of detection seems to predict the
course of further progression. In an
angiographic study of 18 stenosed grafts, no
occlusions were found when stenoses of less
than 50% (0/8) were treated conservatively.
In lesions of 50 to 69% and ≥ 70% of
diameter reduction 57% (4/7) and 100% (3/
3) respectively occluded. (Idu, MM et al.
1993) Others have also verified the
significance of the degree of stenosis for
stenosis progression. (Moody, P et al. 1989;
Caps, MT et al. 1995; Ho, GH et al. 1995)
In all modern series, stenoses thought to
threaten graft patency have undergone
prophylactic revisions, and subsequent studies
on the natural history of vein graft stenoses
comprise only subgroups of patients, who, for
various reasons, did not undergo revision.
These selected patient populations may not
be fully representative. Even though evidence
is provided that stenoses increase the risk of
graft occlusion,  to date, the natural course of
stenotic lesions has not been completely
clarified and the proportion of untreated
grafts that become occluded is unknown.
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4. Treatment of vein
graft stenosis
4.1. Criteria for intervention
It is crucial for the whole concept of
managing stenosed vein grafts that the criteria
for intervention are as optimum as possible in
order to minimise the number of unnecessary
procedures introducing extra risk for the
patient and the patency of the graft. As the
natural history and the proportion of vein
grafts that eventually occlude is not known,
there has been a tendency to apply the same
criteria stenosis that are used when treating
symptomatic stenoses in native arterial tree.
The treatment decision has been based on
angiographic confirmation of a stenosis. A
threshold value of 50% (corresponding V2/
V1 ratio of 2.0) has been used in many
centres as an intervention point. (Mills, JL et
al. 1990; Taylor, PR et al. 1992; Idu, MM et
al. 1993; Mattos, MA et al. 1993; Wilson, YG
et al. 1996) However, more recent studies
have suggested that the cut-off value is
perhaps too low, and intervention is necessary
only for those lesions with a V2/V1 ratio
above 3.0 or 3.5. (Sladen, JG et al. 1989;
Papanicolaou, G et al. 1995; Westerband, A
et al. 1997; Olojugba, DH et al. 1998) In a
small retrospective series by Papanicolau et
al. (1995),  no grafts with a velocity ratio less
than 3.4 occluded or required revision.
Westerband et al. (1997) completed a
prospective study in which the fate of 43
stenosed grafts (V2/V1 > 1.5) was studied.
When applying V2/V1 ratio > 3.5 as the
criteria for further evaluation and
intervention, they found that 46% of stenoses
remained stable or regressed, whereas the
remaining 54% progressed and were revised.
However, three stenosed grafts occluded
prior to intervention. Olojugba et al.
prospectively scanned monthly 38 primary
stenoses with V2/V1 ratio between 2.0 and
2.9. (Olojugba, DH et al. 1998) Overall,
42% of them regressed spontaneously, 29%
remained stable and 29% progressed to a V2/
V1 ratio ≥ 3.0 and underwent correction.
No grafts with V2/V1 ratio between 2.0 and
2.9 occluded under this policy. It seems
probable that ‘watchful anticipation’ is
appropriate treatment for a stenosis with a
V2/V1 ratio < 3.0. This would markedly
reduce the number of interventions without
impairing graft patency.
With the increasing confidence in the
quality of duplex scanning, the mandatory
requirement for angiographic confirmation
before making a treatment decision has been
questioned. (Caps, MT et al. 1995; Treiman,
GS et al. 1997; Calligaro, KD et al. 1998; Idu,
MM et al. 1998) In the data reported by
Caps et al. (1995), preoperative angiography
did not alter the management plan in any of
their cases. Treiman et al. (1997) surgically
revised 31 grafts on the basis of duplex scans
alone, and only two of them occluded within
30 months. Others have suggested that
duplex scanning can replace preoperative
angiography, provided that the stenosis is
well-defined within the conduit or at the
inflow and outflow arteries (Calligaro, KD
et al. 1998) Idu et al. (1998) proposed an
algorithm, which dictates that stenosed grafts
with V2/V1 ratio < 2.5 be subjected to
intensified surveillance, those with a V2/V1
ratio between 2.5 and 4.0 undergo
confirmatory angiography of the severity of
the lesion and those with a V2/V1 ratio
above 4.0 be prescribed corrective measures
solely on the basis of duplex findings. This
policy has, however, encountered some
criticism. Landry et al. calculated that
angiography had significantly contributed
to the preprocedural planning in 42% of
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cases where non-invasive studies signalled a
failing graft. (Landry, GJ et al. 1999)
4.2. Treatment options
4.2.1. Nonoperative management
Many different pharmacological inter-
ventions have shown promise in animal
studies. The combination of aspirin and
dipyridamole significantly reduced the
formation of MIH in femoral vein bypass
grafts in dogs compared to controls (Dobrin,
PB et al. 1988). Several types of ACE-
inhibitors have been studied with conflicting
results (Daemen, MJ and De Mey, JG 1995).
Low molecular heparin suppressed the
formation of MIH in a sheep model (Ao,
PY et al. 1999). However, in humans all
pharmacologic regimens have produced
little or no benefit (Davies, MG and Hagen,
PO 1995).
Irradiation therapy has been demonstrated
to attenuate the formation of MIH in
experimental studies. Endovascular brachy-
terapy has been introduced to clinical work
as an adjunct to PTA in coronary arteries,
but whether it will provide benefits of
clinical value is still unproven (Liermann,
DD et al. 1997; Illig, KA et al. 2000).
The expectations of gene therapy have
been raised in the last decade as a means of
finding solution to several medical conditions,
but to date no real clinical breakthroughs
have been achieved. In experimental models
some evidence has been gathered of successful
gene transfer to vessel wall and anti-
proliferative effect of gene therapy to reduce
the formation of MIH (Cable, DG et al. 1999;
Fortunato, JE et al. 2000).
Whilst no effective clinical treatment
regimen combatting the development of
vein graft stenosis exists, the treatment options
are invasive modalities for correcting lesions
that have already become established. In
practice, the alternatives available are surgical
correction or radiological intervention. The
different factors that are taken into account,
in addition to the general medical condition
and willingness of the patient, are the length
and location of the stenosis, the type of
conduit and the time of occurrence.
4.2.2. Surgery
There are not many large series available on
the outcome for stenosed grafts which have
undergone surgical correction. Nevertheless,
the reported patency rates are impressive,
reaching levels that are comparable with
patency rates of undiseased bypasses (Table
4). In addition, the need for repeat
procedures after primary revision seems to
be quite limited, as the reported stenosis-
free patency rates within 2 years of surgical
correction vary from 65% to 95%. (Stierli, P
and Aeberhard, P 1993; Sanchez, LA et al.
1994; Avino, AJ et al. 1999)
Surgical techniques for graft revision
involves patch angioplasty (VPA) with
autogenous vein and interposition grafts or
extension ”jump” grafts, particularly if the
lesion is at the distal anastomosis. For stenoses
within the graft, the choice is between VPA
and interposition graft, whereas for
anastomotic or juxta-anastomotic lesions it is
between VPA and extension graft. It is
generally believed that VPA will give less
durable results as the diseased segment is not
excluded, resulting in higher restenosis rate
(Bandyk, DF et al. 1991). The studies
comparing different surgical techniques have
contradictory results. Bandyk et al. achieved
inferior primary assisted patency rates at 5
years for extension grafts whereas for Avino
et al., VPA was significantly superior to both
of the other techniques. (Bandyk, DF et al.
1991; Avino, AJ et al. 1999) In contrast,
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Sullivan et al. found them all equally
effective. (Sullivan, TR, Jr. et al. 1996) All
these studies involve a small number of
patients and describe different clinical
philosophies and practices. Typically, VPA is
used primarily for very focal stenoses, while
interposition and extension grafts are
reserved for more diffuse strictures. (Sullivan,
TR, Jr. et al. 1996)
The obvious advantages of surgical
intervention are an established long-term
durability with a low incidence of recurrent
stenoses. In addition, stenosing due to
external compression can be detected and
corrected reliably. Nevertheless, surgery has
considerable perioperative morbidity and is
not free from complications. (Sullivan, TR,
Jr. et al. 1996) Furthermore, repeat surgery
in scarred tissues is at times very difficult,
especially when the lesion occurs at an
anastomosis or is located in a deeply
tunnelled graft. In addition, the occasionally
very limited autogenous vein material
resources are consumed.
4.2.3. Endovascular treatment
modalities
Endovascular techniques include percutaneous
transluminal angioplasty (PTA), stenting and
directional atherectomy. Of these, PTA has
been most extensively studied as an alternative
to surgical intervention. The studies with a
sample size large enough to permit survival
analysis show a quite acceptable long-term
assisted primary patency (Table 4). However,
although many grafts can be treated
successfully, the restenosis rate is high. There is
a large variation in reported incidence of
recurrence, as the stenosis-free patency rates
vary from 0% at 6 months to 100% at 1 year
(Table 5). While some authors claim that
recurrent stenoses can be successfully treated
Table 4. Cumulative assisted primary patency rates of grafts where either surgical or
radiological intervention has been performed for maintenance of graft patency
Open surgical correction
Author (Year) No. of Assisted primary patency
grafts 3 Mo 6 Mo 1 Year 2 Years 3 Years 5 Years
Sladen  (1981) 34 80% 76%
Bandyk (1991) 80 97% 96% 96% 92% 92% 85%
Stierli (1993) 22 95% 95%
Nehler (1994)1 100 99% 99% 98% 96% 92%
Sullivan (1996) 67 98% 98% 97% 97% 87% 72%
Landry (1999)1 168 99% 96% 95% 94% 91% 91%
Percutaneous transluminal angioplasty
Author (Year) No. of Assisted primary patency
grafts 3 Mo 6 Mo 1 Year 2 Years 3 Years 5 Years
Sanchez (1991)2 71 100% 94% 89% 74% 68% 58%
Berkowitz (1992) 58 95% 87% 82% 80% 80%
Houghton (1997)3 42 84%
Tonnessen (1998) 50 74%
1The reports by Nehler et al. (1994) and Landry et al. (1999) comes from the same institute. The former comprises grafts
revised from 1987 to 1993 and the latter grafts revised between 1990 and 1997; it is likely that these reports include
partly same patients.
2Secondary patency, includes a minority of prosthetic bypasses
3Technical failures are excluded
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with a repeat PTA, and recommend it as a
primary therapy for graft stenoses, (Berkowitz,
HD et al. 1992; London, NJ et al. 1993;
Tonnesen, KH et al. 1998) studies with less
favourable long-term data have been reported.
(Perler, BA et al. 1990; Whittemore, AD et al.
1991) No case-matched comparative studies
exist. Open surgical and endovascular
techniques used to repair stenotic segments
are variable with regard to anatomic site,
lesion length, conduit diameter, and time of
appearance after the primary grafting
procedure. The largest published series in
which both treatment modalities were
equally used showed identical stenosis-free
patency rates of 63% at 2 years both for both
surgical and for endovascular intervention.
(Avino, AJ et al. 1999) Typically, PTA was also
used in their study in selected patients to treat
focal (< 4 cm) lesions, whereas more extensive
and diffuse longer lesions were treated
surgically. Nevertheless, they found a similar
outcome regardless of the graft type, treatment
of primary versus recurrent stenosis and site of
the stenosis.
Attempts to refine the indications of PTA
have been made with regard to location of
the stenosis, time of occurrence and its
length. Berkowitz et al. advocated PTA for
proximal graft lesions and surgical revision
for mid-graft and distal anastomotic lesions
because they did much worse with balloon
angioplasty. (Berkowitz, HD et al. 1992)
Accordingly, others have also found a high
restenosis rate for lesions at distal third of the
graft. (Dunlop, P et al. 1995) Somewhat
conflicting results were obtained in a recent
study in which graft body stenoses showed a
better 2-year cumulative primary patency
than proximal or distal juxta-anastomotic
lesions (86%, 45% and 62%, respectively).
(Hoksbergen, AW et al. 1999) Tonnessen et
al. suggested that early lesions can be
successfully treated with PTA, while late
treatment is of less benefit. (Tonnesen, KH
et al. 1998) In their study, the length of
stenosis did not affect the results of PTA. In
contrast, Avino et al. achieved best results for
focal (< 2 cm) and late-appearing (> 3
months) stenoses; the stenosis-free patency
at 1 year was 89% for those lesions. (Avino,
AJ et al. 1999)
Only anecdotal evidence exists on the
suitability of stenting for vein graft stenoses
Table 5. Recurrence rates of stenotic lesions after PTA
Author (Year) Nr of grafts Primary patency
3 Mo 6 Mo 1 Year 2 Years 3 Years 5 Years
Alpert (1979) 12 83%
Greenspan (1985) 6 66%
Thompson (1989) 14 0%
Moody (1990) 8 100%
Taylor (1990) 13 46%
Perler (1991) 19 69% 29% 22%
Whittemore (1991) 54 70% 59% 42% 36% 18%
Sanchez (1994) 95 42%
Spijkerboer (1997) 43 44%
Avino (1999) 56 66% 63%
Hoksbergen (1999)* 58 60% 55%
* Number of stenoses
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(Davies, AH et al. 1993) and its role has not
been addressed. Experiences with stenting
for infrainguinal native arteries do not speak
in favour of durable long-term results.
Directional atherectomy (DA) is an
endovascular technique, in which, under
fluoroscopic control, the lesion is resected
step-by-step around the entire circumference
of the vein lumen. It is postulated that the
actual removal of the atheroma might result
in a lower restenosis rate compared with the
more traumatic remodelling of the atheroma
and arterial wall during PTA. Only one
report of the use of DA in vein graft stenosis
exists. (Porter, DH et al. 1996) In this study,
technical success was achieved in 49 of 52
procedures (94%) and at 3 years the primary
patency rate was 79%, approaching long-
term patency rates of surgical vein patch
angioplasty. A disadvantage of DA is that it is
of limited use in narrow (< 3 mm) grafts.
In summary, the role of PTA is
controversial as a therapy for vein graft
stenoses. PTA is a temping treatment
modality, as it is less invasive, associated with
low morbidity and gives access to anatomical
locations that are difficult to reach with
open surgical techniques. A ”PTA first”-
policy may be proposed, but that seems to
lead to some extra risk for the graft and the
patient, as well as to the increased cost of
repeated procedures. Many authors prefer
surgical repair of peripheral bypass stenoses,
because it is likely to result in better long-
term patency. (Perler, BA et al. 1990; Bandyk,
DF et al. 1991; Whittemore, AD et al. 1991;
Sanchez, LA et al. 1994) However, the ability
to draw firm conclusions is hampered by a
significant difference in the analysis of results.
Perhaps only a prospective randomised
clinical trial to evaluate PTA in comparison
with surgical interventions will provide some
answers. However, PTA can be regarded as a
reasonable option for cases with high
operative risk, lesions with difficult anatomy
or extensive scarring from previous
procedures. The potential benefits and
disadvantages of interventional radiological
techniques in comparison to surgical
techniques are listed in Table 6.
Table 6. The potential advantages and drawbacks of the currently used radiological and
surgical techniques in the treatment of infrainguinal vein graft stenoses
Method Advantages Disadvantages
Open surgical procedure Excellent long-term results Consumes autogenous vein material
Low-technology proven procedures Higher morbidity
The diseased segment can be excluded At times technically very demanding
PTA Well tolerated by the patients Higher recurrence rate
Access to difficult anatomic locations Unproven durability
Repeatable Risks of radiation and contrast agents
Relatively inexpensive
Directional atherectomy Diseased segment is excised Not for small-calibre vein grafts
Expensive
Very limited experience
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5. Vein graft surveillance
5.1. Rationale for vein graft
surveillance
The outcome for a thrombosed graft is bleak,
as the reported salvage patency rates following
graft occlusions requiring thrombectomy or
thrombolysis combined with correction of
the underlying defect range from 20% to
37%. (Hye, RJ et al. 1994) In addition, the
increasing knowledge of the high incidence
of vein graft stenoses, the 3-6 fold increase in
the risk of graft occlusion which they
probably cause and the successful outcome of
prophylactic revision procedures all provide
circumstantial evidence in favour of active
identification of failing grafts in order to
improve the overall outcome of infrainguinal
bypass surgery. Therefore, periodic
surveillance, typically consisting of colour
duplex scanning and ABI measurements, has
become a widely accepted common policy
(TASC 2000).
The ultimate goal of an active surveillance
programme is to prevent unnecessary
amputation. According to a U.K. calculation,
a surveillance programme can, in principle,
be justified as cost-effective if it can be
demonstrated that 2% patients undergoing
reconstruction will avoid a major lower limb
amputation thanks to surveillance. (Harris,
PL 1992)
5.2. The length and intensity of a
surveillance programme
Surveillance programmes, however, put a
considerable strain on the workload of a
vascular surgery unit. The necessity of
repetitive testing over longer periods of time
is expensive, time consuming, and requires
adequate technical support. In the modern
climate of increasing cost-awareness, strong
arguments for the economy in surveillance
programmes have been put forward. (Idu,
MM et al. 1998) The theoretical ways of
improving the cost effectiveness of
surveillance programmes are to simplify the
surveillance methods, to identify the risk
groups at risk of graft failure and to reduce
the length and intensity of the surveillance
programme.
There is a fairly uniform consensus that
during the first year after surgery the first
post-discharge test should be performed
within 4-6 weeks and thereafter at 3-month
intervals. (Cohen, JR et al. 1986; Disselhoff,
B et al. 1989; Sladen, JG et al. 1989; Taylor,
PR et al. 1990; Davies, AH et al. 1994) As
reviewed earlier, the value of pre-discharge
duplex scanning is still unsettled. (Passman,
MA et al. 1995; Wilson, YG et al. 1995;
Olojugba, DH et al. 1998) It is potentially of
benefit in detecting abnormalities missed by
intraoperative assessment. A good-quality
duplex scan is, however, laborious and difficult
to accomplish at that point in time due to
the tenderness of the wound and the poor
visualisation caused by oedema and
haematoma in the area operated. Further-
more, that point in time is not optimal for
reintervention because the patient is still
recovering from the primary procedure.
The vast majority of lesions develop
within the first 12 months, and for that
reason many authors agree, that surveillance
can be discontinued at that time (Taylor, PR
et al. 1990; Mohan, CR et al. 1995;
Giannoukas, AD et al. 1996; Idu, MM et al.
1998). Taylor et al. (1990) were among the
first to propose a limit on the duration of
surveillance programme. In their study of
412 femoro-distal grafts, all stenoses were
detected within one year after the operation,
and none occurred after this. In a series of
171 pure in situ bypasses, only two grafts
that had normal duplex findings for up to 6
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months had to be revised later. (Mohan, CR
et al. 1995) Similarly, Idu et al. (1998), in a
study of 300 grafts, discovered an incidence
of 2% at 9 months and 1% at 12 months for
the development of an event causing de novo
stenosis. They recommended a surveillance
protocol that, following discharge, includes
examinations at 6 weeks, 3 months and 6
months and discontinuation thereafter if
duplex abnormalities or previous revisions
are absent.
Many centres, however, have maintained
the opposite view and propose further
biannual assessment after the first
postoperative year. Some authors favour
surveillance for at least 2 years, (Bandyk, DF
1990; Sanchez, LA et al. 1991) but others
advocate that vigorous surveillance should
be continued indefinitely and have provided
long-term follow-up data as an evidence of
a low but steady graft revision requirement.
(Dunlop, P et al. 1995; Erickson, CA et al.
1996; Ihnat, DM et al. 1999) Dunlop et al.
(1995) surveyed 112 grafts for a median of
34 months. Thirty-eight grafts (34%)
developed at least one stenosis; of these, 8
primary stenoses occurred more than 1 year
after the initial surgery. Erickson et al. (1996)
observed that, in 169 of 556 bypasses where
at least one reintervention was performed
for the maintenance of graft patency, thirty
occurred more than 24 months after the
initial bypass. However, seven of these were
revisions remote from the conduit with no
effect on primary patency. In addition, in
this series stenoses in the vein itself
developed after a median of 8.5 months,
whereas inflow and outflow obstructions
occurred at a median of 15 and 29 months,
respectively. This was explained by the
different nature of the lesions, with slower
progressing arteriosclerosis in the native
arteries being the dominant factor after 24
months. These findings were further
supported by the most recent study, in which
341 grafts were followed up for a mean of 35
months. (Ihnat, DM et al. 1999) Of these,
116 required revision, most (82%) within
the first two postoperative years. However,
an annual 2% to 4% incidence of late-
appearing initial graft stenosis which
persisted during long-term follow-up was
also observed.
It has been established, that early-
appearing lesions are more ”malignant” in
nature and that the majority of stenoses will
develop within the first year. It is clear that
after this time frame it is more questionable
whether a surveillance programme is still
practical and effective as the number of
stenoses found is relatively low.
5.3. The impact in outcome
Before factors like cost-effectiveness and
quality of life can be considered, the
potential clinical merits of surveillance must
be demonstrated, firstly as a maintenance of
patency of a number of grafts which would
otherwise fail and secondly, and more
importantly, as improved limb salvage.
5.3.1 Retrospective series
The first positive reports on the merits of
surveillance were based on the assumption
that all stenotic grafts revised would inevitably
have led to occlusion if left uncorrected.
Thus, the total differential between primary
and secondary patency would represent the
improved graft salvage achieved by careful
surveillance (Figure 5). Berkowitz et al.
(1987) demonstrated a secondary patency
rate of 70%, compared with a primary
patency rate of 47%, at 5 years. They stated
that this improvement in patency was
attributed to surveillance programme thus
salvaging 23% of grafts from occlusion.
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Likewise, Bandyk et al. (1987) found
differences between 3-year secondary and
primary patency in femoral-popliteal and
femoral-tibial in situ bypasses of 41% and
22% respectively, and similarly credited
postoperative surveillance of graft hemo-
dynamics and the success of graft revision
for the superior long-term outcome.
(Bandyk, DF et al. 1987) This view has been
strongly echoed by several authors.
(Disselhoff, B et al. 1989; Mills, JL et al. 1990;
Bergamini, TM et al. 1991; Laborde, AL et al.
1992; Stierli, P et al. 1992; Erickson, CA et al.
1996) This difference is, however strongly
influenced by the unit’s activity in
performing revision procedures on patent
bypasses; the less strict the intervention
criteria the greater the arbitrary shift from
primary to secondary patency. Thus, it is
difficult to justify surveillance simply on the
basis of a significantly better secondary or
primary-assisted patency compared to
primary patency.
As previously stated, even though stenotic
grafts can be identified relatively accurately
by means of duplex, which grafts will go on
to occlude, and should therefore be revised,
is less clear. Despite the fact that only some
of the stenotic grafts eventually fail, it is
estimated that with meticulous surveillance
and selective secondary intervention, a
durable long-term improvement of 10-19%
in primary-assisted and secondary patency
rates can be achieved. (Sladen, JG and
Gilmour, JL 1981; Moody, P et al. 1990)
Indeed, the long-term outcome in reported
surveillance series during the last 10-15 years
has been quite acceptable, with five-year
secondary patency rates ranging from 67%
to 89% (Table 7). The data accumulated
show that the higher the number of revised
grafts, the greater the difference between
primary and secondary patency. The
secondary patency rates and limb salvage
rates does not, however, follow a linear
ascending pattern which one might expect as
a response to increasing number of revisions.
There are several potential explanations for
the failure to demonstrate the merits of
surveillance, in addition to the possible
inefficiency of the revision procedures, on
the basis of these outcome studies. Problems
when comparing these series include
differences with respect to the presence of
CLI and the different types of bypasses
performed. Although it has been shown that
the outcome of in situ and reversed vein
bypass are similar, the amount of ectopic vein
graft varies and, furthermore, the distribution
between femoropopliteal and infrageniculate
bypasses is variable. An additional difficulty
when reviewing this data is that only a
minority of studies report limb salvage rates.
Figure 5. The first reports on the benefits of
surveillance were based on an assumption that
all grafts with detected stenoses would have
occluded without intervention. Thus the total
difference between primary and secondary
patency represents the improved outcome
thanks to graft surveillance (reproduced with
permission from Am J Surg).
Sladen et al. Am J Surg 1981;141:p. 552 Fig 6.
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A comparison with non-surveillance
series is difficult to perform, as all modern
series comprise a protocol of some form of
surveillance and elective revision. Thus, only
comparison with historical control series is
available. A summation analysis compared the
outcomes of published vein bypass series
undergoing duplex-based surveillance and
prophylactic treatment of stenoses to those of
vein grafts followed clinically. (Golledge, J et
al. 1996) A total of 2680 surveillance and
3969 non-surveillance vein grafts were
analysed; the non-surveillance grafts were
from studies published from 1971 to 1990.
While the total number of occluded grafts
was significantly greater for the non-
surveillance group (15% versus 27%), no
difference in the number of amputations was
observed. However, the principles of meta-
analysis could not be strictly followed due to
poor reporting, especially regarding limb
salvage rates, and the absence of randomised
patients. Some of the other problems
encountered which hindered direct
comparison were that it was not always stated,
especially in the non-surveillance series, how
an occlusion was defined and, in cases where
several series were published by the same
author, it was not certain that there was no
repetition of patients.
5.3.2. Comparative studies
There have been few studies directly
comparing duplex and clinical follow-up
following infrainguinal bypass. Moody et al.
compared 63 femoro-popliteal vein grafts
that were prospectively followed-up using
duplex scanning with a historical series of
216 femoro-popliteal vein grafts. (Moody, P
et al. 1990) They found an improvement of
15% in cumulative 1-year secondary patency.
Accordingly, Idu et al. demonstrated a
Table 7. Results of infrainguinal bypass with vein graft in surveillance series with a special
reference to the incidence of revised grafts
Author Year Grafts Revised Primary Secondary Limb salvage
patency patency
(%) 1y 3y 5y 1y 3y 5y 1y 3y 5y
Donaldson 1991 4406 18 (4) 81 76 72 87 84 83 - - 88
Grigg 1988 806 5 (6) 79 - - 85 - - - - -
Golledge 1996 50 3 (6) - - - 88 - - 94 - -
Disselhoff 1989 696 6 (9) - 631 - - 791 - - - -
Rhodes 1999 2285 20 (9) 68 - 57 78 - 68 85 - 78
Green 1990 1773,4 20 (11) 86 70 66 92 80 80 - - -
Shah 1995 20586 253 (12) 84 77 72 91 86 81 97 - 95
Sladen 1981 1739 33 (19) - - 65 90 85 81 - - -
Wilson 1996 27511 59 (21) 67 49 - 84 69 - 91 86 -
Berkowitz 1987 102 22 (22) - - 47 - - 70 - - 86
Laborde 1992 1246 30 (24) - 62 - - 87 - - - -
Bergamini 1991 3616 95 (26) 78 67 63 92 86 81 - - -
Mohan 1995 1716 45 (26) - - 60 - - 89 - - 92
Stierli 1992 43 12 (28) 54 54 - 88 88 - - - -
Idu 1998 3003,8 84 (28) 65 581 - 91 841 - - - -
Erickson 1996 5566 169 (30) 73 64 62 94 89 86 - - -
Dunlop 1995 1127,10 38 (34) 42 32 272 79 72 672 - - 792
1Patency rates at 2 years
2Patency and limb salvage rates at 4 years
3Occlusions within 30 days of primary procedure excluded
4The series include 31 prosthetic bypass grafts
5Only pedal bypasses; CLI indication in all procedures
6In situ vein grafts only
779 in situ and 33 reversed vein grafts
8172 (57%) other than in situ grafts
9Reversed vein grafts only
10PTA as a primary treatment for all stenoses
11The series include 24 prosthetic bypass grafts
43REVIEW OF THE LITERATURE
significantly higher assisted primary patency
rate in 160 vein grafts which underwent
duplex surveillance, compared to 41 vein
grafts whose postoperative follow-up
comprised only conventional clinical follow-
up (91% and 72% respectively at 3 years; first
month graft failures excluded). (Idu, MM et
al. 1993) In addition, limb salvage rate at 5
years improved by 7% in favour of duplex
surveillance group. These findings were later
echoed by a large retrospective study, in
which 317 vein bypasses which had intensive
surveillance were compared with 222 vein
bypasses which had clinically indicated
follow-up. (Bergamini, TM et al. 1995) Both
secondary patency and limb salvage were
improved for bypasses followed by intensive
surveillance, but the difference attained
statistical significance only after 3 years from
the primary procedure. In this study, the
groups were not directly comparable, as
more patients who had CLI at presentation
and had undergone long crural or pedal
bypasses  were more frequent in the non-
surveillance group. In both of these last-
quoted studies, however, the primary patency
rates were no different in the two groups,
indicating that the duplex surveillance group,
for some reason, would have fared better than
the non-surveillance group even without
prophylactic revisions. In contradistinction to
previous studies, Golledge et al. failed to
show any significant difference in the
outcome of duplex surveillance compared
with clinical follow-up, albeit that the
comparison was retrospective to a historical
control series from the same institute.
(Golledge, J et al. 1996) However, as both
secondary patency and limb salvage were
improved in the surveillance group and the
sample size in this study was small (50 vein
grafts in each group), a type II statistical
error may be present.
5.3.3 Randomised studies
There has been only one randomised
controlled trial comparing duplex with
clinical assessment in lower limb bypasses
(Lundell, A et al. 1995). A total of 106 vein
grafts were randomised, with 56 allocated to
intensive duplex surveillance and 50 to
routine follow-up including annual out-
patient visits and measurement of ABI. In
this study, Lundell et al. showed that intensive
duplex surveillance had a 25% advantage in
assisted primary patency rates at 3 years.
However, whilst only 6 more grafts were
revised in the intensive surveillance group,
the total number of occlusions in both the
intensive surveillance group and the routine
follow-up group was high (11 and 20
respectively). This indicates that the observed
advantage in patency rates may not be
attributable solely to the intensive
surveillance. No significant difference was
observed in the limb salvage rates.
There appears to be little firm evidence in
the current literature that infrainguinal vein
graft surveillance programmes unequivocally
improve patency and limb salvage. This has
led some to call for a large randomised
prospective study to definitively evaluate the
merits of surveillance. (Golledge, J et al. 1996;
Beattie, DK et al. 1997; Kirby, PL et al. 1999)
44 AIMS OF THE PRESENT STUDY
The purposes of this study were:
1. To analyse the predictive value of intraoperative flow measurements for the development
of vein graft stenoses.
2. To examine the accuracy of duplex scanning as a method of detecting vein graft stenoses.
3. To test a new, easily performed non-invasive method for vein graft surveillance.
4. To evaluate the potential merits of intensive duplex surveillance on the outcome of
infrainguinal arterial reconstruction in a randomised prospective study.
Aims of the present study
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1. Patients
The study material consisted of patients
who underwent infrainguinal arterial bypass
reconstruction during the period 1991 to
1999 at the Department of Vascular Surgery,
Helsinki University Central Hospital. This
unit serves as an academic teaching hospital
and vascular surgery referral center serving
the population of 1.59 million people living
in the Helsinki metropolitan area. This unit
had adopted an active policy for the treatment
of CLI in the 1980s. As part of this policy, all
potentially mobile patients without absolute
contraindications for surgery and even at
times with limited technical prerequisites,
were offered an open surgical bypass
operation. During these years, a total of 1357
infrainguinal bypass reconstructions for
arterial disease were performed of which 830
utilised vein graft as a bypass material. The
indication for procedure was, in 78% of cases,
CLI.
The characteristics of the patients in the
different studies are presented in Table 8.
The pertinent risk factors were reported in
Materials and methods
Table 8. Patient characteristics and indications for the surgical procedure.
Study I Study II Study III Study IV Study V
Study period 7/1994-6/19991 3-12/1998 1-8/1999 1/1991-12/19931 1/1991-12/19951,2
No. of patients 195 67 51 179 344/1424
No. of grafts 207 69 63 185 362/1474
Mean age 71 68 71 693 72
Gender (M/F) 113/94 49/20 36/27 103/493 86/61
Diabetes (%) 97 (47) 55 (36)3 58 (39)
Hypertension 87 (42) 47 (33)
CAD 91 (44) 72 (47)3 67 (46)
CVD 35 (17) 21 (14)3 23 (16)
COPD 23 (11)
Renal insufficiency 23 (11)
Previous vascular
procedure 87 (42) 60 (39)3
Indication:
   Claudication 23 (11) 9 (13) 20 (13)3 52 (14)
   CLI 175 (86) 58 (84) 63 (100) 128 (84)3 302 (83)
      Rest pain 47 (24)
      Ulcer 83 (40)
      Gangrene 45 (22)
   Other 9 (5) 2 (3) 4 (3)3 8 (2)
1Time of the bypass operation; 2All the patients in Study IV are also included in the Study V; 330-day occlusions,
amputations and deaths are not in the numbers; 4Grafts that had totally accomplished follow-up
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accordance with the Finnvasc Registry
criteria. (Salenius, JP et al. 1993) CLI was
defined in accordance with criteria laid
down by the European Working Group on
Critical Leg Ischaemia whenever applicable
(Beard, JD 1992)
All patients with prosthetic and
composite bypass grafts were excluded, as
were immediate reoperations, i.e. takeback
procedures performed within 30 days of
previous vascular or endovascular
reconstruction. In the randomised studies,
only primary reconstructions were included
(IV,V). Bypass grafts which were subjected
to adjuvant procedures, such as AVF at the
distal anastomosis (I, III) and microvascular
free flap transfer anastomosed to the bypass
graft (I), were excluded.
2. Methods
2.1. Data acquisition
The patients were identified in the registry
of the Department of Vascular Surgery as
having had an infrainguinal bypass with vein
as the graft material (I). The vascular
laboratory, hospital, and outpatient clinical
records were reviewed and the data were
tabulated in a computer database. For
comparative studies on surveillance methods
(II,III), the patients were identified and
recruited during routine outpatient clinical
visits and prospectively followed up with
continuous recording thereafter. For the
randomised studies (IV,V), the patients were
recruited during the immediate post-
operative period following the bypass
operation prior to discharge and their
follow-up data was collected from outpatient
clinical records into a computer database.
2.2. Preoperative examinations
The routine preoperative evaluation
included detailed patient history, physical
examination, chest x-ray, resting ECG and
serume concentration of creatinine. Ankle
blood pressure measurements were
performed in the vascular laboratory by
dedicated technicians using a hand-held
Doppler probe and the ABI calculated. Toe
blood pressure was measured using photo
pletysmography. Selective angiography of
the affected limb was, as a rule, performed
by experienced interventional radiologists,
who routinely examined the ipsilateral
suprainguinal arteries with a duplex scan to
rule out significant flow disturbances in the
aorto-iliac segment.
2.3. Operative technique
The patients were routinely operated on
under combined spinal and epidural
anaesthesia. General anasthesia was chosen
for patients with a concomitant suprainguinal
procedure or when free muscle flap transfer
for coverage of major tissue loss was
combined with the bypass procedure.
Continuous direct arterial pressure and ECG
monitoring was maintained during the
operation and extended to the postoperative
period as necessary. Vancomycin and/or
cefuroxime was given as an antibiotic
prophylaxis. Prior to arteriotomy, the patients
received heparin at a dose of 1 mg/kg which
was neutralised using protamine sulphate if
necessary before the wounds were closed. No
dextran was given.
The vein grafting technique varied with
the surgeon’s preference, vein availability,
and the sites selected for the inflow and
outflow graft anastomoses (Table 9). With
the in situ technique, a policy of only
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partially exposing the graft at the sites of
side branches, located by means of an on-
table angiogram, was preferred until 1994.
Since then, the graft has been fully exposed
and intraoperative angiography has been
largely abandoned. This partly explains the
decreasing number of in situ bypasses
performed during the last few years. The
policy of this unit has been to route the
grafts subcutaneously for easier surveillance
and access. This is another reason for fewer
in situ bypasses, since the grafts to anterior
tibial and fibular arteries are translocated
anterolaterally in the limb. For non-reversed
veins, the valves were destroyed using various
types of valvulotomes according to surgeon’s
preference and the size of the vein. The two
most generally used types were a standard-
size plastic valvulotome (In situ cut®, B.
Braun Melsungen AG, Melsungen,
Germany) and a metal valvulotome with
changeable cutting head (Eze-Sit®, W.L.
Gore & Associates, Flagstaff, Arizona, USA).
The majority of procedures were
performed by attending vascular surgeons
and the remaining by vascular surgeons-in-
training under the guidance of a senior
vascular surgeon
2.4. Intraoperative assessment
Before 1994, the reconstruction was
intraoperatively assessed by means of an on-
table angiogram and rarely by means of
continuous-wave Doppler. The angiographic
technique included injection of contrast
medium directly into the proximal graft while
the inflow artery was kept cross-clamped.
Since the advent of transit-time flow
measurement in July 1994, it has replaced
other modalities, which have been used only
if flow was regarded as insufficient or if they
were otherwise regarded as necessary. During
recent years angioscopy has increasingly
emerged as an intraoperative method both
for the graft preparation and completion
assessment.
The measurement of graft flow was
performed with a transit-time flowmeter
(CardioMed® CM4006, Medistim A/S,
Oslo, Norway). The ultrasonic transit-time
flow-meter uses an ultrasonic pulsed beam
technique, and measures volume flow within
the conduit. A precalibrated probe, sized to
fit the graft, is placed around the vein graft.
The flow measurements have been found to
be highly valid and reproducible, and are not
dependent on vessel diameter, wall thickness
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Table 9. Characteristics of the performed procedures
Study I Study II Study III Study IV Study V
Study period 7/1994-6/19991 3-12/1998 1-8/1999 1/1991-12/19931 1/1991-12/19951,2
Nr of patients 195 67 51 179 344/1424
Nr of grafts 207 69 63 185 362/1474
Outflow artery
Popliteal 67 (32) 14 (20) 5 (8) 53 (35)3 50 (34)
Crural 83 (40) 24 (35) 33 (52) 65 (43)3 52 (35)
Pedal 57 (28) 31 (45) 25 (40) 34 (22)3 45 (31)
Bypass type
In situ 100 (48) 44 (64) 118 (78)3 110 (75)
Ex situ5 107 (52) 25 (36) 34 (22)3 37 (25)
1Time of the bypass operation; 2All the patients in the Study IV are also included in the Study V; 330-day occlusions,
amputations and deaths are not in the numbers; 4Grafts that had totally accomplished follow-up; 5Ex situ refers to
bypasses done with non-anatomical position of the graft
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or hematocrit changes. (Drost, CJ 1978;
Lundell, A et al. 1993; Albäck, A et al. 1996)
The graft flow was measured at the proximal
part of the graft after the distal anastomosis
was completed and the flow opened and
become stable. The measurement was
repeated after injecting 40 mg of papaverine
hydrochloride into the graft. This acts as a
smooth muscle relaxant which causes a
transient vasodilation of the distal vascular
bed and maximal flow capacity (MFC). This
was performed at the discretion of the
operating surgeon and only in patients who
were considered hemodynamically stable, i.e.
in whom the systolic blood pressure was
over 100 mmHg and not fluctuating. If the
intraoperative assessment prompted cor-
rective measures for technical errors within
the bypass, the flow measurement was
repeated thereafter.
2.5. Follow-up and criteria for
graft stenosis or occlusion
2.5.1 Immediate postoperative period
ABI measurements were done routinely on
the first and seventh postoperative day or
before discharge. No predischarge duplex
studies were performed.
2.5.2. Surveillance programme
All patients with infrainguinal vein bypass
grafts were enrolled into a prospective graft
surveillance protocol at outpatient visits,
which included physical examination,
ankle/brachial indices and colour-flow
duplex scanning at 4-6 weeks and 3, 6, 9, 12,
18 and 24 months postoperatively.
2.5.3 Duplex scanning
Colour-flow duplex scanning was used to
scan the entire bypass for anatomic and flow
abnormalities, using a standardised technique.
An ATL Ultramark 9 (Advanced Technology
Laboratories, Stevenage, UK) or HP Image
Point (Hewlett Packard, Andover,
Massachusetts, U.S.A.) (I, II, III) colour
duplex scanner with 7,5 MHz transducer
was used. For deeply located grafts a 5 MHz
probe was used as necessary. Patients were
routinely examined in the supine position.
The whole graft including anastomotic areas,
inflow artery and a few centimeters of
outflow vessel were serially scanned to search
for specific structural abnormalities or
exceptional flow patterns in color-flow
images (lumen narrowing, increased velocity,
aliasing, colour-flow jet). Changes in velocity
are indicated by alterations in the colour-
coded images which can be interrogated
more carefully with doppler. Even when the
colour-flow images are normal, routine
samples of graft flow velocity and blood flow
patterns were collected at multiple sites on
the course of the bypass. The representative
velocity spectra were recorded at a Doppler
scan-corrected angle of 60 degrees from the
middle of the vessel’s lumen.
If evidence of a flow disturbance was
detected in the colour flow image or spectral
waveform, recordings of peak flow velocities
at sites proximal, distal and within the area of
abnormal flow were made in addition to
routine measurements. The severity of the
lesion was assessed by calculating the velocity
ratio, where the V2/V1 ratio = PSVat lesion/
PSVwithin 2 cm of stenosis (Figure 6).
2.5.4. Detection of graft stenosis and
intervention criteria
Intervention criterias included clinical signs
of a failing graft such as onset of disabling
claudication, ischaemic pain or ischaemic
ulcers. A decrease in ABI of 0,15 or more
compared to the immediate postoperative
ABI was considered to indicate for
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significant hemodynamic deterioration of
the bypass.
The duplex scans were compared with
the previous studies. A graft was defined to
be stenosed in the case of a focal stenosis
when exhibiting a velocity disturbance
designated by a V2/V1 ratio greater than
2.0. If the V2/V1 ratio was greater than 3.0,
the velocity shift was defined separately as a
high-degree stenosis. In addition, cases
where no discrete stenosis was found, but
where either the PSV remained under 45
cm/s throughout the course of the graft or
the end-diastolic velocity (EDV) exceeded
25 cm/s, were classified as ’at-risk’ grafts.
2.5.5. Graft revision
Borderline stenoses were dealt by means of
intensified surveillance which usually
included a repeat examination within one
month. Lesions which were high-degree or
where progressive increase in stenosis
severity was identified, were selected for
repair, as were grafts that had a low-flow
state. A prompt angiographic confirmation
was usually scheduled. Angiography-verified
stenoses of more than 50% diameter
reduction underwent revision. However,
during the last two years of the study period,
revision was performed on the basis of
duplex findings alone on condition that the
stenosis was clearly identified and was
limited to the graft.
Open surgical correction was preferred
with a vein segment interposition, vein patch
angioplasty or distal extension grafts as
necessary. From 1997 onwards, PTA has
been performed for graft stenoses in selected
cases, which include short segment (<2cm)
stenoses in the body of a large-caliber graft.
After secondary correction on open graft,
the bypass had the same surveillance
protocol as if it were a primary procedure.
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Figure 6. A stenosis is detected in duplex scan.
Doppler velocity spectra a) proximal to, b) at
the site of, and c) distal to the stenosis are
depicted. The PSV inreases to over 10-fold at
the site of the stenosis with a significant end-
diastolic flow.
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2.5.6. Graft occlusion
A graft occlusion was suspected in cases
showing a sudden return of the symptoms
and signs of CLI and/or loss of previously
palpable pulses on the graft or runoff arteries
with concomitant significant drop in the
ABI measurement. The graft occlusion was
verified either with continuous-wave doppler,
duplex scanning or angiography.
The need for secondary procedures was
considered on an individual basis. In general,
if less than a week had elapsed from the
appearance of graft occlusion symptoms to
patient presentation, graft salvage with
catheter-directed intra-arterial thrombolysis
and subsequent revision of the underlying
causative lesion was attempted. Otherwise a
redo bypass operation was considered.
2.6. Study-specific methods
2.6.1 Retrospective study for risk
group identification (I)
The study consisted of 207 infrainguinal
vascular reconstructions performed on 195
patients from July 1994 to June 1999. Only
patients who had had intraoperative flow
measurement carried out, who had
undergone their first scheduled surveillance
visit and duplex scan or who had had an
adverse outcome (graft occlusion or
amputation) before that visit were included.
If a graft stenosis was detected, only the first
stenosis was recorded, i.e. if a recurrent
stenosis developed at the same bypass later
on during the follow-up it was not added to
the total number of stenoses.
2.6.2 Comparative studies on the
methods for detection of vein graft
stenoses (II, III)
Study II
This study was designed to assess the accuracy
of duplex scanning on vein graft stenosis
detection. The subjects were 69 infrainguinal
vein grafts in 69 patients. During the same
outpatient visit, two duplex examinations
were performed on the same graft, where
the one was performed by one of two
experienced angioradiologists and the other
by one of two vascular surgeons-in-training
with rather limited duplex-experience prior
to the conduction of the study. Each operator
was blinded to the other’s findings. A pro
forma diagram of the bypass anatomy was
included, in which the observer was asked to
fill in graft-flow velocity and blood-flow
patterns at multiple sites in the course of the
bypass. The same diagram also contained
questions regarding the patency of the graft,
presence, localisation and degree of stenoses
and whether any other pathology in the
bypass was present.
If one or both of the scans defined the
graft as abnormal, the patient was referred
promptly for an angiogram. The angiograms
were reviewed at a daily meeting of surgeons
and radiologists. If neither of the scans
indicated abnormality in the vein grafts, the
patients were followed as a part of a normal
surveillance program with repeated duplex
scans, as scheduled, for a minimum of three
months thereafter, and occurrences of graft
occlusion or other graft-related problems
were recorded. A built-up diagnostic standard
was created to control the possibility that the
variation was caused by a unidirectional
systematic error in one of the examinations.
This standard consisted of angiography when
available and three-month follow-up data on
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the grafts that were judged as normal in the
duplex scan by both examiners.
Study III
A total of 70 testing procedures on 58
different grafts and patients were performed.
The aim was to develop and validate a new
non-invasive test for the detection of vein
graft stenosis. The study was designed as
blinded comparative trial in which duplex
scanning was used as the diagnostic standard.
The test is based on a comparison of the
complex waveform analysis of pulse volume
recordings (PVR) obtained simultaneously at
two sites. The principle of the test is to take an
inflow PVR waveform from the aorto-iliac
segment, where, due to obvious anatomical
obstacles in a living patient, the upper arm
serves as a surrogate measure. The outflow
PVR is taken at the lower limb segment
distally to the distal anastomosis of the
bypass. This test is automated on a portable
vascular laboratory multi-cuff unit that is
commercially available (Vasoguard®, Scimed,
Bristol, U.K.). This microprocessor-based
device has custom-made software that collects
a set amount of pulse volume waveforms.
These are averaged, normalized in amplitude
and digitized. The representative waveform
is then put through an integrated 128-point
fast Fourier transform analyser which
produces a discrete spectrum for each
waveform, known as a frequency response
curve. Once produced, the inflow (FTp) and
outflow (FTd) frequency response curves are
displayed as a graph and compared by simple
division. This determines the transfer function
(TF), where TF(f) = FTd(f)/FTp(f). Identical
curves produce a straight line, and the area
beneath this line is equal to 1. If the line
descends, the area is less than 1 and, conversely,
if it ascends the area is greater than one. This
yields a quantitative index of the transfer
function (TFI) which, in theory, correlates
with the relative patency of the intervening
arterial segment (Figure 7)(Appendix 1)
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Figure 7. Schematic
illustration of the
test performance.
The inflow cuff is
placed on the upper
arm and the outflow
cuff distally to the
distal anastomosis.
An averaged
waveform (Wp,Wd)
is collected and a
fast Fourier analysis
is performed (FTp,
FTd). The transfer
function (TF) =
FTd(f)/ FTp(f). If the
curves are identical,
a straight line is produced. The transfer function index (TFI) is the area under the line (n).
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The patient is examined in the supine
position in a quiet room with a constant air
temperature of 21 °C. The TFI-program is
selected from the on-screen menu. The
standard pneumatic cuffs are placed on the
right arm and on the revascularized limb at
the segment below the distal anastomosis of
the bypass graft. The cuffs are then
autoinflated to a venous occlusion pressure
of 60 mmHg and the pulse volume tracing
obtained. When they have settled into a
regular pattern, waveforms are collected for
40 seconds and averaged to produce a mean.
Calculations are then performed and the
TFI derived and displayed. This can be printed
out using the built-in thermal printer.
To produce further data on the
repeatability of TFI, two additional cuffs
were placed on the proximal and distal thigh
of both the operated and the contralateral
limb, as allowed by the multi-cuff unit. After
the first measurement was recorded, the test
was repeated using the same method.
2.6.3 Randomised prospective studies
(IV,V)
Patients were randomized at the time of
operation into two different surveillance
groups according to the date of birth.
Patients born on odd-numbered days were
enrolled in a surveillance program using
clinical examination and ankle brachial
index measurement (ABI-group) whereas
for patients born on even-numbered days
duplex scans were added to the above at
control visits (DD-group). The study end
points were graft occlusion or major
amputation.
In study IV, 185 grafts in 179 patients
were randomised; 90 grafts to the ABI group
and 95 grafts to the DD group. The groups
were well matched with regard to
demographics, risk factors, indications for
and the type of surgical procedure. The
study period was from 1991 to 1993.
Study V is an extension of Study IV where,
originally, 362 grafts in 344 patients where
randomised during the period 1991 to 1995.
A total of 183 grafts were enrolled in the
ABI group and 179 in the DD group.
Furthermore, in order to eliminate a potential
bias caused by patient non-compliance with
the results, the subset of patients who had
surveillance which completely adhered to
the surveillance protocol were more
extensively analysed. The inclusion criteria
for this analysis were: patients alive, not
amputated and with an open graft at the first
outpatient visit and complete surveillance
thereafter during the first postoperative year.
2.7. Statistical analysis
Statistical analysis was performed with the aid
of the SPSS statistical software package (SPSS
for Windows versions 7.0 and 8.0, SPSS,
Chicago, Ill). Continuous variables were
presented as a mean and as 95% confidence
intervals (CI) for the mean (III) or median
and interquartile range (IV,V). For skewed
flow distributions, continuous variables are
presented as a geometricallly corrected mean
and 95% (CI) for mean (I). The significance
of any difference was calculated using the
Student’s T-test or using the Mann Whitney
test. For categorical parameters, comparisons
were performed using Pearson’s Chi-squared
analysis and when appropriate, Fishers exact
test.
The graft patency rates, free-of-stenosis
rates and limb salvage rates were calculated
by means of the life table method (IV) or by
means of Kaplan-Meier survival estimates
(I,V) and comparison was performed using
the logrank test (according to the guidelines
of the SVS/ISCVS (Rutherford, RB et al.
1997)).
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For the methodological studies (II,III),
sensitivity, specificity, positive predictive value,
negative predictive value and accuracy were
calculated. An assessment of repeatability for
continuous data was made using the Bland
and Altman test statistics expressed as limits of
agreement of the mean and ±2 S.D. (Bland,
JM and Altman, DG 1986) The agreement of
categorical data was studied by the use of the
Kappa (k) statistics (II). (Sumner, DS 1985)
A multivariate analysis with the Cox
proportional hazard model using stepwise
backward selection was used to identify
independent associations for significant
group differences as well as to adjusted risk
estimates (I).
P values of less than 0.05 were considered
as statistically significant
MATERIALS AND METHODS
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Results
RESULTS
1. The incidence of graft
stenosis
The overall incidence of duplex-detected
graft stenoses in the follow-up series at one
year was, for the unselected patient
population (IV), 19% and at two years 22%
(I) The 1-year incidence of graft stenosis
rose to 32%, when patients who died, whose
grafts occluded, whose legs were amputated
with an open graft during the immediate
postoperative period or who did not
completely attend the surveillance
programme were excluded (V).
In the ABI-based surveillance programme,
the detected incidence of graft stenosis was
from 8 to 9% (IV,V).
The median time for the detection of
graft stenosis from the bypass operation
varied from 180 to 238 days (I,V). The
location of these stenoses were categorized
as follows: 1 (2%) at the inflow artery; 2 (4%)
at the proximal anastomosis; 7 (15%) in the
proximal graft; 26 (57%) in the distal graft; 8
(17%) at the distal anastomosis and 2 (4%) at
the outflow artery (I). At the time of
detection, the mean V2/V1 ratio was 5.3
(range 2 to 15) (I).
2. Overall outcome of
infrainguinal arterial bypasses
In the aggregated data from 1991 to 1995
(IV,V), the 1-year primary assisted patency,
secondary patency and limb salvage rates
were 67%, 74% and 83% respectively. In the
material collected from July 1994 to June
1999 (I), the respective primary patency and
assisted primary patency rates were 53% and
71% at one year and 48% and 68% at 2 years.
The one-month occlusion rate has remained
constant during the study period at 11%
both in the earlier and in the more recent
series (I,V).
3. Retrospective study for
risk group identification (I)
Pertinent systemic risk factors and intra-
operative parameters were tested for free-
of-stenosis survival. The variables tested
included gender, presence of diabetes mellitus,
smoking, hypertension, CAD, CVD, COPD,
renal insufficiency or a previous vascular
operation, preoperative ABI, indication for
procedure, operative technique and bypass
anatomy, resting graft flow and maximal
flow capacity (MFC). Of these, only flow
variables and female gender significantly
increased the risk for stenosis development
(P = .029). In the multivariate analysis,
gender and graft flow remained as
independent risk factors.
The sample for graft flow was divided
into quartiles (Groups 1 through 4). The
25%, 50% and 75% percentiles where at 60
mL/min, 90 mL/min and 136 ml/min,
respectively. At 24 months the primary
patency rates for Groups 1 through 4 were
32%, 41%, 43% and 75% respectively (P <
.001), and the assisted primary patency rates
were 51%, 66%, 65% and 87% respectively
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(P = .0014). The RR for graft thrombosis or
development of stenosis was 3.9 times higher
in the lowest flow quartile than in the
highest quartile. The 24-month free-of-
stenosis rates for Groups 1 through 4 were
66%, 59%, 66% and 86% respectively (P =
.038). Four de novo stenoses, defined as those
which occurred later than two months after
graft implantation and a normal first
scheduled duplex scan, developed in the
highest flow quartile. Three of these were
female patients. The only male had a late-
appearing stenosis 14 months after
implantation.
The sample of MFC values was also
divided into quartiles. The results of survival
analysis were similar to those for graft flow.
The 2-year free-of-stenosis survival for the
highest maximal flow capacity quartile (>
225 mL/min) was 87% compared to 63%
for the other quartiles (P = .030).
4. Comparative studies on
the methods for detection of
vein graft stenoses (II, III)
Study II
69 vein bypass grafts were provided for
comparing two different duplex examinations
on the same graft. For the interobserver
agreement in differentiating normal grafts
from stenosed grafts, a Kappa value of 0.69
was obtained, indicating ”good” agreement.
A plot of observed PSV values in the graft by
the two examinations is indicated in Figure
8. The limits of agreement for the measured
PSV values, as calculated with the Bland and
Altmann test statistics, were lowest in the
graft (3.0 ± 42.0) and highest in the
anastomotic areas (proximal anastomosis 3.7
± 116.6 and distal anastomosis 14.6 ± 117.8).
The mean difference in the measured V2/V1
ratios of the detected stenoses was 2.2 (range
0.0–11.0). The sensitivity, specificity, accuracy,
PPV and NPV for Duplex 1 were 80%, 91%,
88%, 80% and 91% respectively. For Duplex 2
the respective figures were 85%, 93%, 91%,
85% and 93%.
Study III
Four patients were excluded because a reliable
TFI waveform was not obtained due to atrial
fibrillation, and a further three were excluded
because of incomplete visualisation in the
duplex scanning. This resulted in 63 grafts
eligible for further analysis. The limbs with
normal duplex scanning findings had a mean
TFI of 1.09 (1.01 to 1.16). At-risk grafts had
a mean TFI of 0.89 (0.77 to 1.03)(P = .005).
The difference in the TFI of grafts with mild
and high-degree stenoses was not significant.
When a value of 1.02 was used as a
discriminator, the TFI correctly detected 22
out of 23 at-risk grafts. Of the 40 normal
grafts the TFI correctly detected 26 as being
free of disease. The sensitivity, specificity, PPV,
NPV and accuracy were 96%, 65%, 61%, 96%
and 76% respectively. The only false negative
RESULTS
Figure 8.  A scatterplot of the highest PSV
values in the graft by the two examinations.
The broken lines are at 45 cm/sec.
56
was a clear outlier value of 2.1, which could
be explained by a false inflow value due to a
right-sided subclavian artery stenosis.
If a drop in ABI of 0.15 or more from the
previous value was obtained, the sensitivity,
specificity, PPV, NPV and accuracy were
32%, 78%, 50%, 64% and 63% respectively.
In 12 cases where testing of TFI was
repeated on the same graft with a minimum
interval of one month, 5 grafts where
classified as normal on both visits, whereas in
7 grafts a graft stenosis had been successfully
corrected between the testing occasions. This
was invariably reflected in the TFI values; in
the former group the mean difference in the
measured TFI was 0.06 (range 0.02 to 0.14)
and in the latter group it was higher, with a
mean of 0.33 (range 0.13 to 0.84)(P =.026).
When the repeatability was tested, the limits
of agreement in the proximal thigh, distal
thigh and proximal thigh were ±0.21, ±0.07
and ±0.15 respectively.
5. The impact of an intensive
surveillance programme on
the outcome (IV,V)
Study IV
Four grafts were revised in the ABI group
and 11 in the DD group. The number of
occluded grafts in the ABI group and in the
DD group during the study period were 7
and 12 respectively. The overall 1-year
primary patency, primary assisted patency,
secondary patency and limb salvage rates in
the ABI group were 68%, 74%, 84% and
88% and in the DD group 56%, 65%, 71%
and 81% respectively. The differences were
not statistically significant.
In the DD group, 60% of duplex scan
were carried out as planned. In addition, in
the ABI group 8% of all examinations had
also been done with duplex outside the study
protocol. The duplex scans were performed
by 22 different radiologists or radiologist-in-
training. The mean numbers of control visits
were 3.3 and 3.7 respectively.
Study V
A total of 362 primary infrainguinal bypass
reconstructions on 344 patients were
performed. Of these, 19 grafts (10.4%) in
the ABI group and 21 (11.7%) in the DD
group occluded, 13 (7.1%) and 11 (6.1%)
patients died, whereas the legs of 4 (2.2%)
and 8 (4.5%) were respectively amputated
within the first postoperative month. Thus,
147 grafts in the ABI group and 139 grafts in
the DD group entered the surveillance
period. For the whole study population, the
primary assisted patency, secondary patency
and limb salvage rates for the ABI group and
the DD group were 67%, 74%, and 85% and
67%, 73%, and 81%, respectively.
The numbers of grafts which completely
adhered to the surveillance programme in
the ABI group and DD group were 90 and
57 respectively. There were no differences
between the groups regarding preoperative
risk factors or the indication for, or the type
of, surgical procedure. In addition, the
preoperative and immediate postoperative
ABI values did not differ between the groups.
Six grafts in the ABI group and 8 grafts in
the DD group underwent 6 and 11
independent revision procedures. Of the
revised grafts, none in the ABI group and
two in the DD group occluded later during
the follow-up.The number of occluded
grafts was 13 in the ABI group and 11 in the
DD group. The respective primary assisted
patency, secondary patency and limb salvage
rates in the ABI group and DD group were
77%, 87%, and 94% and 77%, 85% and 93%.
RESULTS
57
Discussion
when suprasystolic pressure is applied to the
graft, as is the case in long crural and
inframalleolar bypasses, a stump pressure is
obtained and hemodynamic changes in the
graft cannot be detected. Toe:brachial indices
do not provide better discrimination.(Ray,
SA et al. 1997) However, as the measurement
is simple to perform, it will probably remain
as an adjunct to other methods which, in
selected cases, may have an effect on clinical
decision-making.
2. Overall outcome of
infrainguinal arterial
bypasses
Overall patency and limb salvage rates are
comparable to those in previous studies of
modern surveillance series (Table 7).
However, clearly superior results with
secondary patency rates exceeding 90% at
one year have been reported mainly in
North American studies. Exact comparison
with these studies is not possible.
Nevertheless a possible reason for lower
results may lie in the policy of aggressive
treatment of CLI. During the period 1988
to 1992 66% of all patients referred for
evaluation of CLI to the outpatient clinic of
our institution underwent a revascularisation
procedure. (Lepäntalo, M and Mätzke S,
1996) The principles of treatment have
remained unchanged since then.
1. The incidence of
graft stenosis
Our findings on the incidence of vein graft
stenosis are well in line with those of previous
studies using duplex surveillance. Further-
more, in a recent prospective multicenter
study of 277 patients the overall stenosis rate
at 12 months was 27%. (Watson, HR et al.
2000) There was however, a large variation
between the centres, as the incidence of
stenosis at individual centres which entered
more than 20 patients varied from 9% to
56%, even though the definition of a hemo-
dynamically significant stenosis was uniform
at all centres. Thus, the variation is likely to be
a result of differences in patient material,
completeness of surveillance follow-up, or
differences in qualifications and experience
of duplex scan operators and vascular
laboratories.
This study confirms that the ABI
measurement as a surveillance method is of
limited use, as its sensitivity in finding
stenoses was only one-third that of duplex
scanning. This is in line with the data from
other groups, where the sensitivity of ABI
measurements has been reported to be 38-
55% in the detection of failing lower
extremity revascularisations. (Lepäntalo, M
et al. 1996) In a considerable number of
limbs a drop in ankle pressure is not evident
before occlusion occurs. (Berkowitz, HD et
al. 1981; Cohen, JR et al. 1986) Furthermore,
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3. Retrospective study for
risk group identification (I)
It has not been settled whether the origin of
graft stenoses lies in local graft-related or
systemic factors. Pre-existing abnormalities
could explain the focal nature of graft MIH.
This is supported by recent studies, in which
graft borderline abnormalities detected
intraoperatively using duplex were highly
predictive of subsequent graft revision or
occlusion during a 3-month follow-up
(Johnson, BL et al. 2000) In those studies, a
longer follow-up would have provided
further evidence of whether intraoperative
duplex can identify the grafts at risk for
MIH. The higher incidence of vein graft
stenosis in females has been confirmed
recently by others too. (Watson, HR et al.
2000) The prevalence of venous disease has
been recognized as more common in women.
(Laurikka, J et al. 1993) Thus, a plausible
explanation for the higher incidence of graft
stenosis in females would be poor vein
quality, which is in accordance with the
hypothesis on preimplantation morpho-
logical changes as a cause of vein graft
stenosis. The other explanation could be a
smaller vein calibre in females. However, it
can be anticipated, that vein graft diameter
cannot be used as such for risk group
definement, as the measurement of the
diameter shows evident variation depending
on the measuring device used, whether the
measurement is performed pre- or post-
implantation, which part of the graft the
measurement is made at and, additionally,
the variable thickness of the vein wall.
It has been suggested that hyperhomo-
cysteinaemia and hypercholesterolemia may
have an association with MIH. (Rapp JH et
al. 1987; Beattie, DK et al. 1999) The risk
analysis in this study had limitations as
coagulation disorders and hyperlipidemia
were not included in the analysis as they
were not routinely screened. However, it is
probable that these factors can be regarded
to be of minor clinical significance.
Since the advent of transit time flow-
meter measurements it has been easy to
measure graft flow accurately and reliably
during surgery. As a method for intra-
operative assessment of the technical
adequacy of the bypass, its role is dubious.
When using in situ grafting technique,
unligated side branch A-V-fistulas are easily
detected. Otherwise, possible technical errors
in the bypass cannot be assessed sufficiently
with flow measurement only. (Blankensteijn,
JD et al. 1995) As a predictor of outcome, it
has been demonstrated that low graft flow
increases the risk of graft thrombosis not
only during the immediate postoperative
period, but also later during the follow-up.
(Lundell, A and Bergqvist, D 1993) Our data
confirms these findings as the difference in
assisted primary patency at 2 years between
lowest and highest flow quartile was 36%
with a tendency to increase during the first
postoperative year.
From a theoretical point of view, the
association of wall shear stress with MIH is
very interesting. Wall shear stress is related to
flow, and inversely related to the third power
of vessel wall diameter, as dictated by
Poiseuille’s law. Wall shear stress has been
shown to be an important determinant of
the release of vasoactive compounds from
the endothelial cells. (Ando, J et al. 1994;
Gimbrone, MA, Jr. et al. 1999) As referred to
in the review of the literature, experimental
studies suggest that low flow and low shear
stress induce MIH, and high flow and high
shear stress inhibit MIH. However, when a
short segment of inferior vena cava was
implanted into the abdominal aorta in rats,
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the intima-media area of the vein graft
increased significantly, and this process was
reversed when the vein segments were re-
implanted into the venous circulation.
(Sterpetti, AV et al. 1996) This fact does not
necessarily rule out the low flow hypothesis,
as it merely suggests that endothelial cell
damage caused by the arterial environment
is required to induce the formation of MIH,
but once the vein is implanted into the
arterial circulation flow conditions regulate
the further development of MIH. Our study
is the first reported clinical verification that
the intraoperatively measured graft flow is
associated with the development of hemo-
dynamically significant stenoses, but does
not, however, provide any explanation for
the localised nature of the lesions.
Creation of an adjuvant AVF distal from
the bypass increases the flow through the
graft. Already in the 1970’s it had been
demonstrated that application of AVF
decreases the amount of subendothelial
proliferation in vein grafts in dogs and it has
been comfirmed in later studies also that
these high flow bypasses developed less MIH
than normal flow bypasses. (Faulkner, SL et
al. 1975; Calligaro, KD et al. 1990; Kohler,
TR et al. 1991; Mattsson, EJ et al. 1997) In
clinical outcome studies, the interest has
been concentrated on combining adjuvant
AVF with a prosthetic infrainguinal bypass,
but the potential clinical advantage of this
method is still undetermined. (Jacobs,
MJHM et al. 1992; Eagleton, MJ et al. 1999;
Hamsho, A et al. 1999) The clinical value of
AVF as an adjunct to vein bypass grafting has
not been studied.
It would be beneficial to find flow criteria
for risk group stratification for a future
surveillance programme. On the basis of the
data reported herein, it seems that high graft
flow is protective against the development
of de novo graft stenosis, as only four grafts in
the highest quartile developed a stenosis
after a normal aerly duplex scan. It is a
matter of discussion whether this risk is low
enough to justify a recommendation that
surveillance for grafts with high flow and a
normal early duplex scan can be dis-
continued, and whether also the gender of
the patient matters. At this point, however,
the merits of the data presented in this series
should be viewed as a preliminary clinical
verification that the intimal growth and
regression in infrainguinal vein grafts is
regulated by blood flow. In our opinion a
larger sample size is needed for more reliable
risk calculation and optimal cut-off point
definition before clinical guidelines can be
drawn.
4. Comparative studies on
the methods for detection of
vein graft stenoses (II, III)
The optimal surveillance method should be
sensitive, specific, reproducible, operator-
independent and economical; none of the
methods available fulfills all of these criteria.
Duplex scanning is the most widely used
method for assessing infrainguinal bypasses.
It is generally considered accurate, provided
it is performed by a skillful and experienced
operator, but this issue has not been more
precisely addressed, nor the length of the
learning curve been stated. In addition, a
duplex examination takes a considerable
amount of time, up to 30 minutes, with the
time doubling if both lower extremities need
to be examined. This causes a marked
increase in the workload of the unit. Thus,
there is a clear need for simpler methods in
vein graft surveillance.
Previous studies on the accuracy of duplex
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scanning identifying graft stenosis have
compared it with angiography, which is
historically regarded as the ‘gold standard’.
(Sladen, JG et al. 1989; Buth, J et al. 1991;
Taylor, PR et al. 1992) To summarize the
results of these studies, it seems that the
specificity of duplex scanning is excellent, as
grafts which were found to be stenosed in the
duplex scan were invariably verified as
pathological in the angiogram. The sensitivity
of duplex scanning is more difficult to
establish, as normal-appearing grafts in the
duplex scan were tested with IV-DSA, a
method apparently inferior to standard
multiplanar intra-arterial angiography.
In study II, the accuracy of duplex
scanning was tested in a different way.  When
the operators are suitably blinded, the
accuracy can be studied utilising
reproducibility analysis. In order to allow
maximum variance to take place, different
duplex ultrasound machines and operators
of varying experience were always paired.
The agreement for categorical data was
found to be ’good’. Remarkable is the fact
that cases of high-degree stenosis were found
very reliably. There was disagreement
between the observers in only two of these
grafts; for one of these grafts the subsequent
angiogram did not verify the presence of
stenosis. The other case was verified as a 70%
stenosis next to the distal anastomosis in a
patient whose distal graft was located in
dense fibrous tissue under a free-flap muscle
transfer anastomosed more proximally to
the graft. However, consideration of results
obtained from continuous variables reveals a
greater variation. The limits of agreement
for doppler velocity measurements at
different sites in the course of the graft are
very wide. This could be explained in the
inflow- and outflow-arteries, as well as in
the graft itself, where the velocity can vary
markedly from one point to another; in
practice it is difficult to standardize a study
in such a way that both observers make their
measurements at exactly the same point. But
the same phenomenon also occurred in the
measurement of velocities at the anastomotic
sites. This, too, is explainable when one
considers the flow pattern in the anastomotic
areas, where flow velocity and flow pattern
change abruptly with relation to the anatomy.
Moreover the correct doppler angle is more
difficult to determine. It is undetermined
whether the use of different duplex
ultrasound machines contributes to the
variation, even though calibrated modern
scanners were used. A large variation could
also be seen in the determination of the V2/
V1 ratio of detected stenoses. This relates to
the fact that the higher the PSV, the more
imprecise its measurement. In addition, the
place where V1 is measured (’within 2 cm of
the stenosed segment’) is quite unsettled. It
is not clear whether this variation in the
assessment of the degree of stenosis also has
clinical relevance. It has been suggested that
the V2/V1 criteria for intervention can be
raised to 3.0. (Olojugba, DH et al. 1998) The
critical issue is whether such a high-degree
stenosis can be reliably differentiated from a
milder one.
The duplex scans were also tested against
built-up control, comprising angiography
or prospective follow-up data. This data
could not reveal whether the observed
variation was caused by a unidirectional
error in one of the examinations. This form
of analysis can only be used as an adjunct to
interobserver analysis, and does not reveal
the ”true” accuracy of duplex scanning.
It is worthy of note that the operators
who had had quite limited experience with
duplex scanning of vein grafts prior to the
commencement of the study achieved results
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comparable to those of very experienced
angioradiologists. This fact suggests that the
required length of hands-on training is
perhaps not as long as anticipated, provided
that the trainee is well-motivated and has a
thorough theoretical knowledge. Further-
more, it seems quite evident that no special
aptitude is needed to perform reproducible
studies.
The TFI proved to be a very sensitive
method for the detection of hemo-
dynamically compromised bypass grafts and,
in practice, all graft stenoses were detected. It
seems that the method is also sensitive for
hemodynamic alterations in the aorto-iliac
segment and in the run-off arteries, as many
false-positive tests were obtained. This is
further supported by findings in those cases
where repeated measurements were available.
When a hemodynamically successful graft
revision was performed, an increase in the
TFI-value was invariably observed. When a
graft appeared normal in repeated scans, the
TFI-value remained stable.
Transfer function index measurement
combines pulse volume recordings with
complex waveform analysis. Complex
waveform analysis, such as Fourier and
Laplace transformation, has been shown to
enhance the accuracy of waveform studies,
but, because of the complexity of the
calculations needed, it has not been adopted
in clinical practice. (Junger, M et al. 1984;
Macpherson, DS et al. 1984) However, with
modern microprocessors and programming
the analysis can be performed with ease and
applied in portable vascular laboratory
machinery. The system concentrates on
maintaining the venous occlusion pressure
at 60 mmHg, and the pulse volume wave-
form itself is analysed. The requirement for
exact air volume and calibration of the cuffs
is obviated. When both inflow and outflow
curves are obtained and normalised in
amplitude, only the difference in shape
remains important. Furthermore, when both
curves are obtained, information on hemo-
dynamics from abdominal aorta to outflow
vascular bed is gathered. This leads to a well-
standardized test which measures the
hemodynamic system physiologically with
open arterial circulation.
In practice, the measurement of TFI is
quick and simple to carry out, as the test
takes approximately 10 minutes to perform
and bilateral testing can be performed
simultaneously. Good quality waveforms are
easily obtained, providing valid and well-
repeatable results even with very limited
experience. The system is not operator-
dependent, because the equipment is fully
automatic and the calculations made by the
computer. The testing is well tolerated by the
patients, due especially to the fact that the
cuffs do not need to be inflated to supra-
systolic pressures. With the commercially
available device the measurement of the ABI,
when needed, can be done subsequently with
the same setting.
Some limitations exist. The system is not
suitable for some patients with cardiac
arrhytmias such as atrial fibrillation. The limits
of agreement are quite wide in the upper
thigh. This indicates that the accuracy of TFI
measurement is perhaps not acceptable when
the volume of the measured segment
increases. Nevertheless, this should not pose
as big a problem in vein graft surveillance as
in the diagnosis of aortoiliac disease.
In order to improve the specificity of the
test, further validation is needed. This can be
accomplished with a prospective study, in
which follow-up values are compared with
the baseline value obtained after the
immediate postoperative period. Thus, only
developing de novo lesions are detected and
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the confounding impact of hemodynamic
alterations in the native arterial tree already
present at the time of the primary procedure
is likely to be eliminated.
To summarize, it seems that good methods
exist for the detection of vein graft stenosis.
Duplex scanning can be regarded as the best
method for this purpose, and the historical
value of angiography as the ”gold standard”
in screening can be questioned; furthermore,
its compulsory use prior to the treatment
decisions is perhaps not necessary. However,
the initial outlay and maintenance costs of
duplex scanning are high. In the absence of
the economic resources and technical skills
required for duplex, TFI can become an
excellent alternative for more simplified
screening programmes. After further
validation, the specificity of the TFI can be
expected to improve to a level where no
other non-invasive testing is needed. When
pathological values are encountered, a prompt
angiogram could be performed solely on the
basis of TFI findings.
5. The impact of an intensive
surveillance programme on
the outcome (IV,V)
These studies demonstrated that, with the
use of duplex scanning in the postoperative
surveillance of infrainguinal vein grafts, a 2.5-
fold increase in the detection and revision
rate of significant graft stenoses could be
achieved compared to ABI surveillance.
Disappointingly, the higher revision rate in
the DD group over the ABI group was not
reflected as an improvement in outcome;
neither in patency nor limb salvage rates. A
significant proportion of grafts occluded
without warning signs, and for the majority
of these the cause of occlusion could not be
retrospectively defined. Thus, the question
remains: does the surveillance programme
actually detect those grafts that are pre-
destined to fail without intervention, or was
our result falsely negative due to inherent
problems in the study design?
According to power estimations, the
sample size of over 362 vein grafts should be
sufficient to demonstrate, when present, a
difference in survival of about 14% with a
power of 80%. So, despite a relatively large
study, a type II statistical error cannot be
ruled out. However, as the survival curves of
the both groups followed an equal pattern
throughout the follow-up period, it is very
unlikely that increasing the sample size
would have given a different result. Our
method of randomisation according to day
of birth can be criticised, as it was not
blinded. It was already known prior to
surgery which group the patient belonged
to, and, theoretically, this could have had an
effect on the treatment decisions. However,
as the surveillance programme was actually
commenced one month after randomisation,
and the failures due to technical reasons had
virtually taken place before that point time,
this should not cause any bias. As a result, it
could be verified that the groups were found
to be well matched with regard to pre-
operative and operation data.
The results of a surveillance programme
can be disappointing if a considerable
proportion of the scheduled visits are actually
missed. The critically ischaemic patient group
is elderly and frequently multi-diseased,
requiring treatment by other specialities and
institutions. This leads to difficulties in
keeping to the surveillance protocols, if they
are kept to at all. The proportion lost-to-
follow-up can be reasonably low, as in our
study (9%), but the screening might still have
been unacceptably incomplete, leading to a
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lower than expected stenosis detection rate.
The accomplishment of the surveillance
programme in our study cannot be compared
with that of other groups, as this kind of data
has not been reported previously, although it
should be included in future studies on vein
graft surveillance. However, no difference in
outcome could be demonstrated between
the groups, even when only grafts whose
surveillance was carried out strictly as planned
were included in the analysis (V). Thus, the
poor accomplishment of surveillance does
not suffice as the only explanation of why no
difference was found between the groups.
It can be suspected that the quality of
duplex studies was variable, as 22 different
radiologists performed the duplex scans, 39%
of which were performed by radiologists-
in-training under supervision. However, as
discussed earlier, the incidence of detected
stenoses compares well with other single-
center studies. The results of Study II also
indicate that duplex scanning can be
performed with acceptable accuracy even
after a short period of training. This study
was prompted after analysing the results of
Studies IV and V, partly to obtain some
answers to the question of why these studies
failed to show any benefit from the duplex-
based surveillance. The majority of grafts
that occluded did so without any obvious
reason, and the question of whether
significant pathology was missed in the
duplex examination prior to occlusion
remains partly unanswered. It seems quite
evident that a considerable number of vein
grafts can also occlude after the immediate
postoperative period without the presence
of a distinct focal lesion.
As referred to in the review of the
literature, the duplex criteria defining a
stenosed graft are well established, and they
were applied in the present study. The
threshold for intervention was probably
sensitive enough, as others have suggested
that stenoses with a V2/V1 ratio below 3.0
to 3.5 can be dealt by means of intensified
follow-up for stenosis progression without
endangering the graft patency. The revision
procedures were by large successful; only
two of the revised grafts subsequently
occluded.
Previous studies have been able to
provide only circumstantial evidence that
patients actually do benefit from vein graft
surveillance. In addition, prior to our studies,
only one small randomised trial has been
published. (Lundell, A et al. 1995) That study
can be criticised for small sample size and
frequent occlusions in the intensive
surveillance group too. Thus, the scientific
basis for vein graft surveillance is not solid,
and our studies were not able to prove the
case either.
The clinical benefits must be
demonstrated first before even trying to
analyse the cost-effectiveness of surveillance.
Nevertheless, it seems obvious that frequent
surveillance beyond 1 year cannot be regarded
as cost-effective because of the reduced
incidence of graft stenosis after this period.
(Ho, GH et al. 1995; Idu, MM et al. 1998)
To demonstrate the potential benefits of
vein graft surveillance on the outcome of
infrainguinal bypass surgery, a large
randomised multicenter trial (which has
already begun) is definitely needed. (Kirby,
PL et al. 1999) The patient recruitment for
this study is taking place at present, and it is
estimated that a sample of 1200 vein grafts
will be needed to prove the case. Hopefully,
in the near future, this trial will be able to
provide some definite answers to several
critical issues in vein graft surveillance.
Whatever the result might be, it can
already be seen, on the basis of our studies
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that the results of vein graft surveillance will
be disappointing without a very serious
approach to surveillance. Furthermore, it is
evident that the surveillance programmes
need to be economised. This is achievable
when surveillance is concentrated on
patients at high risk of vein graft stenosis.
Intraoperative flow measurements seem very
promising in this respect. The workload of
surveillance programmes can be further
decreased by simplifiying the methods of
surveillance. The preliminary results of TFI
measurement have shown that this new
method of assessing circulation in the lower
extremities can become a very valuable tool
for this purpose.
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Summary
grafts which occluded. The respective 2-
year primary and assisted primary patency
rates in the lowest through the highest flow
quartiles were 32%, 41%, 43% and 75% (p <
0.001) and 51%, 66%, 65% and 87% (p =
0.0014). The free-of-stenosis rates were
significantly higher for the highest flow
quartile. In univariate and multivariate
analysis of pertinent potential risk factors,
female gender and low graft flow remained
as independent predictors of stenosis
development.
The interobserver agreement in duplex
scanning for vein grafts was studied in a
blinded comparative trial of 69 infrainguinal
vein grafts. The examinations showed a
perfect agreement on the type of pathology
in 58 grafts. In k statistics the value was 0.69,
representing good agreement. The mean
differences and limits of agreement were,
however, wide for PSV measurements made
at different sites of the graft.
The transfer function index (TFI) of
pulse volume recordings was studied as a
potential new method of detecting
hemodynamically significant graft stenoses.
Seventy testing procedures were performed,
of which 12 were repeated measurements
on the same grafts with at least a one-month
time interval between the measurements.
Duplex scanning was used as a diagnostic
standard. With a cut of value of 1.02, the TFI
correctly identified 22 out of 23 grafts, in
which pathology was present in the duplex
scan. The sensitivity, specificity and accuracy
were 96%, 65%, and 76%, respectively. The
Infainguinal arterial bypass reconstruction
with a good-quality autogenous vein graft is
the treatment of choice for symptomatic
PAOD, especially when the vitality of the leg
is threatened. Despite increasing experience
and technical refinements, the high failure
rate of these procedures is still a matter of
concern. In the intermediate postoperative
period, bypass failures are mainly caused by
the development of hemodynamically
significant focal vein graft stenoses, which
account for approximately 60% of all graft
occlusions. As the outcome of an occluded
bypass is dismal and no effective measures
against the development of hyperplastic
lesions exist, the strategy has been one of
prophylactic surgical or endovascular
correction of established stenoses. The present
study consists of clinical investigations into
vein graft stenosis in infrainguinal arterial
bypasses with a special emphasis on risk group
definement, diagnostic methods and the
impact of an intensive postoperative
surveillance programme on the outcome.
Intraoperative graft volume flow
measurement with a transit-time flowmeter
was performed in 207 infrainguinal vein
grafts. After the operation the patients were
enrolled in an intensive duplex-based
surveillance programme. The clinical end
points were stenosis development or graft
occlusion. The median follow-up time was
13.3 months; the graft flow for event-free
grafts was 102 ml/min compared to 82 ml/
min for grafts where development of a
stenosis was detected and 68 ml/min for
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repeatability of the method was satisfactory.
A total of 362 infrainguinal vein grafts
were prospectively randomised into a follow-
up regime with or without duplex scanning
(DD group and ABI group) at 1, 3, 6, 9, and
12 months postoperatively. Although the
grafts were revised more frequently in the
DD group, the effect of revision procedures
was not reflected in the clinical outcome
measures. The primary assisted patency,
secondary patency and limb salvage rates
were 67%, 74%, and 85% for the ABI group
and 67%, 73%, and 81% for the DD group.
However, surveillance which completely
adhered to the protocol was difficult to
accomplish, which may bias the results. When
only the grafts for which surveillance was
completely accomplished were included in
the analysis, the outcome was still similar for
both groups.
In conclusion, this study verifies that the
development of MIH is associated with
chronic alterations in blood flow in the graft
and that intraoperative volume flow
measurements may have a role in risk group
stratification with consequences in clinical
practice. Duplex scanning is, at present, the
best method for detecting hemodynamically
significant vein graft lesions, but it needs
manpower and technical skills, and thereby
considerably increases the workload of a
vascular unit. In this respect, the TFI is a very
promising new method for detecting an at-
risk vein graft accurately and reliably. After
further validation, the TFI could become
the first-line screening method in vein graft
surveillance. This study failed to show the
potential benefits of intensive duplex-based
surveillance in improving the patency or
limb salvage of infrainguinal vein graft
reconstructions in the intermediate post-
operative period. A large, randomised
multicenter trial on vein graft surveillance is
needed.
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Conclusions
1. Intraoperative graft flow predicts the outcome of infrainguinal arterial bypasses with a
vein graft also after the immediate postoperative period. Furthermore, low graft flow is
strongly associated with the development of clinically significant vein graft stenoses.
2. Duplex scanning is an accurate tool for detecting vein graft stenoses. With a theoretical
knowledge of the principles of examination of the vein graft with duplex, the required
practical skills can be acquired after a relatively short learning curve
3. The TFI of pulse volume recordings is a new method for assessing circulation in the lower
extremities. The results showed that, with the use of TFI, a stenosed vein graft is detected
very reliably.
4. This study failed to demonstrate the potential merits of an intensive vein graft surveillance
programme. A large randomised multicenter trial is warranted.
CONCLUSIONS
68
Acknowledgements
Docent Mikko Hippeläinen, M.D., and
Professor Tatu Juvonen, M.D., for expert work
as reviewers. Their constructive criticism and
valuable comments had a major impact on
completion of this thesis.
An essential part of this work was done with
my collaborators in the original articles. The
value of the contributions of Anders Albäck,
M.D., Ilkka Kantonen, M.D., and Sorjo
Mätzke, M.D. in the Department of Vascular
Surgery cannot be overestimated. In
particular, my good friend Anders Albäck
played a major role throughout these years
by placing his ideas, time and enthusiasm at
my disposal. The continuous support and
encouragement of our angioradiologists,
Professor Johan Edgren, M.D., and Wolf-
Dieter Roth, M.D., is kindly appreciated.
Professor Anssi Sovijärvi, M.D., and Docent
Riitta Lassila M.D. gave their cooperation in
this study and provided insight into aspects
of medicine which are difficult for a simple
surgeon to understand.
This study is based on a large amount of
everyday work done, and the patients treated,
over an eight year-period by the staff at the
Department of Vascular Surgery. Without
their dedication and professional skill, the
results presented in this thesis would not
have been achieved.
Anita Mäkelä, R.N., and Elina Malkki, R.N.,
for their generous patience and help in
collecting vast amounts of clinical data and
This study was performed in the Department
of Vascular Surgery, Helsinki University Central
Hospital and in the Fourth Department of
Surgery, University of Helsinki.
I would have never been able to accomplish
this work without the help of number of
people to whom I wish to express my
deepest gratitude.
Professor Juhani Ahonen, M.D., the Head of
the Fourth Department of Surgery, for
providing the excellent research facilities
and for his personal support in the field of
vascular surgery.
The guidance of my supervisor Docent
Mauri Lepäntalo, M.D., has been an example
to follow. His thorough knowledge of vascular
surgery, continuous support, efficient way of
working and never-failing optimism has been
impressive and indispensable in helping this
study to fruition. He has always found the
time and patience for constructive discussions
on how to solve the myriad problems
encountered during this study and on the
wider issues of the outside world.
Michael Luther, M.D., who took me by the
hand during my first steps in vascular surgery
and introduced me to the subject of this
study. His clinical insight, vast experience
and critical way of thinking made it a
pleasure to be his slave in Vasa Central
Hospital.
ACKNOWLEDGEMENTS
69
personal in the vascular laboratory for
practical aid with noninvasive studies.
Hanna Oksanen, M.Sc, Ph.D., and Jukka
Ollgren M.Sc., for their valuable consulting
aid with the statistical analysis.
Mr. Barry White for a prompt and excellent
language revision.
Finska Läkaresällskapet, the Finnish Society
for Angiology and the Kaiko Anniversary
Fund for financial support.
Fellow surgeons at the Departments of
Vascular Surgery and Cardiothoracic Surgery
for sharing their clinical knowledge, for
helping me on my way by taking a greater
share of the clinical work burden at periods
when I needed time for the study, and, most
importantly, for their friendship.
Relatives and friends, for their endurance
and charity, although I have not had enough
time for them during the past years.
Finally, Virpi, Anni and Ella. Even though
there were a few moments when a lack of
privacy and patience just about reached
statistical significance, without you and your
love around me, this project would had had
a closer resemblance to a struggle. Thank
you.
Espoo, Esbo, February 2001
Leo Ihlberg
ACKNOWLEDGEMENTS
70
71
Albäck, A., F. Biancari, O. Saarinen and M. Lepäntalo
(1998). ”Prediction of the Immediate Outcome of
Femoropopliteal Saphenous Vein Bypass by
Angiographic Runoff Score.” Eur J Vasc Endovasc
Surg 15: 220-224.
Albäck, A., I. Kantonen, L. Ihlberg and M. Lepäntalo
(1999). ”Valvulotomy of Non-reversed Saphenous
Vein Bypass Grafts: a Randomised, Blinded,
Angioscopy-controlled Study.” Eur J Vasc
Endovasc Surg 18: 144-148.
Albäck, A. and M. Lepäntalo (1998). ”Immediate
occlusion of in situ saphenous vein bypass grafts: a
survey of 329 reconstructions.” Eur J Surg
164(10): 745-50.
Albäck, A., H. Mäkisalo, A. Nordin and M. Lepäntalo
(1996). ”Validity and reproducibility of transit
time flowmetry.” Ann Chir Gyn 85: 325-331.
Ando, J., H. Tsuboi, R. Korenaga, Y. Takada, N.
Toyama-Sorimachi, M. Miyasaka and A. Kamiya
(1994). ”Shear stress inhibits adhesion of cultured
mouse endothelial cells to lymphocytes by
downregulating VCAM-1 expression.” Am J
Physiol 267(3 Pt 1): C679-87.
Ao, P. Y., W. J. Hawthorne, R. Coombs and J. P.
Fletcher (1999). ”Suppression of intimal
hyperplasia with low molecular weight heparin in
a sheep model.” Int Angiol 18(2): 131-9.
Arora, S., G. H. Meier, H. Pedersen, C. Brophy, K.
Lacey and R. J. Gusberg (1995). ”Non-invasive
impedance analysis: a new non-invasive test for
graft surveillance.” Cardiovasc Surg 3(6): 659-64.
Ascer, E., F. J. Veith, S. K. Gupta, S. A. White, C. W.
Bakal, K. Wengerter and S. Sprayregen (1988).
”Short vein grafts: a superior option for arterial
reconstructions to poor or compromised outflow
tracts?” J Vasc Surg 7(2): 370-8.
Avino, A. J., D. F. Bandyk, A. J. Gonsalves, B. L.
Johnson, T. J. Black, B. R. Zwiebel, M. J. Rahaim
and A. Cantor (1999). ”Surgical and endovascular
intervention for infrainguinal vein graft stenosis.” J
Vasc Surg 29(1): 60-70; discussion 70-1.
Bandyk, D. F. (1990). ”Postoperative surveillance of
infrainguinal bypass.” Surg Clin North Am 70(1):
71-85.
Bandyk, D. F., T. M. Bergamini, J. B. Towne, D. D.
Schmitt and G. R. Seabrook (1991). ”Durability
of vein graft revision: the outcome of secondary
procedures.” J Vasc Surg 13(2): 200-8.
Bandyk, D. F., R. F. Cato and J. B. Towne (1985). ”A
low flow velocity predicts failure of
femoropopliteal and femorotibial bypass grafts.”
Surgery 98(4): 799-809.
Bandyk, D. F., B. L. Johnson, A. K. Gupta and G. E.
Esses (1996). ”Nature and management of duplex
abnormalities encountered during infrainguinal
vein bypass grafting.” J Vasc Surg 24(3): 430-6;
discussion 437-8.
Bandyk, D. F., H. W. Kaebnick, G. W. Stewart and J. B.
Towne (1987). ”Durability of the in situ
saphenous vein arterial bypass: a comparison of
primary and secondary patency.” J Vasc Surg 5(2):
256-68.
Bandyk, D. F., G. R. Seabrook, P. Moldenhauer, J.
Lavin, J. Edwards, R. Cato and J. B. Towne (1988).
”Hemodynamics of vein graft stenosis.” J Vasc
Surg 8(6): 688-95.
Barnes, R. W., B. W. Thompson, C. M. MacDonald, M.
L. Nix, A. Lambeth, A. D. Nix, D. W. Johnson and
B. H. Wallace (1989). ”Serial noninvasive studies
do not herald postoperative failure of
femoropopliteal or femorotibial bypass grafts.”
Ann Surg 210(4): 486-93; discussion 493-4.
Beard, J. D. (1992). ”Second European Consensus
Document on Chronic Critical Leg Ischemia.”
Eur J Vasc Surg 6 Suppl A: 1-32.
Beard, J. D., M. Wyatt, D. J. Scott, R. N. Baird and M.
Horrocks (1989). ”The non-reversed vein
femoro-distal bypass graft: a modification of the
standard in situ technique.” Eur J Vasc Surg 3(1):
55-60.
Beattie, D. K., R. M. Greenhalgh and A. H. Davies
(1997). ”Vein graft surveillance: is the case
proven?” Ann R Coll Surg Engl 79(1): 1-2.
Beattie, D. K., M. Sian, R. M. Greenhalgh and A. H.
Davies (1999). ”Influence of systemic factors on
pre-existing intimal hyperplasia and their effect on
the outcome of infrainguinal arterial reconstruction
with vein.” Br J Surg 86(11): 1441-7.
References
REFERENCES
72
Belkin, M., M. S. Conte, M. C. Donaldson, J. A.
Mannick and A. D. Whittemore (1995). ”Preferred
strategies for secondary infrainguinal bypass:
lessons learned from 300 consecutive
reoperations.” J Vasc Surg 21(2): 282-93.
Belkin, M., W. C. Mackey, R. McLaughlin, S. E.
Umphrey and T. F. O’Donnell (1992). ”The
variation in vein graft flow velocity with luminal
diameter and outflow level.” J Vasc Surg 15(6):
991-8; discussion 998-9.
Belkin, M., K. B. Raftery, W. C. Mackey, R. L.
McLaughlin, S. E. Umphrey, A. Kunkemueller and
O. D. TF (1994). ”A prospective study of the
determinants of vein graft flow velocity:
implications for graft surveillance.” J Vasc Surg
19(2): 259-65; 265-7.
Benveniste, G. L., J. P. Royle, A. K. Roberts, G. Fell, M.
C. Hoare, Y. Wang and J. K. Lauri (1988). ”The
detection of early femoro-distal vein graft stenosis
by treadmill exercise testing.” J Cardiovasc Surg
(Torino) 29(6): 723-6.
Bergamini, T. M., S. M. George, Jr., H. T. Massey, P. K.
Henke, T. W. Klamer, G. E. Lambert, F. B. Miller, R.
N. Garrison and J. D. Richardson (1995).
”Intensive surveillance of femoropopliteal-tibial
autogenous vein bypasses improves long-term
graft patency and limb salvage.” Ann Surg 221(5):
507-15.
Bergamini, T. M., J. B. Towne, D. F. Bandyk, G. R.
Seabrook and D. D. Schmitt (1991). ”Experience
with in situ saphenous vein bypasses during 1981
to 1989: determinant factors of long-term
patency.” J Vasc Surg 13(1): 137-47; discussion
148-9.
Berguer, R., R. F. Higgins and D. J. Reddy (1980).
”Intimal hyperplasia. An experimental study.” Arch
Surg 115(3): 332-5.
Berkowitz, H. D., A. D. Fox and D. H. Deaton (1992).
”Reversed vein graft stenosis: early diagnosis and
management.” J Vasc Surg 15(1): 130-41.
Berkowitz, H. D., S. Greenstein, C. F. Barker and L. J.
Perloff (1989). ”Late failure of reversed vein
bypass grafts.” Ann Surg 210(6): 782-786.
Berkowitz, H. D. and S. M. Greenstein (1987).
”Improved patency in reversed femoral-
infrapopliteal autogenous vein grafts by early
detection and treatment of the failing graft.” J Vasc
Surg 5(5): 755-61.
Berkowitz, H. D., C. L. Hobbs, B. Roberts, D. Freiman,
J. Oleaga and E. Ring (1981). ”Value of routine
vascular laboratory studies to identify vein graft
stenosis.” Surgery 90(6): 971-9.
Bertele, V., M. C. Roncaglioni, J. Pangrazzi, E. Terzian
and E. G. Tognoni (1999). ”Clinical outcome and
its predictors in 1560 patients with critical leg
ischaemia. Chronic Critical Leg Ischaemia
Group.” Eur J Vasc Endovasc Surg 18(5): 401-10.
Bland, J. M. and D. G. Altman (1986). ”Statistical
methods for assessing agreement between two
methods of clinical measurement.” Lancet i: 307-
310.
Blankensteijn, J. D., J. P. Gertler, D. C. Brewster, R. P.
Cambria, G. M. LaMuraglia and W. M. Abbott
(1995). ”Intraoperative determinants of
infrainguinal bypass graft patency: a prospective
study.” Eur J Vasc Endovasc Surg 9(4): 375-82.
Brennan, J. A., A. K. Walsh, J. D. Beard, A. A. Bolia and
P. R. Bell (1991). ”The role of simple non-
invasive testing in infra-inguinal vein graft
surveillance.” Eur J Vasc Surg 5(1): 13-7.
Brewster, D. C., A. J. LaSalle, J. G. Robison, E. C.
Strayhorn and R. C. Darling (1983).
”Femoropopliteal graft failures. Clinical
consequences and success of secondary
reconstructions.” Arch Surg 118(9): 1043-7.
Buth, J., B. Disselhoff, C. Sommeling and L. Stam
(1991). ”Color-flow duplex criteria for grading
stenosis in infrainguinal vein grafts.” J Vasc Surg
14(6): 716-26.
Buxton, B., R. P. Lambert and T. T. Pitt (1980). ”The
significance of vein wall thickness and diameter in
relation to the patency of femoropopliteal saphenous
vein bypass grafts.” Surgery 87(4): 425-31.
Cable, D. G., J. A. Caccitolo, N. Caplice, T. O’Brien, R.
D. Simari, R. C. Daly, J. A. Dearani, C. J. Mullany,
T. A. Orszulak and H. V. Schaff (1999). ”The role
of gene therapy for intimal hyperplasia of bypass
grafts.” Circulation 100(19 Suppl): II392-6.
Calligaro, K. D., E. Ascer, M. Torres and F. J. Veith
(1990). ”The effect of adjunctive arteriovenous
fistula on prosthetic graft patency: a controlled
study in a canine model.” J Cardiovasc Surg 31(5):
646-50.
Calligaro, K. D., J. R. Syrek, M. J. Dougherty, I. Rua, S.
McAffee-Bennett, K. J. Doerr, C. A. Raviola and
D. A. DeLaurentis (1998). ”Selective use of duplex
ultrasound to replace preoperative arteriography
for failing arterial vein grafts.” J Vasc Surg 27(1):
89-94; discussion 94-5.
Cambria, R. A., R. C. Lowell, P. Gloviczki and V. M.
Miller (1994). ”Chronic changes in blood flow
alter endothelium-dependent responses in
autogenous vein grafts in dogs.” J Vasc Surg 20(5):
765-73.
REFERENCES
73
Caps, M. T., K. Cantwell Gab, R. O. Bergelin and D. E.
Strandness, Jr. (1995). ”Vein graft lesions: time of
onset and rate of progression.” J Vasc Surg 22(4):
466-74.
Carter, S. A. (1992). ”Ankle and toe systolic pressures
comparison of value and limitations in arterial
occlusive disease.” Int Angiol 11(4): 289-97.
Chan, P., M. Patel, L. Betteridge, E. Munro, M.
Schachter, J. Wolfe and P. Sever (1993). ”Abnormal
growth regulation of vascular smooth muscle cells
by heparin in patients with restenosis.” Lancet
341(8841): 341-2.
Chang, B. B., R. P. Leather, J. L. Kaufman, A. M.
Kupinski, P. W. Leopold and D. M. Shah (1990).
”Hemodynamic characteristics of failing
infrainguinal in situ vein bypass [see comments].” J
Vasc Surg 12(5): 596-600.
Chervu, A. and W. S. Moore (1990). ”An overview of
intimal hyperplasia.” Surg Gynecol Obstet 171(5):
433-47.
Cheshire, N. J., J. H. Wolfe, M. A. Barradas, A. W.
Chambler and D. P. Mikhailidis (1996). ”Smoking
and plasma fibrinogen, lipoprotein (a) and serotonin
are markers for postoperative infrainguinal graft
stenosis.” Eur J Vasc Endovasc Surg 11(4): 479-86.
Cohen, J. R., J. A. Mannick, N. P. Couch and A. D.
Whittemore (1986). ”Recognition and management
of impending vein-graft failure. Importance for
long-term patency.” Arch Surg 121(7): 758-9.
Corson, J. D., A. M. Karmody, D. M. Shah and R. P.
Leather (1984). ”Retrograde valve incision for
insitu vein-arterial bypass utilising a valvulotome.”
Ann R Coll Surg Engl 66(3): 173-4.
Cullen, P. J., A. L. Lehay, S. B. Ryan, K. D. McBride, D.
J. Moore and G. D. Shanik (1986). ”The influence
of duplex scanning on early patency rates of in
situ bypass to the tibial vessels.” Ann Vasc Surg
1(3): 340-6.
Daemen, M. J. and J. G. De Mey (1995). ”Regional
heterogeneity of arterial structural changes.”
Hypertension 25(4 Pt 1): 464-73.
Dalsing, M. C., D. F. Cikrit, S. G. Lalka, A. P. Sawchuk
and C. Schulz (1995). ”Femorodistal vein grafts:
the utility of graft surveillance criteria.” J Vasc
Surg 21(1): 127-34.
Davidson, J. T. d. and J. T. Callis (1993). ”Arterial
reconstruction of vessels in the foot and ankle.”
Ann Surg 217(6): 699-708; discussion 708-10.
Davies, A. H., T. R. Magee, R. N. Baird, E. Sheffield
and M. Horrocks (1993). ”Pre-bypass
morphological changes in vein grafts.” Eur J Vasc
Surg 7(6): 642-7.
Davies, A. H., T. R. Magee, E. Sheffield, R. N. Baird
and M. Horrocks (1994). ”The aetiology of vein
graft stenoses.” Eur J Vasc Surg 8(4): 389-94.
Davies, A. H., T. R. Magee, S. G. Tennant, P. M.
Lamont, R. N. Baird and M. Horrocks (1994).
”Criteria for identification of the “at-risk”
infrainguinal bypass graft.” Eur J Vasc Surg 8(3):
315-9.
Davies, A. H., T. R. Magee, J. F. Thompson, P. Murphy,
A. Jones, M. Horrocks, P. M. Lamont and R. N.
Baird (1993). ”Stenting for vein graft stenosis.”
Eur J Vasc Surg 7(3): 339-41.
Davies, A. H., T. R. Magee, M. Wyatt, R. Baird and M.
Horrocks (1993). ”Impedance analysis versus
colour Duplex in femorodistal vein graft
surveillance.” Eur J Vasc Surg 7(1): 14-5.
Davies, M. G. and P. O. Hagen (1995).
”Pathophysiology of vein graft failure: a review.”
Eur J Vasc Endovasc Surg 9(1): 7-18.
Disselhoff, B., J. Buth and J. Jakimowicz (1989). ”Early
detection of stenosis of femoro-distal grafts. A
surveillance study using colour-duplex scanning.”
Eur J Vasc Surg 3(1): 43-8.
Dobrin, P. B., F. N. Littooy and E. D. Endean (1989).
”Mechanical factors predisposing to intimal
hyperplasia and medial thickening in autogenous
vein grafts.” Surgery 105(3): 393-400.
Dobrin, P. B., F. N. Littooy, J. Golan, B. Blakeman and
J. Fareed (1988). ”Mechanical and histologic
changes in canine vein grafts.” J Surg Res 44(3):
259-65.
Donaldson, M. C. (1996). ”Evaluation of patients with
suspected hypercoagulability: what tests to order.”
Semin Vasc Surg 9(4): 277-83.
Donaldson, M. C., J. A. Mannick and A. D.
Whittemore (1991). ”Femoral-distal bypass with
in situ greater saphenous vein. Long-term results
using the Mills valvulotome.” Ann Surg 213(5):
457-64.
Donaldson, M. C., J. A. Mannick and A. D.
Whittemore (1992). ”Causes of primary graft
failure after in situ saphenous vein bypass
grafting.” J Vasc Surg 15(1): 113-8.
Donaldson, M. C., D. S. Weinberg, M. Belkin, A. D.
Whittemore and J. A. Mannick (1990). ”Screening
for hypercoagulable states in vascular surgical
practice: a preliminary study.” J Vasc Surg 11(6):
825-31.
Dormandy, J. A. and G. D. Murray (1991).
”The fate of the claudicant – a prospective
study of 1969 claudicants.” Eur J Vasc Surg 5(2):
131-3.
REFERENCES
74
Dougherty, M. J., K. D. Calligaro and D. A.
DeLaurentis (1998). ”The natural history of
“failing” arterial bypass grafts in a duplex
surveillance protocol.” Ann Vasc Surg 12(3): 255-
9.
Dougherty, M. J., K. D. Calligaro and D. A.
DeLaurentis (1998). ”Revision of failing lower
extremity bypass grafts.” Am J Surg 176(2): 126-
30.
Drost, C. J. (1978). ”Vessel diameter-independent
volume flow measurements using ultrasound.”
Proc San Diego Biomed Symp 17: 299.
Dunlop, P., K. Varty, T. Hartshorne, P. R. Bell, A. Bolia
and N. J. London (1995). ”Percutaneous
transluminal angioplasty of infrainguinal vein graft
stenosis: long-term outcome.” Br J Surg 82(2):
204-6.
Eagleton, M. J., K. Ouriel, C. Shortell and R. M.
Green (1999). ”Femoral-infrapopliteal bypass with
prosthetic grafts.” Surgery 126(4): 759-64;
discussion 764-5.
Edwards, J. E., L. M. Taylor, Jr. and J. M. Porter (1990).
”Treatment of failed lower extremity bypass grafts
with new autogenous vein bypass grafting.” J Vasc
Surg 11(1): 136-44.
Eldrup-Jorgensen, J., D. P. Flanigan, L. Brace, A. P.
Sawchuk, S. G. Mulder, C. P. Anderson, J. J.
Schuler, J. R. Meyer, J. R. Durham and T. H.
Schwarcz (1989). ”Hypercoagulable states and
lower limb ischemia in young adults.” J Vasc Surg
9(2): 334-41.
Erickson, C. A., J. B. Towne, G. R. Seabrook, J. A.
Freischlag and R. A. Cambria (1996). ”Ongoing
vascular laboratory surveillance is essential to
maximize long- term in situ saphenous vein
bypass patency.” J Vasc Surg 23(1): 18-26,
discussion 26-7.
Faries, P. L., F. W. Logerfo, S. Arora, M. C. Pulling, D. I.
Rohan, C. M. Akbari, D. R. Campbell, G. W.
Gibbons and F. B. Pomposelli, Jr. (2000). ”Arm
vein conduit is superior to composite prosthetic-
autogenous grafts in lower extremity
revascularization.” J Vasc Surg 31(6): 1119-27.
Faulkner, S. L., R. D. Fisher, D. M. Conkle, D. L. Page
and H. W. Bender, Jr. (1975). ”Effect of blood flow
rate on subendothelial proliferation in venous
autografts used as arterial substitutes.” Circulation
52(2 Suppl): I163-72.
Fillinger, M. F., J. L. Cronenwett, S. Besso, D. B. Walsh
and R. M. Zwolak (1994). ”Vein adaptation to the
hemodynamic environment of infrainguinal
grafts.” J Vasc Surg 19(6): 970-8; discussion 978-9.
Fisher, C. M., A. Burnett, V. Makeham, J. Kidd, M.
Glasson and J. P. Harris (1996). ”Variation in
measurement of ankle-brachial pressure index in
routine clinical practice.” J Vasc Surg 24(5): 871-5.
Fligelstone, L. J., P. G. Cachia, H. Ralis, P. Whattling,
R. H. Morgan, A. A. Shandall and I. F. Lane (1995).
”Lupus anticoagulant in patients with peripheral
vascular disease: a prospective study.” Eur J Vasc
Endovasc Surg 9(3): 277-83.
Fortunato, J. E., H. J. Mauceri, H. Kocharyan, R. H.
Song, R. Salloum, J. Vosicky, K. Swedberg, S.
Malik, F. Abusharif, S. Glagov, R. R. Weichselbaum
and H. S. Bassiouny (2000). ”Gene therapy
enhances the antiproliferative effect of radiation in
intimal hyperplasia.” J Surg Res 89(2): 155-62.
Fowkes, F. G., E. Housley, C. C. Macintyre, R. J.
Prescott and C. V. Ruckley (1988). ”Variability of
ankle and brachial systolic pressures in the
measurement of atherosclerotic peripheral arterial
disease.” J Epidemiol Community Health 42(2):
128-33.
Franco, R. F., M. D. Trip, H. ten Cate, A. van den Ende,
M. H. Prins, J. J. Kastelein and P. H. Reitsma
(1999). ”The 20210 G—>A mutation in the 3'-
untranslated region of the prothrombin gene and
the risk for arterial thrombotic disease.” Br J
Haematol 104(1): 50-4.
Giannoukas, A. D., A. E. Androulakis, N. Labropoulos
and J. H. Wolfe (1996). ”The role of surveillance
after infrainguinal bypass grafting.” Eur J Vasc
Endovasc Surg 11(3): 279-89.
Gibbs, R. G. J., D. K. Beattie, R. M. Greenhalgh and A.
H. Davies (1997). ”Vein graft surveillance: current
tends.” Br J Surg 84: 63.
Gimbrone, M. A., Jr., K. R. Anderson, J. N. Topper, B. L.
Langille, A. W. Clowes, S. Bercel, M. G. Davies, K.
R. Stenmark, M. G. Frid, M. C. Weiser-Evans, A. A.
Aldashev, R. A. Nemenoff, M. W. Majesky, T. E.
Landerholm, J. Lu, W. D. Ito, M. Arras, D. Scholz, B.
Imhof, M. Aurrand-Lions, W. Schaper, T. E. Nagel,
N. Resnick, C. F. Dewey, M. A. Gimbrone and P. F.
Davies (1999). ”Special communicationthe critical
role of mechanical forces in blood vessel
development, physiology and pathology [In Process
Citation].” J Vasc Surg 29(6): 1104-51.
Golledge, J. (1997). ”Lower-limb arterial disease [see
comments].” Lancet 350(9089): 1459-65.
Golledge, J., D. K. Beattie, R. M. Greenhalgh and A. H.
Davies (1996). ”Have the results of infrainguinal
bypass improved with the widespread utilisation of
postoperative surveillance?” Eur J Vasc Endovasc
Surg 11(4): 388-92.
REFERENCES
75
Golledge, J., I. Wright and I. F. Lane (1996).
”Comparison of clinical follow-up and duplex
surveillance of infrainguinal vein bypasses.”
Cardiovasc Surg 4(6): 766-70.
Green, R. M., J. McNamara, K. Ouriel and J. A.
DeWeese (1990). ”Comparison of infrainguinal
graft surveillance techniques.” J Vasc Surg 11(2):
207-14.
Grigg, M. J., A. N. Nicolaides and J. H. Wolfe (1988).
”Detection and grading of femorodistal vein
graft stenoses: duplex velocity measurements
compared with angiography.” J Vasc Surg 8(6):
661-6.
Grigg, M. J., J. H. Wolfe, A. Tovar and A. N. Nicolaides
(1988). ”The reliability of duplex derived
haemodynamic measurements in the assessment of
femoro-distal grafts.” Eur J Vasc Surg 2(3): 177-81.
Gupta, A. K., D. F. Bandyk, D. Cheanvechai and B. L.
Johnson (1997). ”Natural history of infrainguinal
vein graft stenosis relative to bypass grafting
technique.” J Vasc Surg 25(2): 211-20; discussion
220-5.
Gupta, S. K., F. J. Veith, H. B. Kram and K. A.
Wengerter (1990). ”Significance and management
of inflow gradients unexpectedly generated after
femorofemoral, femoropopliteal, and
femoroinfrapopliteal bypass grafting.” J Vasc Surg
12(3): 278-83.
Hall, K. V. (1964). ”The arterial homograft used as
“bypass” in patients with femoro-popliteal
arteriosclerotic obstruction.” Acta Chir Scand 127:
353-366.
Hamsho, A., D. Nott and P. D. Harris (1999).
”Prospective Randomised Trial of Distal
Arteriovenous Fistula as an Adjunct to Femoro-
infrapopliteal PTFE Bypass.” Eur J Vasc Endovasc
Surg 17: 197-201.
Harris, P. L. (1992). ”Vein graft surveillance—all part
of the service [editorial].” Br J Surg 79(2): 97-8.
Harward, T. R., D. Coe, T. C. Flynn and J. M. Seeger
(1992). ”The use of arm vein conduits during
infrageniculate arterial bypass.” J Vasc Surg 16(3):
420-6.
Hickey, N. C., I. A. Thomson, C. P. Shearman and M.
H. Simms (1991). ”Aggressive arterial
reconstruction for critical lower limb ischaemia
[see comments].” Br J Surg 78(12): 1476-8.
Ho, G. H., F. L. Moll, M. M. Kuipers, E. D. Van de
Pavoordt and A. Algra (1995). ”Long-term
surveillance by duplex scanning of nonrevised
infragenicular graft stenosis.” Ann Vasc Surg 9(6):
547-53.
Hobson, R. W. d., O. D. JA, Z. Jamil and K. Mehta
(1980). ”Below-knee bypass for limb salvage.
Comparison of autogenous saphenous vein,
polytetrafluoroethylene, and composite
dacron-autogenous vein grafts.” Arch Surg 115(7):
833-7.
Hoksbergen, A. W., D. A. Legemate, J. A. Reekers, D. T.
Ubbink and M. J. Jacobs (1999). ”Percutaneous
transluminal angioplasty of peripheral bypass
stenoses.” Cardiovasc Intervent Radiol 22(4): 282-
6.
Hye, R. J., C. Turner, K. Valji, Y. G. Wolf, A. C. Roberts,
J. J. Bookstein and E. J. Plecha (1994). ”Is
thrombolysis of occluded popliteal and tibial
bypass grafts worthwhile?” J Vasc Surg 20(4): 588-
96; discussion 596-7.
Idu, M. M., J. D. Blankenstein, P. de Gier, E. Truyen
and J. Buth (1993). ”Impact of a color-flow
duplex surveillance program on infrainguinal vein
graft patency: a five-year experience.” J Vasc Surg
17(1): 42-52; discussion 52-3.
Idu, M. M., J. Buth, P. Cuypers, W. C. Hop, E. D. van
de Pavoordt and J. M. Tordoir (1998).
”Economising vein-graft surveillance programs.”
Eur J Vasc Endovasc Surg 15(5): 432-8.
Idu, M. M., J. Buth, W. C. Hop, P. Cuypers, E. D. van
de Pavoordt and J. M. Tordoir (1998). ”Vein graft
surveillance: is graft revision without
angiography justified and what criteria should
be used?” J Vasc Surg 27(3): 399-411; discussion
412-3.
Idu, M. M., J. Buth, W. C. Hop, P. Cuypers, E. D. van
de Pavoordt and J. M. Tordoir (1999). ”Factors
influencing the development of vein-graft stenosis
and their significance for clinical management.”
Eur J Vasc Endovasc Surg 17(1): 15-21.
Ihnat, D. M., J. L. Mills, D. L. Dawson, J. D. Hughes, R.
T. Hagino, C. A. DeMaioribus, A. T. Gentile and A.
Westerband (1999). ”The correlation of early flow
disturbances with the development of
infrainguinal graft stenosis: a 10-year study of 341
autogenous vein grafts.” J Vasc Surg 30(1): 8-15.
Illig, K. A., A. B. Soni, J. Williams, C. K. Shortell, P.
Okunieff, M. Schell, P. Rubin and R. M. Green
(2000). ”Irradiation for intimal hyperplasia:
implications for peripheral arterial bypass.” J Am
Coll Surg 190(3): 364-70.
Inoue, Y., T. Iwai, T. Kubota, N. Kure, Y. Muraoka and
M. Endo (1997). ”One-point measurement of the
peak-to-peak pulsatility index as an indicator for
evaluation of infrainguinal bypass procedures.” Jpn
J Surg 27: 305-309.
REFERENCES
76
Irvine, C., Y. G. Wilson, I. C. Currie, C. McGrath, J.
Scott, A. Day, D. Stansbie, R. N. Baird and P. M.
Lamont (1996). ”Hyperhomocysteinaemia is a risk
factor for vein graft stenosis.” Eur J Vasc Endovasc
Surgery 12(3): 304-9.
Jacobs, M. J. H. M., I. D. Gregoric and G. J. Reul
(1992). ”Prosthetic graft placement and creation
of a distal arteriovenous fistula for secondary
vascular reconstruction in patients with severe
limb ischemia.” J Vasc Surg 15(4): 612-618.
Jager, K. A., D. J. Phillips, R. L. Martin, C. Hanson, G.
O. Roederer, Y. E. Langlois, H. J. Ricketts and D. E.
Strandness, Jr. (1985). ”Noninvasive mapping of
lower limb arterial lesions.” Ultrasound Med Biol
11(3): 515-21.
Jensen, L. P., O. M. Nielsen and T. V. Schroeder (1996).
”The importance of complete follow-up for
results after femoro- infrapopliteal vascular
surgery.” Eur J Vasc Endovasc Surg 12(3): 282-6.
Jensen, L. P. and T. V. Schroeder (1999).
Methodological problems related to follow-up
and patency assessment. The Durability of Vascular
and Endovascular Surgery. R. M. Greenhalgh.
London, W.B. Saunders: 289-296.
Johnson, B. L., D. F. Bandyk, M. R. Back, A. J. Avino
and S. M. Roth (2000). ”Intraoperative duplex
monitoring of infrainguinal vein bypass
procedures.” J Vasc Surg 31(4): 678-90.
Junger, M., B. L. Chapman, C. J. Underwood and D.
Charlesworth (1984). ”A comparison between
two types of waveform analysis in patients with
multisegmental arterial disease.” Br J Surg 71(5):
345-8.
Kaiser, V., A. D. Kester, H. E. Stoffers, P. J. Kitslaar and J.
A. Knottnerus (1999). ”The influence of
experience on the reproducibility of the ankle-
brachial systolic pressure ratio in peripheral
arterial occlusive disease.” Eur J Vasc Endovasc
Surg 18(1): 25-9.
Khamashta, M. A., M. J. Cuadrado, F. Mujic, N. A.
Taub, B. J. Hunt and G. R. Hughes (1995). ”The
management of thrombosis in the
antiphospholipid-antibody syndrome [see
comments].” N Engl J Med 332(15): 993-7.
Kirby, P. L., A. R. Brady, S. G. Thompson, D. Torgerson
and A. H. Davies (1999). ”The Vein Graft
Surveillance Trial: rationale, design and methods.
VGST participants.” Eur J Vasc Endovasc Surg
18(6): 469-74.
Kohler, T. R., T. R. Kirkman, L. W. Kraiss, B. K. Zierler
and A. W. Clowes (1991). ”Increased blood flow
inhibits neointimal hyperplasia in endothelialized
vascular grafts.” Circ Res 69(6): 1557-65.
Komori, K., T. Ishii, K. Mawatari, T. Odashiro, H. Itoh,
K. Okadome and K. Sugimachi (1995).
”Endothelium-dependent relaxation in response
to adenosine diphosphate is impaired under poor
runoff conditions in the canine femoral artery.” J
Surg Res 58(3): 302-6.
Laborde, A. L., A. Y. Synn, M. J. Worsey, T. R. Bower, J.
J. Hoballah, W. J. Sharp, T. F. Kresowik and J. D.
Corson (1992). ”A prospective comparison of
ankle/brachial indices and color duplex
imaging in surveillance of the in situ saphenous
vein bypass.” J Cardiovasc Surg (Torino) 33(4):
420-5.
Landry, G. J., G. L. Moneta, L. M. Taylor, Jr., R. B.
McLafferty, J. M. Edwards, R. A. Yeager and J. M.
Porter (1999). ”Duplex scanning alone is not
sufficient imaging before secondary procedures
after lower extremity reversed vein bypass graft.” J
Vasc Surg 29(2): 270-80; discussion 280-1.
Landwehr, P., R. Schindler, U. Heinrich, W. Dolken, T.
Krahe and K. Lackner (1991). ”Quantification of
vascular stenosis with color Doppler flow
imaging: in vitro investigations.” Radiology
178(3): 701-4.
Langille, B. L. (1996). ”Arterial remodeling: relation to
hemodynamics.” Can J Physiol Pharmacol 74(7):
834-41.
Laster, J., D. Cikrit, N. Walker and D. Silver (1987).
”The heparin-induced thrombocytopenia
syndrome: an update.” Surgery 102(4): 763-70.
Laurikka, J., T. Sisto, O. Auvinen, M. Tarkka, E. Laara
and M. Hakama (1993). ”Varicose veins in a
Finnish population aged 40-60 [see comments].” J
Epidemiol Community Health 47(5): 355-7.
Leather, R. P., D. M. Shah, B. B. Chang and J. L.
Kaufman (1988). ”Resurrection of the in situ
saphenous vein bypass. 1000 cases later.” Ann Surg
208(4): 435-42.
Leopold, P. W., B. B. Chang, A. M. Kupinski, A. A.
Shandall, J. Cezeaux, J. L. Kaufman, D. M. Shah
and R. P. Leather (1989). ”Flow/velocity
characteristics of arterial bypass stenoses.” J Surg
Res 46(1): 23-8.
Lepäntalo, M. and S. Mätzke (1996). ”Outcome of
unreconstructed chronic critical leg ischaemia.”
Eur J Vasc Endovasc Surg 11(2): 153-7.
Lepäntalo, M., S. Mätzke and M. Luther (1996). Is it
necessary to assess pressure after infrainguinal
bypass? Trials and tribulations of vascular surgery.
Greenhalgh RM and Fowkes FGR. London,
Saunders: 277-288.
REFERENCES
77
Lewis, D. R., C. McGrath, C. D. Irvine, A. Jones, P.
Murphy, F. C. Smith, R. N. Baird and P. M. Lamont
(1998). ”The progression and correction of duplex
detected velocity shifts in angiographically normal
vein grafts [see comments].” Eur J Vasc Endovasc
Surg 15(5): 394-7.
Liermann, D. D., R. Bauernsachs, B. Schopohl and H.
D. Bottcher (1997). ”Five year follow-up after
brachytherapy for restenosis in peripheral arteries.”
Semin Interv Cardiol 2(2): 133-7.
London, N. J., R. D. Sayers, M. M. Thompson, A. R.
Naylor, T. Hartshorne, D. A. Ratliff, P. R. Bell and
A. Bolia (1993). ”Interventional radiology in the
maintenance of infrainguinal vein graft patency.”
Br J Surg 80(2): 187-93.
Londrey, G. L., L. P. Bosher, P. W. Brown, F. D.
Stoneburner, Jr., J. W. Pancoast and R. K. Davis
(1994). ”Infrainguinal reconstruction with arm
vein, lesser saphenous vein, and remnants of
greater saphenous vein: a report of 257 cases.” J
Vasc Surg 20(3): 451-6; discussion 456-7.
Londrey, G. L., D. E. Ramsey, K. J. Hodgson, L. D.
Barkmeier and D. S. Sumner (1991).
”Infrapopliteal bypass for severe ischemia:
comparison of autogenous vein, composite, and
prosthetic grafts.” J Vasc Surg 13(5): 631-636.
Lundell, A. and D. Bergqvist (1993). ”Prediction of
early graft occlusion in femoropopliteal and
femorodistal reconstruction by measurement of
volume flow with a transit time flowmeter and
calculation of peripheral resistance.” Eur J Vasc
Surg 7(6): 704-8.
Lundell, A., D. Bergqvist and C. Cederholm (1993).
”Patency of the plantar arch as a prognostic
indicator in patients with critical leg ischaemia; a
retrospective study.” Eur J Surg 159(11-12): 625-9.
Lundell, A., D. Bergqvist, E. Mattsson and B. Nilsson
(1993). ”Volume blood flow measurements with a
transit time flowmeter: an in vivo and in vitro
variability and validation study.” Clinical
Physiology 13(5): 547-57.
Lundell, A., B. Lindblad, D. Bergqvist and F. Hansen
(1995). ”Femoropopliteal-crural graft patency is
improved by an intensive surveillance program: a
prospective randomized study.” J Vasc Surg 21(1):
26-33.
Lundell, A. and K. Nyborg (1999). ”Do residual
arteriovenous fistulae after in situ saphenous vein
bypass grafting influence patency?” J Vasc Surg
30(1): 99-10.
Luscher, T. F. and M. Barton (1997). ”Biology of the
endothelium.” Clin Cardiol 20(11 Suppl 2): II-3-10.
Luther, M. (1997). ”Treatment of chronical critical leg
ischaemia - a cost benefit analysis.” Ann Chir
Gynaecol (suppl.) 213.
Luther, M. and M. Lepäntalo (1997). ”Arterial
reconstruction to the foot arteries—a viable
option?” Eur J Surg 163(9): 659-65.
Lytle, B. W., F. D. Loop, D. M. Cosgrove, N. B.
Ratliff, K. Easley and P. C. Taylor (1985). ”Long-
term (5 to 12 years) serial studies of internal
mammary artery and saphenous vein coronary
bypass grafts.” J Thorac Cardiovasc Surg 89(2):
248-58.
Macpherson, D. S., D. H. Evans and P. R. Bell (1984).
”Common femoral artery Doppler wave-forms: a
comparison of three methods of objective analysis
with direct pressure measurements.” Br J Surg
71(1): 46-9.
Marcaccio, E. J., A. Miller, G. A. Tannenbaum, P. T.
Lavin, G. W. Gibbons, F. B. Pomposelli, Jr., D. V.
Freeman, D. R. Campbell and F. W. LoGerfo
(1993). ”Angioscopically directed interventions
improve arm vein bypass grafts.” J Vasc Surg 17(6):
994-1002; discussion 1003-4.
Marin, M. L., F. J. Veith, T. F. Panetta, R. E. Gordon, K.
R. Wengerter, W. D. Suggs, L. Sanchez and M. K.
Parides (1993). ”Saphenous vein biopsy: a
predictor of vein graft failure.” J Vasc Surg 18(3):
407-14; discussion 414-5.
Mattos, M. A., P. S. van Bemmelen, K. J. Hodgson, D.
E. Ramsey, L. D. Barkmeier and D. S. Sumner
(1993). ”Does correction of stenoses identified
with color duplex scanning improve infrainguinal
graft patency.” J Vasc Surg 17: 54-66.
Mattsson, E. J., R. L. Geary, L. W. Kraiss, S. Vergel, J. K.
Liao, M. A. Corson, Y. P. Au, S. R. Hanson and A.
W. Clowes (1998). ”Is smooth muscle growth in
primate arteries regulated by endothelial nitric
oxide synthase?” J Vasc Surg 28(3): 514-21.
Mattsson, E. J., T. R. Kohler, S. M. Vergel and A. W.
Clowes (1997). ”Increased blood flow induces
regression of intimal hyperplasia.” Arterioscler
Thromb Vasc Biol 17(10): 2245-9.
McCarthy, M. J., K. Varty, A. R. Naylor, N. J.
London and P. R. Bell (1998). ”Bilateral
infrainguinal vein grafts and the incidence of vein
graft stenosis.” Eur J Vasc Endovasc Surg 15(3):
231-4.
McCollum, C., C. Alexander, G. Kenchington, P. J.
Franks and R. Greenhalgh (1991). ”Antiplatelet
drugs in femoropopliteal vein bypasses: a
multicenter trial.” J Vasc Surg 13(1): 150-61;
discussion 161-2.
REFERENCES
78
McLafferty, R. B., G. L. Moneta, P. A. Masser, L. M.
Taylor, Jr. and J. M. Porter (1995). ”Progression of
atherosclerosis in arteries distal to lower extremity
revascularizations.” J Vasc Surg 22(4): 450-5;
discussion 455-6.
Miller, A., S. J. Jepsen, P. A. Stonebridge, A. Tsoukas, G.
W. Gibbons, F. B. Pomposelli, Jr., D. V. Freeman, D.
R. Campbell, F. J. Schoen and F. W. LoGerfo
(1990). ”New angioscopic findings in graft failure
after infrainguinal bypass.” Arch Surg 125(6): 749-
54; discussion 755.
Miller, A., E. J. Marcaccio, G. A. Tannenbaum, C. J.
Kwolek, P. A. Stonebridge, P. T. Lavin, G. W.
Gibbons, F. B. Pomposelli, Jr., D. V. Freeman, D. R.
Campbell and et al. (1993). ”Comparison of
angioscopy and angiography for monitoring
infrainguinal bypass vein grafts: results of a
prospective randomized trial.” J Vasc Surg 17(2):
382-96; discussion 396-8.
Miller, J., J. A. Walsh, R. K. Foreman, P. A. Dupont, R.
Luethke, M. J. James and J. Iannos (1990).
”Vascular outflow resistance and angiographic
assessment of lower limb arterial reconstructive
procedures.” Austr N Z J Surgery 60(4): 275-81.
Mills, J. L. (1993). ”Mechanisms of vein graft failure:
the location, distribution, and.” Semin Vasc Surg
6(2): 78-91.
Mills, J. L., R. M. Fujitani and S. M. Taylor (1993).
”The characteristics and anatomic distribution of
lesions that cause reversedvein graft failure: A five-
year prospective study.” J Vasc Surg 17(1): 195-204;
discussion 204-6.
Mills, J. L., E. J. Harris, L. M. Taylor, Jr., W. C. Beckett
and J. M. Porter (1990). ”The importance of
routine surveillance of distal bypass grafts with
duplex scanning: a study of 379 reversed vein
grafts [see comments].” J Vasc Surg 12(4): 379-86.
Mohan, C. R., J. J. Hoballah, M. T. Schueppert, W. J.
Sharp, T. F. Kresowik, E. V. Miller and J. D. Corson
(1995). ”Should all in situ saphenous vein bypasses
undergo permanent duplex surveillance?” Arch
Surg 130(5): 483-7; discussion 487-8.
Moody, A. P., P. R. Edwards and P. L. Harris (1992).
”The aetiology of vein graft strictures: a prospective
marker study.” Eur J Vasc Surg 6(5): 509-11.
Moody, P., L. M. de Cossart, H. M. Douglas and P. L.
Harris (1989). ”Asymptomatic strictures in
femoro-popliteal vein grafts.” Eur J Vasc Surg 3(5):
389-92.
Moody, P., D. A. Gould and P. L. Harris (1990). ”Vein
graft surveillance improves patency in femoro-
popliteal bypass.” Eur J Vasc Surg 4(2): 117-21.
Morinaga, K., H. Eguchi, T. Miyazaki, K. Okadome
and K. Sugimachi (1987). ”Development and
regression of intimal thickening of arterially
transplanted autologous vein grafts in dogs.” J Vasc
Surg 5(5): 719-30.
Nehler, M. R., G. L. Moneta, R. A. Yeager, J. M.
Edwards, L. M. Taylor, Jr. and J. M. Porter (1994).
”Surgical treatment of threatened reversed
infrainguinal vein grafts.” J Vasc Surg 20(4): 558-
63.
Nicholls, S. C., T. R. Kohler, R. L. Martin, R. Neff, D.
J. Phillips and D. E. Strandness, Jr. (1986).
”Diastolic flow as a predictor of arterial stenosis.” J
Vasc Surg 3(3): 498-501.
Nielsen, T. G. (1996). ”Natural history of infrainguinal
vein bypass stenoses: early lesions increase the risk
of thrombosis.” Eur J Vasc Endovasc Surg 12(1):
60-4.
Nielsen, T. G., B. G. Nordestgaard, F. von Jessen, J. J.
Andreasen, A. Wiik, N. H. Heegaard and T. V.
Schroeder (1997). ”Antibodies to cardiolipin may
increase the risk of failure of peripheral vein
bypasses.” Eur J Vasc Endovasc Surg 14(3):
177-84.
Nielsen, T. G., H. Sillesen and T. V. Schroeder (1995).
”Simple hyperaemia test as a screening method in
the postoperative surveillance of infrainguinal in
situ vein bypasses.” Eur J Vasc Endovasc Surg
10(3): 298-303.
Nitecki, S., B. Brenner, A. Hoffman, N. Lanir, A.
Schramek and S. Torem (1993). ”Lower limb
ischaemia in primary antiphospholipid syndrome.”
Eur J Vasc Surg 7(4): 414-9.
O’ Mara, C. S., W. R. Flinn, N. D. Johnson, J. J. Bergan
and J. S. Yao (1981). ”Recognition and surgical
management of patent but hemodynamically
failed arterial grafts.” Ann Surg 193(4): 467-76.
O’ Mara, C. S., W. R. Flinn, H. L. Neiman, J. J. Bergan
and J. S. Yao (1981). ”Correlation of foot arterial
anatomy with early tibial bypass patency.” Surgery
89(6): 743-52.
Okadome, K., T. Onohara, S. Yamamura, S. Mii and K.
Sugimachi (1991). ”Evaluation of proposed
standards for runoff in femoropopliteal arterial
reconstructions: correlation between runoff score
and flow waveform pattern. A preliminary report.”
J Cardiovasc Surg 32(3): 353-9.
Olojugba, D. H., M. J. McCarthy, A. R. Naylor, P. R.
Bell and N. J. London (1998). ”At what peak
velocity ratio value should duplex-detected
infrainguinal vein graft stenoses be revised?”
Eur J Vasc Endovasc Surg 15(3): 258-60.
REFERENCES
79
Olojugba, D. H., M. J. McCarthy, A. Reid, K. Varty, A.
R. Naylor, P. R. Bell and N. J. London (1999).
”Infrainguinal revascularisation in the era of vein-
graft surveillance—do clinical factors influence
long-term outcome?” Eur J Vasc Endovasc Surg
17(2): 121-8.
Olojugba, D. H., K. Varty, T. Hartsthorne, A. R. Naylor,
P. R. Bell and N. J. London (1998). ”Predischarge
duplex imaging of infrainguinal vein grafts does
not predict the development of stenoses.” Br J
Surg 85(9): 1225-7.
Ouriel, K., R. M. Green, J. A. DeWeese and C.
Cimino (1996). ”Activated protein C resistance:
prevalence and implications in peripheral vascular
disease.” J Vasc Surg 23(1): 46-51, Discussion 51-2.
Panetta, T. F., M. L. Marin, F. J. Veith, J. Goldsmith, R.
E. Gordon, A. M. Jones, M. L. Schwartz, S. K.
Gupta and K. R. Wengerter (1992). ”Unsuspected
preexisting saphenous vein disease: an
unrecognized cause of vein bypass failure.” J Vasc
Surg 15(1): 102-111.
Papanicolaou, G., K. W. Beach, R. E. Zierler, P. R.
Detmer and D. E. Strandness, Jr. (1995).
”Hemodynamics of stenotic infrainguinal vein
grafts: theoretic considerations.” Ann Vasc Surg
9(2): 163-71.
Papanicolaou, G., R. E. Zierler, K. W. Beach, J. A.
Isaacson and D. E. Strandness, Jr. (1995).
”Hemodynamic parameters of failing infrainguinal
bypass grafts.” Am J Surg 169(2): 238-44.
Passman, M. A., G. L. Moneta, M. R. Nehler, L. M.
Taylor, Jr., J. M. Edwards, R. A. Yeager, D. B.
McConnell and J. M. Porter (1995). ”Do normal
early color-flow duplex surveillance examination
results of infrainguinal vein grafts preclude the
need for late graft revision?” J Vasc Surg 22(4):
476-81.
Peltonen, S., F. Biancari, L. Lindgren, H. Mäkisalo, E.
Honkanen and M. Lepäntalo (1998).
”Outcome of infrainguinal bypass surgery for
critical leg ischaemia in patients with chronic
renal failure.” Eur J Vasc Endovasc Surg 15(2):
122-7.
Perler, B. A., F. A. Osterman, S. E. Mitchell, J. F.
Burdick and G. M. Williams (1990). ”Balloon
dilatation versus surgical revision of infra-
inguinal autogenous vein graft stenoses: long-term
follow-up.” J Cardiovasc Surg (Torino) 31(5): 656-
61.
Pohjolainen, T. (1991). The Finnish lower limb
amputee: Academic dissertation. Helsinki, From
the rahabilitation unit of the invalid foundations.
Porter, D. H., M. P. Rosen, J. J. Skillman, R. G.
Sheiman, K. C. Kent and D. Kim (1996). ”Mid-
term and long-term results with directional
atherectomy of vein graft stenoses.” J Vasc Surg
23(4): 554-67.
Porter, K. E., M. M. Thompson, I. M. Loftus, E.
McDermott, L. Jones, M. Crowther, P. R. Bell and
N. J. London (1999). ”Production and inhibition
of the gelatinolytic matrix metalloproteinases in a
human model of vein graft stenosis.” Eur J Vasc
Endovasc Surg 17(5): 404-12.
Qvarfordt, P., E. Ribbe and J. Thorne (1988). ”Distal
bypass with the saphenous vein in situ. Technical
aspects and early results.” Int Angiol 7(1): 2-6.
Rapp JH, Qvarfordt P, Krupski WC, Ehrenfeld WK
and S. R (1987). ”Hypercholesterolemia and early
restenosis after carotid endarterectomy.” Surgery
101(3): 277-82.
Ray, S. A., T. M. Buckenham, A. M. Belli, R. S. Taylor
and J. A. Dormandy (1997). ”The nature and
importance of changes in toe-brachial pressure
indices following percutaneous transluminal
angioplasty for leg ischaemia.” Eur J Vasc Endovasc
Surg 14(2): 125-33.
Ray, S. A., M. R. Rowley, D. H. Bevan, R. S. Taylor
and J. A. Dormandy (1997). ”Hypercoagulable
abnormalities and postoperative failure of arterial
reconstruction [see comments].” Eur J Vasc
Endovasc Surg 13(4): 363-70.
Ray, S. A., P. D. Srodon, R. S. Taylor and J. A.
Dormandy (1994). ”Reliability of ankle:brachial
pressure index measurement by junior doctors.”
Br J Surg 81(2): 188-90.
Ridker, P. M., C. H. Hennekens and J. P. Miletich
(1999). ”G20210A mutation in prothrombin gene
and risk of myocardial infarction, stroke, and
venous thrombosis in a large cohort of US men
[see comments].” Circulation 99(8): 999-1004.
Robinson, K. D., D. T. Sato, R. T. Gregory, R. G. Gayle,
R. J. DeMasi, F. N. Parent, 3rd and J. R. Wheeler
(1997). ”Long-term outcome after early
infrainguinal graft failure.” J Vasc Surg 26(3): 425-
37; discussion 437-8.
Robison, J. G. and B. M. Elliott (1991). ”Does
postoperative surveillance with duplex scanning
identify the failing distal bypass?” Ann Vasc Surg
5(2): 182-5.
Rutherford, R. B., J. D. Baker, C. Ernst, K. W.
Johnston, J. M. Porter, S. Ahn and D. N. Jones
(1997). ”Recommended standards for reports
dealing with lower extremity ischaemia: Revised
version.” J Vasc Surg 26(3): 517-538.
REFERENCES
80
Rutherford, R. B., D. P. Flanigan, S. K. Gupta, K. W.
Johnston, A. Karmody, A. D. Whittemore, J. D.
Baker, C. B. Ernst, C. Jamieson and S. Mehta
(1986). ”Suggested standards for reports dealing
with lower extremity ischaemia. Prepared by the
Ad Hoc Commitee on Reporting Standards,
Society for Vascular Surgery/North American
Chapter, International Society for Cardiovascular
Surgery.” J Vasc Surg 4: 80-94.
Salenius, J. P., M. Lepantalo, K. Ylonen and M. Luther
(1993). ”Treatment of peripheral vascular
diseases—basic data from the nationwide vascular
registry FINNVASC.” Ann Chir Gynaecol 82(4):
235-40.
Sanchez, L. A., S. K. Gupta, F. J. Veith, J. Goldsmith, R.
T. Lyon, K. R. Wengerter, T. F. Panetta, M. L.
Marin, J. Cynamon, G. Berdejo and et al. (1991).
”A ten-year experience with one hundred fifty
failing or threatened vein and
polytetrafluoroethylene arterial bypass grafts.” J
Vasc Surg 14(6): 729-36.
Sanchez, L. A., W. D. Suggs, M. L. Marin, T. F. Panetta,
K. R. Wengerter and F. J. Veith (1994). ”Is
percutaneous balloon angioplasty appropriate in
the treatment of graft and anastomotic lesions
responsible for failing vein bypasses?” Am J Surg
168(2): 97-101.
Sayers, R. D., S. Raptis, M. Berce and J. H. Miller
(1998). ”Long-term results of femorotibial bypass
with vein or polytetrafluoroethylene.” Br J Surg
85(7): 934-8.
Sayers, R. D., M. M. Thompson, N. J. London, K. Varty,
A. R. Naylor, J. S. Budd, D. A. Ratliff and P. R. Bell
(1993). ”Selection of patients with critical limb
ischaemia for femorodistal vein bypass.” Eur J Vasc
Surg 7(3): 291-7.
Schmitt, D. D., G. R. Seabrook, D. F. Bandyk, R. F.
Cato, J. W. Edwards, D. L. Karp, J. L. Block and J. B.
Towne (1990). ”Early patency of in situ saphenous
vein bypasses as determined by intraoperative
velocity waveform analysis.” Ann Vasc Surg 4(3):
270-5.
Seeger, J. M., H. A. Pretus, L. C. Carlton, T. C. Flynn,
C. K. Ozaki and T. S. Huber (1999). ”Potential
predictors of outcome in patients with tissue loss
who undergo infrainguinal vein bypass grafting.” J
Vasc Surg 30(3): 427-35.
Shah, D. M., R. C. Darling, 3rd, B. B. Chang, K. M.
Fitzgerald, P. S. Paty and R. P. Leather (1995).
”Long-term results of in situ saphenous vein
bypass. Analysis of 2058 cases.” Ann Surg 222(4):
438-46; discussion 446-8.
Sisto, T., S. Yla-Herttuala, J. Luoma, H. Riekkinen and
T. Nikkari (1990). ”Biochemical composition of
human internal mammary artery and saphenous
vein.” J Vasc Surg 11(3): 418-22.
Sladen, J. G. and J. L. Gilmour (1981). ”Vein graft
stenosis. Characteristics and effect of treatment.”
Am J Surg 141(5): 549-53.
Sladen, J. G., J. D. Reid, P. L. Cooperberg, P. B.
Harrison, T. M. Maxwell, M. O. Riggs and L. D.
Sanders (1989). ”Color flow duplex screening of
infrainguinal grafts combining low- and high-
velocity criteria.” Am J Surg 158(2): 107-12.
Sterpetti, A. V., A. Cucina, S. Lepidi, B. Randone, F.
Stipa, C. Aromatario, D. Travi, L. S. D’Angelo, A.
Cavallaro and S. Stipa (1996). ”Progression and
regression of myointimal hyperplasia in
experimental vein grafts depends on platelet-
derived growth factor and basic fibroblastic
growth factor production.” J Vasc Surg 23(4): 568-
75.
Stierli, P. and P. Aeberhard (1993). ”Behaviour of
surgically corrected infrainguinal vein grafts.” J
Cardiovasc Surg (Torino) 34(5): 361-7.
Stierli, P., P. Aeberhard and M. Livers (1992). ”The
role of colour flow duplex screening in infra-
inguinal vein grafts [see comments].” Eur J Vasc
Surg 6(3): 293-8.
Stonebridge, P. A., A. Miller, A. Tsoukas, C. M. Brophy,
G. W. Gibbons, D. V. Freeman, F. B. Pomposelli, Jr.,
D. R. Campbell and F. W. LoGerfo (1991).
”Angioscopy of arm vein infrainguinal bypass
grafts.” Ann Vasc Surg 5(2): 170-5.
Sullivan, T. R., Jr., H. J. Welch, M. D. Iafrati, W. C.
Mackey and T. F. O’Donnell, Jr. (1996). ”Clinical
results of common strategies used to revise
infrainguinal vein grafts.” J Vasc Surg 24(6): 909-
17; discussion 917-9.
Sumner, D. S. (1985). Evaluation of noninvasive
testing procedures: data analysis and interpretation.
Noninvasive Diagnostic Techniques in Vascular
Disease. E. F. Bernstein. St. Louis, Mosby.
Sumner, D. S. and M. A. Mattos (1995). Influence of
surveillance programs on femoro-distal bypass
graft patency. The Ischemic Extremity. Advances
in treatment. J. S. T. Yao and W. H. Pearce. Norwalk
Connecticut, Appleton and Lange.
Sumner, D. S., D. J. Porter, D. J. Moore and R. E.
Winders (1985). ”Digital subtraction angiography:
intravenous and intra-arterial techniques.” J Vasc
Surg 2(2): 344-53.
Szilagyi, D. E., J. P. Elliott, J. H. Hageman, R. F. Smith
and C. A. Dall’olmo (1973). ”Biologic fate of
REFERENCES
81
autogenous vein implants as arterial substitutes:
clinical, angiographic and histopathologic
observations in femoro-popliteal operations for
atherosclerosis.” Ann Surg 178(3): 232-46.
Takolander, R., W. Fischer-Colbrie, T. Jogestrand, H.
Ohlsen, P. Olofsson and J. Swedenborg (1995).
”The “Ad hoc” estimation of outflow does not
predict patency of infrainguinal reconstructions.”
Eur J Vasc Endovasc Surg 10: 187-191.
Tangelder, M. J., A. Algra, J. A. Lawson and B. C.
Eikelboom (2000). ”Risk factors for occlusion of
infrainguinal bypass grafts [In Process Citation].”
Eur J Vasc Endovasc Surg 20(2): 118-24.
Tangelder, M. J., J. A. Lawson, A. Algra and B. C.
Eikelboom (1999). ”Systematic review of
randomized controlled trials of aspirin and oral
anticoagulants in the prevention of graft occlusion
and ischemic events after infrainguinal bypass
surgery.” J Vasc Surg 30(4): 701-9.
TASC (2000). ”Trans-Atlantic Inter-Society
Consensus (TASC): Management of peripheral
arterial disease (PAD).” Eur J Vasc Endovasc Surg
19(Supplement A).
Taylor, L. M., Jr., J. M. Edwards and J. M. Porter
(1990). ”Present status of reversed vein bypass
grafting: five-year results of a modern series.” J
Vasc Surg 11(2): 193-205.
Taylor, P. R., M. R. Tyrrell, M. Crofton, B. Bassan, M.
Grigg, J. H. Wolfe, A. O. Mansfield and A. N.
Nicolaides (1992). ”Colour flow imaging in the
detection of femoro-distal graft and native artery
stenosis: improved criteria.” Eur J Vasc Surg 6(3):
232-6.
Taylor, P. R., J. H. Wolfe, M. R. Tyrrell, A. O. Mansfield,
A. N. Nicolaides and R. E. Houston (1990).
”Graft stenosis: justification for 1-year
surveillance.” Br J Surg 77(10): 1125-8.
Taylor, S. M., J. L. Mills, R. M. Fujitani, J. C.
McAlhany and D. F. Bandyk (1994). ”Does arterial
inflow failure cause distal vein graft thrombosis? A
prospective analysis of 450 infrainguinal vascular
reconstructions.” Ann Vasc Surg 8(1): 92-8.
Tisi, P. V., A. J. Crow and C. P. Shearman (1996). ”Arm
vein reconstruction for limb salvage: long-term
outcome.” Ann R Coll Surg Engl 78(6): 497-500.
Tonnesen, K. H., P. Holstein, L. Rordam, J. Bulow, U.
Helgstrand and M. Dreyer (1998). ”Early results of
percutaneous transluminal angioplasty (PTA) of
failing below-knee bypass grafts.” Eur J Vasc
Endovasc Surg 15(1): 51-6.
Tordoir, J. H., J. P. van der Plas, M. J. Jacobs and P. J.
Kitslaar (1993). ”Factors determining the
outcome of crural and pedal revascularisation for
critical limb ischaemia.” Eur J Vasc Surg 7(1): 82-
6.
Towne, J. B., D. D. Schmitt, G. R. Seabrook and D. F.
Bandyk (1991). ”The effect of vein diameter on
patency of in situ grafts.” J Cardiovasc Surg 32(2):
192-6.
Treiman, G. S., P. F. Lawrence, K. Bhirangi and C. E.
Gazak (1999). ”Effect of outflow level and
maximum graft diameter on the velocity
parameters of reversed vein bypass grafts.” J Vasc
Surg 30(1): 16-25.
Treiman, G. S., P. F. Lawrence, S. W. Galt and L. W.
Kraiss (1997). ”Revision of reversed infrainguinal
bypass grafts without preoperative arteriography.” J
Vasc Surg 26(6): 1020-8.
Turnipseed, W. D. and C. W. Acher (1985).
”Postoperative surveillance. An effective means of
detecting correctable lesions that threaten graft
patency.” Arch Surg 120(3): 324-8.
Turnipseed, W. D. and I. A. Sproat (1992). ”A
preliminary experience with use of magnetic
resonance angiography in assessment of failing
lower extremity bypass grafts.” Surgery 112(4):
664-8; discussion 668-9.
Varty, K., N. J. London, J. A. Brennan, D. A. Ratliff and
P. R. Bell (1993). ”Infragenicular in situ vein
bypass graft occlusion: a multivariate risk factor
analysis.” Eur J Vasc Surg 7(5): 567-71.
Varty, K., K. Porter, P. R. Bell and N. J. London (1996).
”Vein morphology and bypass graft stenosis.” Br J
Surg 83(10): 1375-9.
Watson, H. R., J. Buth, T. V. Schroeder, M. H. Simms
and M. Horrocks (2000). ”Incidence of stenoses
in femorodistal bypass vein grafts in a
multicentre study.” Eur J Vasc Endovasc Surg
20(1): 67-71.
Veith, F. J., R. K. Weiser, S. K. Gupta, E. Ascer, L. A.
Scher, R. H. Samson, S. A. White-Flores and S.
Sprayregen (1984). ”Diagnosis and management
of failing lower extremity arterial reconstructions
prior to graft occlusion.” J Cardiovasc Surg
(Torino) 25(5): 381-4.
Wengerter, K. R., F. J. Veith, S. K. Gupta, E. Ascer and
S. P. Rivers (1990). ”Influence of vein size
(diameter) on infrapopliteal reversed vein graft
patency.” J Vasc Surg 11(4): 525-31.
Wesly, R. L., R. N. Vaishnav, J. C. Fuchs, D. J. Patel and
J. C. Greenfield, Jr. (1975). ”Static linear and
nonlinear elastic properties of normal and
arterialized venous tissue in dog and man.” Circ
Res 37(4): 509-20.
REFERENCES
82
Westerband, A., J. L. Mills, S. Kistler, S. S. Berman, G.
C. Hunter and J. M. Marek (1997). ”Prospective
validation of threshold criteria for intervention in
infrainguinal vein grafts undergoing duplex
surveillance.” Ann Vasc Surg 11(1): 44-8.
Whitney, D. G., E. M. Kahn and J. W. Estes (1976).
”Valvular occlusion of the arterialized saphenous
vein.” Am Surg 42(12): 879-87.
Whittemore, A. D., A. W. Clowes, N. P. Couch and J. A.
Mannick (1981). ”Secondary femoropopliteal
reconstruction.” Ann Surg 193(1): 35-42.
Whittemore, A. D., M. C. Donaldson and J. A.
Mannick (1993). ”Infrainguinal reconstruction for
patients with chronic renal insufficiency.” J Vasc
Surg 17(1): 32-9.
Whittemore, A. D., M. C. Donaldson, J. F. Polak and J.
A. Mannick (1991). ”Limitations of balloon
angioplasty for vein graft stenosis.” J Vasc Surg
14(3): 340-5.
Wilson, Y. G., A. H. Davies, I. C. Currie, C. McGrath,
M. Morgan, R. N. Baird and P. M. Lamont (1995).
”The value of pre-discharge Duplex scanning in
infrainguinal graft surveillance.” Eur J Vasc
Endovasc Surg 10(2): 237-42.
REFERENCES
Wilson, Y. G., A. H. Davies, I. C. Currie, M. Morgan, C.
McGrath, R. N. Baird and P. M. Lamont (1996).
”Vein graft stenosis: incidence and intervention.”
Eur J Vasc Endovasc Surg 11(2): 164-9.
Wolfe, J. H., M. L. Thomas, C. W. Jamieson, N. L.
Browse, K. G. Burnand and D. L. Rutt (1987).
”Early diagnosis of femorodistal graft stenoses.” Br
J Surg 74(4): 268-70.
Woodburn, K. R., A. Murtagh, P. Breslin, A. W. Reid,
D. P. Leiberman, D. G. Gilmour and J. G. Pollock
(1995). ”Insonation and impedance analysis in
graft surveillance.” Br J Surg 82(9): 1222-5.
Wyatt, M. G., R. M. Muir, W. G. Tennant, D. J. Scott,
R. N. Baird and M. Horrocks (1991). ”Impedance
analysis to identify the at risk femorodistal graft.” J
Vasc Surg 13(2): 284-91.
Yao, S. T., J. T. Hobbs and W. T. Irvine (1969). ”Ankle
systolic pressure measurements in arterial disease
affecting the lower extremities.” Br J Surg 56(9):
676-9.
Zhang, Q., A. D. Houghton, J. Derodra, D. H. King, J. F.
Reidy and P. R. Taylor (1995). ”Impedance analysis
compared with Quickscan in the detection of
graft- related stenoses.” Eur J Vasc Endovasc Surg
9(2): 218-21.
83
Original publications
